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Summary 
 
Late-onset neonatal sepsis is an obstinate complication frequently accompanying 
the use of central venous catheters (CVCs) in neonatal intensive care units (NICUs).  
Coagulase-negative staphylococci (CoNS) are the major cause of catheter-related 
late-onset neonatal sepsis at the Royal Women’s Hospital (RWH) NICU, Melbourne.  
In spite of “susceptible” results obtained from conventional in vitro antimicrobial 
susceptibility tests, failures of CoNS-related neonatal sepsis responding to 
conventional antimicrobial agents have been repeatedly reported.  
 
The pathogenesis of CoNS infections is mainly due to their abilities to form 
biofilms on polymer surfaces and their multi-drug-resistant characteristic.  This 
thesis investigated the antimicrobial susceptibilities of clinical CoNS isolates in 
different stages of the biofilm formation process; planktonic culture at log phase, 
early adherent monolayer, mature biofilm and planktonic culture at stationary phase.  
Some parameters important for antimicrobial susceptibility tests, i.e. initial inocula, 
bacterial physiological status, and antimicrobial killing outcome, were adjusted for 
a parallel and comprehensive comparison.  Planktonic cells exhibited similar 
antimicrobial susceptibilities in comparison with early adherent monolayers.  A 
mature biofilm showed similar resistance to antimicrobial eradication to planktonic 
cells at stationary phase.  More importantly, mature biofilms were much more 
resistant to antimicrobial killing than either planktonic culture at log phase or early 
adherent monolayers.  This finding explains why CoNS biofilm-related infections 
often fail to respond to conventional antimicrobials.  More interesting, oxacillin at 
a concentration achievable in serum was able to enhance the further growth of 
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established biofilms of some Staphylococcus capitis isolates.  
 
In order to investigate mechanisms of high resistance of bacterial biofilms to various 
antimicrobial agents, this study quantitatively examined the percentage of 
tolerant-but-killable cells and non-killable persister cells in bacterial populations of 
different growth modes.  More tolerant-but-killable cells were found in biofilms 
than in planktonic cultures at log phase.  Persister cells were only present in 
biofilms, not planktonic cultures at log phase.  Both tolerant-but-killable cells and 
persister cells play important roles in the resistance of biofilms to antimicrobial 
agents.  In addition, both types of cells were found to have normal morphology and 
were phenotypically resistant to antimicrobial agents.  The roles of densely adherent 
growth mode and bacterial ability to build up extracellular polymer substance (EPS) 
matrix on biofilm resistance were also assessed, by comparing the antimicrobial 
susceptibilities of multilayer biofilms formed by biofilm-positive strains, and 
monolayer biofilms formed by their mutants/variants.  Results of this investigation 
showed that ability of CoNS to adhere to a polymer surface and grow into a highly 
dense mode, rather than their ability to build up biofilm matrix, contributed to their 
high resistance to antimicrobial agents. 
 
Finally, different antimicrobial agents were tested for their efficacies in eradication 
of biofilm cells as catheter lock solutions (CLS), to find powerful anti-biofilm 
strategies in the treatment of neonatal sepsis.  Ethanol was found to be superior to 
most conventional antimicrobial agents and their combinations.   Exposure to 40% 
ethanol lock solution for 1 h was found to be sufficient for biofilm eradication. 
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Chapter 1: Literature review and aims 
 
1.1 Neonatal sepsis  
 
Neonatal sepsis, namely bloodstream infections occurring within the first 90 days 
after birth, is frequently encountered in NICUs and has been recognized as the 
commonest cause of neonatal morbidity and mortality (Bizzarro et al., 2005; 
Sankar et al., 2008).  Approximate 12% of cases of neonatal sepsis result in death, 
based on data over a 15-year period in the United States of America (USA), from 
1988 to 2003 (Bizzarro et al., 2005).  According to the time of the appearance of 
clinical manifestations, neonatal sepsis can be divided into two sub-types: 
early-onset sepsis, which occurs within the first 72 h of life and late-onset sepsis, 
which appears from 72 h to 4 weeks after birth.  In the last two decades, late-onset 
sepsis has constituted the majority of neonatal sepsis in NICUs (Sankar et al., 
2008).  
 
Late-onset neonatal sepsis is generally caused by organisms acquired from the 
hospital environment either around the time of birth or while in hospital.  
Coagulase-negative staphylococci, predominantly Staphylococcus epidermidis are 
the commonest causative pathogens of neonatal sepsis (Isaacs, 2003; Stoll et al., 
2002).  In the USA, CoNS account for 73% of all bacteremia in NICUs and the 
number still continues to increase each year (Rogers et al., 2009).  Neonatal sepsis 
caused by CoNS is generally recognized as a relatively benign infection when 
compared with those of other organisms.  However, it still accounts for a certain 
number of neonatal deaths, directly or by the intercurrent necrotising enterocolitis 
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(Bizzarro et al., 2005; Isaacs, 2003).  A number of conditions have been listed as 
risk factors of late-onset sepsis, including the presence of intravascular catheters, 
mechanic ventilation, gestational age less than 30 weeks, prolonged hospitalization, 
very-low-birth-weight (VLBW) (< 1500 g), steroid exposure, total parenteral 
nutrition, and delayed feeding (Bizzarro et al., 2005; Johnson-Robbins et al., 1996; 
Maas et al., 1998).  In NICUs, newborns of VLBW and with CVCs are a 
particularly high risk population for CoNS infections (Hanna & Raad, 2005).  
 
At the RWH, Melbourne, late-onset neonatal sepsis has an incidence of 1 to 8 cases 
per 1000 live births.  If the newborn is unwell, there is a high index of suspicion 
for neonatal sepsis and empirical antimicrobial regimens are initially recommended.  
The first line treatment used in the RWH NICU is flucloxacillin and gentamicin.  
Vancomycin alone or in combination with gentamicin is used when septic shock is 
suspected.  Other antimicrobials are occasionally used in NICUs for late-onset 
sepsis.  Ciprofloxacin, which has showed a promising anti-staphylococcal effect in 
various in vitro studies, is only rarely used in neonates as studies in beagle dogs 
showed chondrotoxicity (Stahlmann et al., 2000).  Rifampicin, although alone 
often generates resistance in gram-positive cocci, has been used in conjunction with 
fusidic acid or flucloxacillin as these combinations are extremely effective against 
CoNS-related neonatal sepsis.  After the initial empirical antimicrobial usage, 
drug choice can be rationalized on the basis of culture results and clinical course.  
However, in the RWH NICU, the efficacy of the clinical treatment guided by the in 
vitro antimicrobial susceptibility tests is often not satisfactory.  Removal and 
replacement of indwelling devices is often necessary for an optimum curative 
outcome (Dr. Andrew Daley, personal communication). 
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1.2 Coagulase-negative staphylococci  
 
1.2.1 Microbiological profile of CoNS 
 
Coagulase-negative staphylococci are gram-positive spherical cocci belonging to 
the genus Staphylococcus.  Microscopically, these bacteria appear in pairs, clusters, 
or short chains in arrangement.  They are catalase-positive, non-motile, 
non-spore-forming, unencapsulated or limited capsulated.  The absence of 
secreted enzyme coagulase is the key characteristic of CoNS, differentiating them 
from coagulase-positive staphylococci, such as Staphylococcus aureus, which is 
able to clot plasma and is generally accepted as a pathogenic bacterium related to 
acute infections.  Other characteristics, such as the colony morphology, 
pigmentation, and hemolysis vary among species and even strains in CoNS.  
Phenotypic variation was frequently found among CoNS (Deighton et al., 1992a; 
Handke et al., 2004), and this might be due to the high level of sequence diversity 
of CoNS, even in a single species (Miragaia et al., 2007).  Based on their 
susceptibilities to novobiocin, CoNS can be divided into two categories, 
novobiocin-susceptible and novobiocin-resistant.  To date, there are 37 CoNS 
species (including 18 subspecies) validly published, among which 15 are 
recognized as human pathogenic species (Table 1.1) (Cervera et al., 2009) 
(http://www.bacterio.cict.fr/s/staphylococcus.html).  
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Table 1.1 CoNS species and subspecies 
Species Subspecies Nature hosts Identified by Year 
Staphylococcus arlettae  Mammals, birds Schleifer et al. 1985 
Staphylococcus auricularis  Humans, primates Kloos and Schleifer 1983 
subsp. Capitis Humans Kloos and Schleifer 1975 Staphylococcus capitis a 
 subsp. Urealyticus Humans, primates Bannerman and Kloos 1991 
Staphylococcus caprae  Humans, goats Devriese et al. 1983 
subsp. Carnosus Meat and fish products Schleifer and Fischer 1982 Staphylococcus carnosus 
 subsp. Utilis Fermented small fish and shrimp Probst et al. 1998 
Staphylococcus caseolyticus  Cattles, whales Schleifer et al. 1982 
Staphylococcus chromogenes  Cattle, horse, and goats Hajek et al. 1987 
subsp. Cohnii Humans Schleifer and Kloos 1975 Staphylococcus cohnii 
 subsp. Urealyticus Humans, primates Kloos and Wolfshohl 1991 
Staphylococcus condimenti  Soy sauce mash Probst et al. 1998 
Staphylococcus epidermidis  Humans, mammals, and birds Evans 1996 
subsp. Equorum Humans, horses, cattles, 
and goats Schleifer et al. 1985 Staphylococcus equorum 
 
subsp. Linens Cheeses Place et al. 2003 
Staphylococcus felis  Cats Igimi et al. 1989 
Staphylococcus fleurettii  Cheeses Vernozy-Rozand et al. 2000 
Staphylococcus gallinarum  Poutry, birds Devriese et al. 1983 
Staphylococcus haemolyticus  Humans, primates, 
and domestic mammals Schleifer and Kloos 1975 
subsp. Hominis Humans Kloos and Schleifer 1975 Staphylococcus hominis 
 subsp. Novobiosepticus Humans Kloos et al. 1998 
Staphylococcus kloosii  Mammals Schleifer et al. 1985 
Staphylococcus lentus  Domestic mammals, dolphins Schleifer et al. 1983 
Staphylococcus lugdunensis  Humans Freney et al. 1988 
Staphylococcus muscae  Domestic animals, flies Hajek et al. 1992 
Staphylococcus nepalensis  Goats Spergser et al. 2003 
Staphylococcus pasteuri  Humans, animals, foods Chesneau et al. 1993 
Staphylococcus pettenkoferi  Humans Trülzsch et al. 2007 
Staphylococcus piscifermentans  Fermented fish Tanasupawat et al. 1992 
Staphylococcus pulvereri  Humans, animals Zakrzewska-Czerwińska et al. 1995 
Staphylococcus saccharolyticus  Humans Kilpper-Bälz and Schleifer 1984 
subsp. Saprophyticus Humans, mammals Shaw et al. 1951 Staphylococcus saprophyticus 
 subsp. Bovis Cows Hajek et al. 1996 
Staphylococcus schleiferi subsp. Schleiferi Humans Freney et al. 1988 
subsp. Carnaticus Humans, mammals, birds Kloos et al. 1997 
subsp. Rodentium Humans, mammals Kloos et al. 1997 
Staphylococcus sciuri 
 
 subsp. Sciuri Humans, mammals Kloos et al. 1976 
Staphylococcus simiae  Monkeys Pantucek et al. 2005 
Staphylococcus simulans  Humans, mammals Kloos and Schleifer 1975 
subsp. Casei Cheeses Place et al. 2003 Staphylococcus succinus 
 subsp. Succinus Amber Lambert et al. 1998 
Staphylococcus vitulinus  Meat products,  domestic mammals, and whales Webster et al. 1994 
Staphylococcus warneri  Humans, primates, 
and domestic mammals Kloos and Schleifer 1975 
Staphylococcus xylosus  Humans, mammals, and birds Schleifer and Kloos 1975 
a Species and subspecies in bold have been frequently associated with neonatal sepsis in NICUs. 
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1.2.2 Clinical profile of CoNS 
 
Most CoNS were recognized as harmless organisms as they produce resident 
populations on human bodies, mainly inhabiting human skin and mucous 
membranes of respiratory and gastrointestinal systems (Aly et al., 1977; Keyworth 
et al., 1992).  Over the last decades, CoNS have been widely accepted as major 
opportunistic pathogens of low virulence causing hospital-acquired infections 
(Christensen et al., 1982; Grieble et al., 1981; Longauerova, 2006).  The National 
Nosocomial Surveillance System Report, October 2004 (National Center for 
Infectious Diseases, Center for Disease Control and Prevention, Public Health 
Service, US Department of Health and Human Services) listed S. epidermidis, the 
representative species of CoNS, as the commonest causative agent of nosocomial 
infections.  Coagulase-negative staphylococci predominantly cause infections in 
immuno-compromised patients or otherwise healthy individuals with breached skin 
and mucous barriers (Vuong & Otto, 2002).  The former group includes 
HIV-positive or AIDS patients, intravenous drug abusers, patients under 
immunosuppressive therapy, post-chemotherapy patients, and premature newborns.  
The latter category includes people having trauma and implanted medical devices 
such as CVCs, as both circumstances establish the portal for CoNS to enter human 
body (Vuong & Otto, 2002).  Human infections associated with CoNS include 
meningitis, otitis media, pneumonia, enterocolitis, surgical wound infections, 
urinary tract infections, and a series of medical device-related infections, including 
prosthetic valve endocarditis, vascular graft infections, intravascular catheter 
infections, cardiac pacemaker infections, prosthetic joint infections, intraocular lens 
infections, breast implant infections, genitourinary prosthesis infections, 
haemodialysis shunt and graft infections, central nervous system shunt infections, 
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and infections of many other surgically inserted applicances (Cervera et al., 2009; 
Rogers et al., 2009; von Eiff et al., 2002; von Eiff et al., 2005).  Most CoNS 
infections present subacute or even chronic clinical pictures, rather than fulminant 
manifestations.  Despite their relatively benign profile, CoNS attribute to a high 
morbidity to hospitalized patients, accompanied by an increased average cost and 
an excessive hospital stay (Eggimann et al., 2004; O'Grady et al., 2002).         
S. epidermidis is the most frequently encountered CoNS causing nosocomial 
infections (NNIS, 2004; Rogers et al., 2009).  Other CoNS species, such as 
Staphylococcus haemolyticus, S. capitis, Staphylococcus warneri and 
Staphylococcus hominis, have also been implicated in different hospital acquired 
infections, in particular those involving implanted medical devices (Ponce de Leon 
et al., 1986). 
 
1.2.3 Pathogenesis of CoNS Infections 
 
To establish an infection, bacteria must possess a group of molecules termed 
virulence factors that are crucial for its invasion of the host, its survival within the 
host, and the induction of the clinical symptoms.  Virulence factors contributing to 
the CoNS pathogenicity are still far from being completely understood.  Unlike S. 
aureus, CoNS are unable to produce significant amounts of extracellular enzymes 
and tissue-damaging toxins (Otto, 2004b; Otto, 2009); those reported for CoNS 
species refer to table 1.2.  Beside these conventional exotoxins and extracellular 
enzymes, other factors may play more important roles in the establishment, 
maintenance and persistence of CoNS infections.  The most extensively studied 
factors include biofilm production, quorum sensing (QS) responses, multiple 
antimicrobial resistance, and production of small colony variants (SCVs).
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Table 1.2 Exotoxins and extracellular enzymes of CoNS species 
Name Category Species  Effects 
Staphylococcal cysteine protease staphopain B (SspB) Cysteine proteases S. epidermidis Tissue damage? 
Extracellular cysteine protease (Ecp) Cysteine proteases S. epidermidis Tissue damage? 
Staphylococcal efflux pump (SepA) Metalloprotease or elastase S. epidermidis Lipase maturation, AMP resistance, and  
potential tissue damage 
Glutamyl endopeptidase, S. epidermidis (GluSe) Glutamylendopeptidase S. epidermidis Degradation of fibrinogen and complement 
factor C5 
Staphylococcal serine protease (SspA ) Serine protease S. epidermidis Degradation of fibrinogen and complement  
factor C5 
Extracellular serine protease (Esp) Serine protease S. epidermidis Degradation of fibrinogen and complement  
factor C5 
Glycerol ester hydrolase (GehC and GehD) Lipases S. epidermidis, S. simulans, S. capitis, S. hominis, 
S. schleiferi, S. cohnii, S. warneri, and S. caparae 
Persistence in fatty acid secretions? 
Fatty acid modifying enzymes (FAME) Unidentified S. epidermidis, S. simulans, S. capitis, S. hominis, 
S. schleiferi, S. cohnii, and S. caprae 
Detoxification of bactericidal fatty acids 
Urease Urease S. simulans, S. capitis subsp. urealytics, S. homonis, 
S. warneri, and S. caprae 
Ureolysis, pH changes and 
bacterial invasiveness 
Phenol-soluble modulins (PSMs), e.g. Delta (δ) toxin Tissue-damaging toxins 
 
S. epidermidis Pro-inflammatory cytolysins, e.g. causing  
necrotizing enterocolitis 
D-alanylation of teichoic acids (Dlt) AMP-related proteins S. epidermidis D-alanylation of teichoic acids 
Multiple peptide resistance factor protein (MprF) AMP-related proteins S. epidermidis Lysylation of phospholipids 
Vancomycin resistance associated (VraF and VraG) AMP-related proteins S. epidermidis Putative AMP exporters 
Antimicrobial peptide-sensing system (APS) AMP-related proteins S. epidermidis Senses AMPs and regulates AMP resistance  
mechanisms 
Staphyloferrins Iron importer S. epidermidis Bacterial iron acquisition 
Siderophores Iron importer S. epidermidis Bacterial iron acquisition 
Staphylococcal iron transporter ABC (SitABC) Iron importer S. epidermidis Bacterial iron acquisition 
(Adopted from Otto, 2009) 
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1.2.3.1 Virulence factors related to biofilm production 
 
It has been widely accepted that the pathogenesis of CoNS infections depends 
mostly on their ability to form biofilms on polymer surfaces (Klingenberg et al., 
2005; von Eiff et al., 2002).  Biofilm is a structured community of bacterial cells 
adherent to an inert or living surface and/or embedded in a self-produced EPS 
matrix (Costerton et al., 1999; Karatan & Watnick, 2009).  The bacteria within the 
biofilms are protected from physical, chemical and biological stresses, including 
antimicrobial agents, antibodies and the antimicrobial products of phagocytic cells 
(Costerton et al., 1999; Vuong & Otto, 2002).  Numerous studies have reported 
that biofilm-positive strains or strains carrying intercellular adhesion genes (ica), 
which encode polysaccharide intracellular adhesin (PIA), are more pathogenic than 
those unable to form biofilms or lack of ica genes (Arciola et al., 2001; Votava & 
Woznicova, 2000).  Synthesis of PIA, the main EPS component of CoNS biofilms, 
was found to play an important role in establishing S. epidermidis infections in 
animal models (Deighton et al., 1996; Fluckiger et al., 2005; Francois et al., 2003; 
Rupp et al., 1999), though its essential role is still debated (Arciola et al., 2006; 
Chokr et al., 2007; Eftekhar & Speert, 2009; Fitzpatrick et al., 2005b; Fluckiger et 
al., 2005; Kristian et al., 2004).  Virulence factors related to biofilm formation of S. 
epidermidis have been summarized by Otto et al. (2004, 2009) (Table 1.3).  A 
detailed description of the roles of these components in CoNS biofilm formation is 
presented in section 1.3.5.  In addition, insertion element IS256 might also play a 
role in biofilm-related CoNS infections (Vuong et al., 2004b; Ziebuhr et al., 2000); 
insertion of IS256 into the ica or staphylococcal accessory gene regulator (agr) loci 
leads to abolishment of PIA production or dysfunction of the global regulator arg 
QS system (Vuong et al., 2004b; Ziebuhr et al., 2000).
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Table 1.3 Virulence factors of S. epidermidis related to biofilm formation 
Virulence factors Function 
  
Stage 1: Primary attachment to abiotic surfaces 
AtlE (autolysin E) Adhesin: affects surface hydrophobicity 
Aae (autolysin/adhesin) Adhesin 
SSP1 and SSP2 (staphylococcal surface proteins) Fimbria-like proteins: attachment to polystyrene 
Teichoic acids Affecting attachment through the binding of autolysins? 
Stage 1: Attachment to conditioning film (host matrix proteins) 
Fbe (fibrinogen-binding protein)/SdrG  
(serine-aspartate dipeptide repeat protein G) 
Fibrinogen binding, inhibition of phagocytosis 
SdrF Binding collagen 
SdrH Putative binding function only 
Ebp (elastin-binding protein) Binding elastin? 
AtlE and Aae Binding various matrix proteins, including fibrinogen,  
fibronectin and vitronectin 
Embp (extracellular matrix-binding protein) Binding fibronectin, preventing the macrophage phagocytosis and  
binding albumin? 
GehD Collagen binding 
Stage 2: Formation of microcolonies  
PIA (polysaccharide intercellular adhesin) Exopolysaccharide: cell-cell adhesion, haemagglutination, protects  
the bacteria from IgG, AMPs, phagocytosis and complement attack 
Bap/Bhp (biofilm-associated protein) Intercellular adhesion, independent of PIA 
Aap (accumulation-associated protein) Intercellular adhesion, independent of PIA, requiring proteolytic 
processing for its activation 
Teichoic acids Components of biofilms  
Global regulation of biofilm production 
Sar Positive regulator of PIA production 
Alternative transcription factor SigB Positive regulator of PIA production, via negatively regulating icaR 
RsbU Positive regulator of PIA production, via positively regulating SigB 
Quorum-sensing systems  
Agr 
LuxS 
 
Agr: reduce the bacterial adherence/enhance biofilm detachment 
LuxS: negatively regulate PIA production  
RNAIII activating protein/target of RNAIII- 
activating protein (RAP/TRAP) 
A regulatory system of agr QS system? 
Other Biofilm related factors 
Poly-gamma-glutamic acid (PGA) Component of EPS, and protects bacteria from antimicrobial  
proteins and phagocytosis 
(Adopted from Otto et al. 2004, 2009)
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1.2.3.2 CoNS quorum sensing responses and relevant virulence 
factors  
 
Quorum sensing is an intercellular signaling activity responsive to the confinement 
of growth environment or an increase in population density of a bacterial 
community, by which bacteria are able to modulate the transcription of genes 
important for their survival and pathogenicity (Carnes et al., 2010; Jayaraman & 
Wood, 2008; Kong et al., 2006).  Bacteria with activated QS systems generally 
demonstrate greater virulence and viability over non-QS bacteria (Carnes et al., 
2010; Kong et al., 2006; Vuong et al., 2003; Yarwood & Schlievert, 2003). 
 
There are two different QS systems reported in the literature in Staphylococcus spp., 
the agr QS system and LuxS QS system; both act as global regulators of virulence 
factors of CoNS (Li et al., 2008; Yarwood & Schlievert, 2003).  The arg QS 
system is specific for the genus Staphylococcus and includes two divergent 
transcripts, RNAII and RNAIII (Kong et al., 2006).  RNAII encodes the agr 
operon, including agrD (encoding a precursor signaling peptide), agrB (processing 
and secretion of the signal peptide), agrC (encoding the kinase sensor) and argA 
(encoding the response activator) (Novick et al., 1995).  In the process of arg QS 
response, the autoinducer precursor, argD is presumably trimmed and combines 
with argB to generate an activating ligand, which is a signaling molecule with 7-9 
amino acids in length, namely autoinducing peptide (AIP) (Mayville et al., 1999; 
Otto et al., 1998).  The AIP then binds to the transmembrane protein ArgC and 
triggers its autophosphorylation.  The two-component regulatory system is in turn 
switched on; the phosphorylated ArgC further activates ArgA, which binds to P2 
and P3, the promoters for two adjacent agr effector RNAII and RNAIII, leading to 
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their activiation and accomplishing the full circuit (Kong et al., 2006; Novick et al., 
1993; Queck et al., 2008).  Activation of RNAIII results in the expression of 
exotoxins such as delta-toxin and other phenol-soluble modulins (PSMs), some 
degradative exoenzymes and surface proteins in Staphylococcus spp. (Novick et al., 
1993; Queck et al., 2008; Wang et al., 2007a; Wang et al., 2007b).  In addition to 
its modulation of extracellular toxins and enzymes, arg QS system plays a more 
important role on biofilm formation in CoNS (Vuong et al., 2004b; Yarwood & 
Schlievert, 2003).  It was found that staphylococcal biofilms formed by agr mutant 
strains were comparatively thicker than those of wild strains (Vuong et al., 2000; 
Vuong et al., 2003).  The negative regulation of CoNS biofilm by arg QS system 
is due to the downregulation of the adhesin (e.g. autolysin AltE; important in the 
initial stage of biofilm formation) production  and up-regulation of protease 
(degrading adhesions and agglutinins) and PSM (e.g. δ-haemolysin; possessing 
detergent properties) synthesis  (Novick & Geisinger, 2008; Vuong et al., 2003; 
Yao et al., 2005).  No influences of agr QS on the PIA production have been 
reported (Vuong et al., 2003).  In addition, agr QS system also plays an important 
role in the interaction between CoNS and the innate human immune system, 
including elicting the production of the cytokine tumor necrosis factor α, causing 
chemotaxis of human neutrophils, producing extracellular protease against human 
antimicrobial peptide, and controlling the general and oxidative stress responses 
(Vuong et al., 2004b; Yao et al., 2006). 
 
RNAIII activating protein/target of RNAIII-activating protein (RAP/TRAP) was 
proposed as another QS system involved in the pathogenicity of Staphylococcus spp. 
(Gov et al., 2004; Kiran et al., 2008).  This system uses a 277-amino acid residue 
protein RAP to induce the phosphorylation of TRAP, which is a 
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membrane-associated 167-amino acid residue protein.  TRAP has been 
hypothesized as the sensor of a two-component signaling system and has been 
shown to regulate the expression of many toxins via arg QS system (Korem et al., 
2005).  In an animal model of S. epidermidis infection, bacteria lacking TRAP or 
failing to phosphorylate TRAP were unable to establish the infection (Balaban et al., 
2003).  There seems to be an overlap between the TRAP/RAP QS system and the 
arg QS system.  The phosphorylation of TRAP leads to activation of agr and the 
eventual expression of RNAIII, and on the other hand, AIP in agr QS system 
indirectly downregulates the phosphorylation of TRAP (Balaban et al., 2001).   
Therefore it is more likely that TRAP/RAP is a regulatory system of agr QS system, 
rather than an individual QS system (Korem et al., 2005; Novick, 2003).   
 
Another quorum sensing system, LuxS system, is universally present in both 
gram-negative and positive bacteria, but poorly understood in Staphylococcus spp.  
In the LuxS QS response, the highly conserved enzyme LuxS catalyzes the 
synthesis of autoinducer-2 (AI-2), by converting S-ribosyl homocysteine to 
homosyteine and 4,5-dihydroxy-2,3-pentanedione (DPD), the precursor of AI-2 
(Surette et al., 1999).  AI-2 functions as a signal which activates the AI-2-specific 
sensor/regulator systems once a threshold level is reached, and in turn controls the 
expression of various virulence-associated genes.  Recently, Li et al. (2008) 
examined genome-wide transcriptional profiling of S. epidermidis using microarray 
and revealed a luxS-dependent regulation of PSMs and Lrg proteins (Li et al., 2008).  
Xu et al. (2006) compared the isogenic mutant strains of S. epidermidis which were 
deficient in LuxS QS system with the wild type strains and found that inactivating 
this system led to an increased virulence in a catheter-associated animal infection 
model (Xu et al., 2006).  Mutation in luxS gene has been found to result in an 
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increase of biofilm formation of S. epidermidis; this is mostly likely via 
derepressing icaADBC expression and consequential PIA production (Xu et al., 
2006).   Conversely, a more recent study suggested that the expression of the ica 
genes might be impacted by the metabolic function mediated by LuxS QS system 
rather than a direct AI-2 control (Li et al., 2008). 
 
The expression of QS systems and their role in CoNS pathogenicity are likely to be 
phase dependent (Horswill et al., 2007).  One study found that arg QS system 
played an important role in bacterial invasion, however, a mutant lacking functional 
agr showed a better ability in colonizing a medical device and forming a biofilm 
(Vuong et al., 2004b).  In a recent animal study, a rapid burst of agr activity was 
found upon the initial entry of the bacteria into the subcutaneous tissue, 
accompanied by expression of virulence factors for bacterial invasiveness, then 
followed by a rapid decline of agr QS response, which was likely to equip the 
bacteria with better ability to colonize the surface and form a biofilm (Wright et al., 
2005).  Therefore, given the biofilm formation is an important virulence factor of 
CoNS infections, the presence of QS systems might trigger rather than maintain 
medical device-associated infections. 
 
1.2.3.3 Antimicrobial resistance of CoNS isolated from NICUs 
 
Clinical strains of CoNS are commonly resistant to a large number of antimicrobials 
of different classes, such as oxacillin, gentamicin, fluoroquinolones, tetracycline, 
chloramphenicol, erythromycin, clidamycin, sulphonamides and penicillin 
(Diekema et al., 2001; Jaglic et al., 2009; Krediet et al., 2004; Rogers et al., 2009).  
In a recent surveillance carried out at the University of Geneva Hospitals, 95% of S. 
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epidermidis isolates were resistant to penicillin, 70% to methicillin, 70% to 
cephalosporins, 44% to gentamicin, 61% to ciprofloxacin, 65% to erythromycin.  
In contrast, 86 % of isolates remained susceptible to rifampicin, 100% to linezolid 
and vancomycin, and 99 % to teicoplanin (Uckay et al., 2009).    
 
Resistance to methicillin in nosocomial strains of CoNS is common (Krediet et al., 
2001).  These strains possess the staphylococcal cassette chromosome mecA gene, 
which encodes a penicillin-binding protein (PBP), PBP2a, with a decreased affinity 
for methicillin and its structurally similar antimicrobial agents (Chambers et al., 
1985; Gill et al., 2005).  Methicillin-resistant CoNS are usually multiple resistant 
to at least both gentamicin and methicillin (Christensen et al., 1982; Raad et al., 
1998b).  Vancomycin is recommended for treatment of infections with 
methicillin-resistant strains of CoNS, however, emergence of vancomycin-resistant 
and vancomycin intermediate-resistant CoNS strains have been reported (Biavasco 
et al., 2000; Center et al., 2003; Gagnon et al., 1993; Garrett et al., 1999; Schwalbe 
et al., 1987).  CoNS populations isolated from the hospital environment show 
heterogeneous resistance to vancomycin (1 out of 104 to 108 CoNS) (D'Mello et al., 
2008).  Resistance of CoNS to newly developed antimicrobial agents, including 
streptogramins, linezolid, and tigecycline, although rare, has also been reported 
(Cetin et al., 2008; Cieloszyk et al., 2007; Claesson et al., 2009). 
 
An association between multi-drug resistance and biofilm production has been 
reported.  A significantly higher rate of biofilm development was found in S. 
aureus strains with greater multi-resistance compared with those of less resistance 
(Kwon et al., 2008).  In another study, linezolid-resistant CoNS (minimum 
inhibitory concentration (MIC) > 32 µg/mL) demonstrated a weaker ability to 
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adhere to polystyrene, compared with strains at the lower end of the MIC range 
(MICs: 8-16 µg/mL).  The mechanism behind this negative correlation between 
antimicrobial resistance and biofilm formation is unknown, however, it could be 
due to the attenuation of bacterial virulence (biofilm formation) by acquisition of 
antimicrobial resistance (Dandache et al., 2009). 
 
1.2.3.4 Emergence of CoNS small colony variants 
 
The presence of SCVs has also been related to the pathogenesis of CoNS infections, 
in particular those associated to implanted medical devices (Baddour & Christensen, 
1987; Baddour et al., 1988; von Eiff et al., 1999).   
 
Staphylococcal SCVs are a small subpopulation which may be detected upon 
culturing of clinical specimens, especially after antimicrobial treatment (Adler et al., 
2003; von Eiff et al., 1999).  In vivo, the emergence of SCVs has been proposed to 
be related to the exposure of bacteria to aminoglycosides at sub-inhibitory 
concentrations, followed by activation of stress-related alternative sigma factor B 
(sigB) (Mitchell et al., 2009).  In vitro, the SCV phenotype of CoNS has been 
produced by inserting an ermB cassette into one of the hemin biosynthetic genes, 
hemB, which encodes the prosthetic group of cytochromes and plays an important 
role in electron transport (Al Laham et al., 2007; Granick & Beale, 1978).  The 
CoNS SCVs were characterized by deficiency in electron transport and being 
auxotrophic to hemin (Al Laham et al., 2007; von Eiff et al., 1999).  
Morphologically, these cells present as tiny and unpigmented colonies of < 1/10 of 
the size of normal cells, and show strong adhesion to the agar surface (Al Laham et 
al., 2007).  When SCVs are grown in a planktonic mode, they form larger cell 
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clusters relative to their parent strains (Al Laham et al., 2007).  Physiologically, 
SCVs have been characterized with a slow growth rate, some substantial changes in 
biochemical traits, such as fermentation or utilization of a series of carbohydrates, 
and certain enzyme activities (Al Laham et al., 2007).  All these morphological 
and physiological changes are likely due to the interruption of the electron transport 
chain in SCVs, which renders the cells unable to use oxygen or nitrate as a terminal 
electron acceptor in the process of oxidative phosphorylation (Kohler et al., 2003).  
In a microbiology diagnostic laboratory, SCVs present difficulty in identification 
and susceptibility testing, due to their fastidious and auxotrophic growth 
characteristics and tendency to revert to the normal form upon further cultivation.  
 
The role of SCVs in CoNS pathogenesis has not been completely clarified.  
Although rare, SCVs have been isolated from CoNS infections (Adler et al., 2003; 
Baddour et al., 1990; von Eiff et al., 1999).  It was proposed that the SCVs were 
able to survive intracellularly in non-specific phagocytes and thus became protected 
from the host immune system and the action of antimicrobial agents (Sendi & 
Proctor, 2009).  In addition, other properties of SCVs, such as reduced 
susceptibility to antimicrobial agents, especially aminoglycoside and teicoplanin, 
enhanced PIA production due to the up-regulation of icaA, might also favor its 
survival (Al Laham et al., 2007; Wu et al., 2009b).  Although SCVs may be less 
able to initiate infections, they appear to mediate persistence and recurrence of the 
infections (Baddour et al., 1988). 
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1.2.4 Transmission and establishment of CoNS on 
implanted catheters  
 
When a patient is admitted into a NICU and medical devices such as CVCs are 
inserted, CoNS can transfer from patients’ skin and mucous membranes, or from the 
hands of clinical staff, to the surface of the medical devices and then establish a 
biofilm there (O'Grady et al., 2002).  Short-term catheters (in place less than 10 
days, e.g. peripheral intravenous catheters and short-term, nontunneled CVCs) are 
more likely to support heavy biofilms on their external surface.  The bacteria 
usually originate from the skin of the patients at the insertion site and migrate along 
the external surface and establish biofilm there (Rupp, 2003).  In contrast, 
long-term catheters (e.g. CVCs) more frequently have biofilms on the catheter 
luminal surface (Raad et al., 1993).  Bacteria from the hands of health care staff 
contaminate the hub of CVCs, move to the lumen surface and then travel up the 
lumen and establish biofilm there (Garland et al., 2008).  Organisms may also 
originate from another nidus of infection and reach CVCs via haematogenous 
seeding, however, these cases are relatively rare (Anaissie et al., 1995).  
Occasionally the catheter colonization can occur via infusate contamination 
(Eggimann et al., 2004). 
 
1.3 Biofilm formation of CoNS 
 
1.3.1 Introduction 
 
In most natural environments or hospital settings, bacteria predominantly grow in 
 20 
biofilms, instead of living in a free-floating (planktonic) form (Costerton et al., 
1999; Hall-Stoodley et al., 2004).  Biofilm is a sessile microbial community, in 
which the cells are irreversibly attached to a substratum or to each other, and/or 
embedded in a matrix of self-produced EPS, exhibiting an altered phenotype with 
respects to growth rate, stress tolerance and gene transcription (Donlan, 2002; 
Karatan & Watnick, 2009). 
 
CoNS are a model of biofilm-forming gram-positive bacteria (Otto, 2008; von Eiff 
et al., 2002).  Properties of CoNS biofilms have been studied by many researchers, 
using both laboratory and clinical strains, in vitro and in vivo (Arciola et al., 2006; 
Cafiso et al., 2004; Christensen et al., 1985; Deighton & Balkau, 1990). 
 
1.3.2 Biofilm phenotypes 
 
Based on their abilities to form biofilms on abiotic substratum, CoNS have been 
divided into three categories: biofilm-positive, biofilm-weak, and biofilm-negative 
(Christensen et al., 1985; Deighton et al., 2001).  These conventional biofilm 
phenotypes were determined by examining the biomass of overnight growth on the 
polymer surface with a spectrometer after staining the formed slimy materials with 
crystal violet.  However, it should be noted that even the so-named 
“biofilm-negative” CoNS can form a layer of adherent cells on the polymer surface 
(Christensen et al., 1985).  Recently Karatan and Watnick (2009) published new 
definitions of biofilm phenotype to re-group bacteria, “monolayer biofilm” and 
“multilayer biofilms”.  A monolayer biofilm refers to a layer of bacteria attaching 
to the abiotic surface, without forming a cluster.  It responds to the conventionally 
defined “biofilm-negative” or “weak” phenotypes and indicates the bacteria can 
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only conduct the “initial attachment” stage of biofilm formation.  Multilayer 
biofilms correspond to the “biofilm-positive” phenotype in Deighton’s 
categorization of CoNS.  Bacteria forming multilayer biofilms are believed to be 
able to reach the previously defined “cell to cell adherence” stage in which the 
bacteria are attached to both the polymer surface and to neighboring bacteria 
(Karatan & Watnick, 2009).  
 
1.3.3 Structure of medical biofilms  
 
Monolayer biofilms generally show a homogenous collection of surface-attached 
cells, without forming apparent bacterial clusters and EPS.  In contrast, multilayer 
biofilms are characterized by a more complex heterogeneous collection of cells and 
the presence of EPS (Karatan & Watnick, 2009).  Two different microscopic 
structures of multilayer biofilms have been reported: 1) a flat, uniform and densely 
packed biofilm structure; and 2) a three-dimensional mushroom-shaped 
multicellular structure.  The former structure was found with biofilms formed by 
“biofilm-positive” but PIA-negative CoNS isolates, or by some gram-negative 
bacteria when citrate was used as the carbon/energy source (Fredheim et al., 2009; 
Ramsey & Whiteley, 2004).  The latter structure has been demonstrated using 
confocal laser scanning microscopy (CLSM) when PIA-positive isolate of S. 
epidermidis RP62a was grown with typtone soya broth (TSB) supplemented with 
glucose (Fredheim et al., 2009), or when Pseudomonas fluorescence was cultured in 
a flow chamber in the presence of glucose (Pereira et al., 2002).  Typically, a 
three-dimensional biofilm structure consists of mushroom-shaped macrocolonies 
surrounded by an EPS matrix and separated by fluid-filled channels (Fig. 1.1).  
The structural difference between monolayer and multilayer biofilms seems to be 
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due to the different media used or involvement of liquous flow in biofilm growth.  
It is more likely that, a flat homogenous structure is formed with a low 
concentration of nutrients, however, in the presence of sufficient nutrients and shear 
force, cells clusters and surrounding liquous channels are formed. 
 
1.3.3.1 Extracellular polymer substance in biofilms 
 
The generation of an EPS matrix within which bacteria are enclosed, is the typical 
morphological characteristic of conventional or multilayer biofilms.  An EPS 
matrix is mostly composed of water, extracellular polysaccharide, proteins, 
extracellular DNA (eDNA), teichoic acids, lipids and a host of other small 
molecules (Branda et al., 2005; Kogan et al., 2006; Lauderdale et al., ; Whitchurch 
et al., 2002).  The principal substantial composition of biofilm matrix differs in 
different bacterial strains at different growth stages (Fredheim et al., 2009).  In 
CoNS, PIA was generally considered as the principal component of biofilm EPS 
(Rohde et al., 2001).  It is a cationic glucosamine-based exopolysaccharide and is 
composed of large type I and small type II polysaccharides containing N-acetylated 
residues (Mack et al., 1996; Otto, 2008). 
 
A few studies suggested that PIA and its encoding ica genes might not be of 
universal importance in CoNS biofilm formation.  Kogan et al. (2006) and Rohde 
et al. (2005) grew multilayer biofilms in vitro with staphylococcal strains lacking 
ica genes (Kogan et al., 2006; Rohde et al., 2005).  Arciola et al. (2006) and 
Rohde et al. (2007) isolated ica-negative staphylococcal strains from 
biofilm-associated infections (Arciola et al., 2006; Rohde et al., 2007).  One 
explanation for these findings might be that PIA production is not critical for 
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biofilm formation but contributes to the distinct biofilm architecture (Stapper et al., 
2004; Wozniak et al., 2003).  In the PIA/ica-negative biofilms, matrices are mainly 
composed of proteins, teichoic acids and eDNA.  Some specific proteins, such as 
Bap, Aae, and Aap, were found to be responsible for the vital step of cell-cell 
accumulation and biofilm formation in the absence of PIA (Conrady et al., 2008; 
Hussain et al., 1997; Sun et al., 2005; Tormo et al., 2005a).  In these cases, 
extracellular teichoic acids containing glycerol, glucose, glucosamine and in some 
cases, ribitol and 1,5-anhydro-ribitol are the main carbohydrate-containing 
polymers of the EPS (Kogan et al., 2006).  Extracellular DNA is another 
component of CoNS biofilms, which is at least partially acquired from autolysis of 
cells within the biofilms, however its exact role in biofilm formation is not clear 
(Qin et al., 2007b). 
  
1.3.4 Clinical significance of medical biofilms  
 
Biofilms are able to protect the embedded bacteria from a variety of physical, 
chemical and biological stresses and become a stubborn source of microbial 
infections, leading to relapses of chronic infections, or prolonged infection process 
by impairing or delaying the re-epithelialization process (Costerton et al., 1999; 
Schierle et al., 2009).  The significance of CoNS biofilms in a disease process 
have been previously summarized by Costerton et al. (1999): a) biofilm-grown 
bacteria are more resistant to adverse environmental conditions, such as lack of 
nutrients and competition from other bacterial species, b) biofilm cells are more 
resistant to the clearance of host immune system, c) cells in biofilms have 
dramatically reduced susceptibilities to antimicrobial agents, and d) detachment of 
cells or biofilm aggregates may result in active bacterial dissemination and acute 
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infections in neighbouring tissues (Costerton et al., 1999). 
 
1.3.4.1 Biofilm tolerance to human immune system 
 
The CoNS bacterial cells become at least partially tolerant to human innate immune 
system after growing as biofilms (Cheung & Otto, 2010; Kadouri et al., 2007).  
Upregulation of phagocytosis and antimicrobial peptide (AMP) release by 
activating neutrophils and other phagocytes is the first-line human innate immune 
response to CoNS invasion (Hajjar et al., 2001; Stevens et al., 2009).  The 
physical barrier of PIA may prevent phagocytic cells from reaching the target cells 
(Vuong et al., 2004c), thus compromising the phagocytosis activity of 
polymorphonuclear leukocytes (PMNLs) (Bernard et al., 2007; Johnson et al., 1986; 
Zimmerli et al., 1984).  A recent study using time-lapse video microscopy found 
that the PMNLs were immobilized in S. epidermidis biofilms and the phagocytosis 
was limited to bacteria trapped in the immediate vicinity (Guenther et al., 2009).  
In addition to the physical barrier effect, PIA induces the premature release of 
lysozymes of phagocytic cells, thus protecting CoNS from killing by AMPs, such as 
peptide IL-37, β-defensin 3 and dermicidin (Fedtke et al., 2004; Leid et al., 2005; 
Vuong et al., 2004c).  It was suggested that biofilm growth mode might also 
stimulate further production of the exopolymer poly-gamma-glutamic acid (PGA).  
PGA is a surface macromolecule present in CoNS biofilms and is upregulated 
during biofilm formation (Kocianova et al., 2005).  PGA has been found to render 
CoNS more resistant to killing by AMPs and opsonophagocytosis by neutrophils 
(Kocianova et al., 2005). 
 
Beside its role on human innate immunity, biofilms also exert an effect on the more 
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specific acquired immune system.  Staphylococcal biofilms have shown potent 
immuno-modulatory properties, e.g. inhibiting the genesis of mononuclear cells, 
such as T and B lymphocytes, and adversely acting on both cytotoxic and humoral 
defense responses (Lew et al., 2001).  In addition, the presence of PIA protects 
CoNS from immunoglobulin attack, by protecting the cells from antibody 
recognition and complement deposition (Kristian et al., 2008; Pourmand et al., 
2006; Vuong et al., 2004c).   
 
1.3.5 Development of biofilms by CoNS 
 
1.3.5.1 General model for CoNS biofilm formation 
 
Upon receiving environmental signals, such as presence of foreign bodies and 
activation of quorum sensing factors, free-living cells form an early adherent 
monolayer, and then further grow as a mature biofilm (Kolter & Greenberg, 2006; 
Spoering & Gilmore, 2006).  
 
The development of a mature CoNS biofilm in vivo from planktonic cells consists 
of five consecutive stages: 1) pre-formation of a conditioning film on the polymer 
surface, 2) attachment of the planktonic bacteria to the surface and formation of 
monolayers; 3) formation of microcolonies; 4) biofilm maturation and structuring; 5) 
detachment of surface bacteria and return to the planktonic growth mode (Fig. 1.1).  
In the specific case of S. epidermidis, bacteria first grow two-dimensionally on the 
polymer surface, and subsequently expand vertically to achieve an multilayer 
biofilm with a three-dimensional structure (Kajiyama et al., 2009).  In this process, 
bacteria switch among different growth modes: planktonic cells, an early adherent 
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Fig. 1.1 General model of biofilm development by CoNS.  Shown is a model for the biofilm developmental pathway of CoNS that includes 
each stage, the corresponding physical, biological and global regulatory factors which are predicted to be involved in biofilm formation.
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monolayer, mature biofilms, and planktonic cells again (O'Toole et al., 2000). 
 
i. Pre-formation of a conditioning film 
 
When a CVC is inserted into a blood vessel, it will be immediately coated with 
platelets, plasma, and tissue proteins including albumin, immunoglobulin, collagen, 
fibrinogen, fibronectin and lamini (Gottenbos et al., 2002; Peters, 1988).  These 
components form a layer of structure on the catheter surface, which is termed 
conditioning film (Gottenbos et al., 2002).  This positively charged film alters the 
characteristics of the catheter surface and reduces repulsion between negatively 
charged cells and the substratum.  More importantly, this conditioning film 
provides specific binding sites for some large bacterial surface proteins and the 
interactions result in a tight attachment of bacteria to the modified catheter surfaces 
(Espersen et al., 1990; Herrmann et al., 1988).   
 
ii. Bacterial attachment and monolayer formation  
 
All mature biofilm structures originate from colonization of planktonic bacteria to 
the polymer surface.  There might be two types of initial attachment of CoNS to 
the substratum: attachment to the conditioning film-coated surface and attachment 
to the uncoated surface.  Both  procedures occur within seconds after CoNS 
encounter a polymer surface (Peters et al., 1982). 
 
When the surrounding environmental conditions are propitious for biofilm 
formation, CoNS increase the expression of adhesins on their outermembrane 
surface, through which, the bacteria increase their ability to stick to the polymer 
surfaces.  Unlike some gram-negative bacteria, which use flagella and pili to 
  28 
attach the polymer surface, the prerequisite for CoNS attachment is the presence of 
cell surface proteins as efficient adhesins.  Several bacterial surface structural 
components promote attachment to the conditioned surfaces, including teichoic 
acids, Aae (autolysin/adhesion), and a large group of outer-membrane or 
periplasmic proteins designated as MSCRAMMs (microbial surface components 
recognizing adhesive matrix molecules, i.e. SdrG/Fbe, SdrF, SdrH, AtlE , Embp, 
GehD, and Ebp  (Bowden et al., 2002; Heilmann et al., 1997; Heilmann et al., 
2003; Makin & Beveridge, 1996; O'Toole & Kolter, 1998b).  MSCRAMMs harbor 
binding sites for human matrix proteins such as fibronectin, collagen, laminin, 
vitronectin, elastin and fibrinogen, and demonstrate an adhesive function (Bowden 
et al., 2002; Patti et al., 1994).  Covalently anchored proteins SdrG (Fbe) and SdrF 
bind fibrinogen and collagen in vitro and in vivo (Arrecubieta et al., 2007; Guo et 
al., 2007; Hartford et al., 2001).  Extracellular matrix-binding protein (Embp) is 
another surface-associated protein widely distributed in clinical isolates of S. 
epidermidis.  This protein mediates bacterial attachment to host matrix by 
specifically binding to fibronectin and plays an important role in the early stage of 
biofilm formation (Christner et al., 2010; Williams et al., 2002).  An extracellular 
lipase, GehD, was found to be a surface-associated collagen-binding adhesin and 
might contribute to the attachment of S. epidermidis to host matrix coated 
indwelling materials (Bowden et al., 2002).  Elastin-binding protein (Ebp) was 
previously suggested to able to mediate the initial attachment of S. aureus to host 
tissues via its interaction with host matrix protein elastin (Park et al., 1991; Park et 
al., 1996); a similar role on CoNS has not been proven.  Two biofunctional 
autolysins and adhesins, AtlE and Aae, show a less-specific interaction with 
fibrinogen, fibronectin and vitronectin (Heilmann et al., 1997; Heilmann et al., 
2003).  In addition, cell-wall teichoic acids also significantly increase the adhesion 
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of S. epidermidis to immobilized fibronectin (Hussain et al., 2001). 
     
Non-specific binding between bacteria and unmodified polymer surface also occur, 
although it is not clear if this direct attachment plays a significant role in the 
pathogenesis of medical device-associated infections.  This adherence depends on 
the bacterial surface characteristics and the nature of the polymer surfaces.  The 
interaction was mediated by non-specific physiochemical forces, such as Van der 
Waals forces, hydrophobic interaction, and polarity (Donlan, 2001; von Eiff et al., 
2002).  Some bacterial surface macromolecules are also involved in this 
attachment, such as staphylococcal surface proteins, SSP-1 and SSP-2, AtlE, and 
teichoic acids, likely by contributing to the hydrophobic character of the cell surface 
(Heilmann et al., 1997; Shiro et al., 1994; Tormo et al., 2005a; Veenstra et al., 
1996).   
 
As described in section 1.2.3.2, a global stress regulator, agr QS system, affects the 
initial attachment of CoNS to a polymer surface, presumably due to the 
up-regulation of surface proteins, such as AltE (Vuong et al., 2000).   . 
 
By the end of the early attachment stage, a confluent layer of CoNS, referred to as 
an early adherent monolayer, covers the polymer surface.  This stage lasts 
approximately 1 to 2 hours.  The metabolic activities of S. epidermidis at this stage 
are similar to those of planktonic bacteria at mid-log phase (Vandecasteele et al., 
2004). 
 
iii. Formation of microcolonies  
 
After forming an early adherent monolayer, some bacteria multiply locally and then 
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reach a mound-shaped cellular aggregation, which is named microcolony.  
Microcolony formation of CoNS is mediated by some secreted or surface 
macromolecules, of which PIA is the most important (Mack et al., 1996).  PIA 
mediates the cell-cell interaction after the formation of an adherent monolayer.  
PIA-negative strains failed to accumulate on polymer surfaces and form 
characteristic microcolony architecture (Mack et al., 1996).  In rare cases, some 
surface proteins of CoNS, including AaP, BhP, EmBP, and SSP, also work as 
alternative aggregating substances for cellular accumulation (Christner et al., 2010; 
Rohde et al., 2005; Rohde et al., 2007).  Most of these surface proteins appear to 
be preferentially expressed in vivo (Christner et al., 2010).  Rohde et al. (2005) 
found the proteolytic processing of Aap led to intercellular adhesion and 
consequential biofilm formation in some PIA-negative CoNS isolates, indicating 
the Aap can also operate as an individual intracellular adhesin beside PIA (Rohde et 
al., 2005).  BhP, a homolog of Bap that occurs in human strains of S. epidermidis, 
was also proposed to play an important role in the stage of agglutination and 
proliferation (Gill et al., 2005; Zhang et al., 2003a).  Christner et al. (2010) 
compared the biofilm formation phenotype of Embp-producing S. epidermidis 1585 
and its Embp-negative mutant, and found that Embp with both FIVAR and GA 
domains possessed intercellular adhesive properties (Christner et al., 2010).  These 
authors also suggested that Embp and PIA could act in parallel or independently of 
each other as intercellular adhesins.  Staphylococcal surface proteins also possibly 
contribute to cell-cell adhesion of S. epidermidis over greater distances, likely due 
to its fibril-like characteristic (Banner et al., 2007; Veenstra et al., 1996).     
 
Teichoic acid and eDNA were also found to demonstrate an cell-cell 
interconnecting function in this stage, probably depending on their polyanionic 
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characteristics (Otto, 2009).  Teichoic acids can mediate intercellular adhesion and 
biofilm formation in the cases of ica-independent biofilms, completely independent 
of PIA (Hussain et al., 1992).  Treatment of S. epidermidis with deoxyribonuclease 
(DNase) I disperses the biomass of S. epidermidis biofilms of 6 h old (late 
accumulation stage), not those of mature biofilms, suggesting that eDNA of S. 
epidermidis functions as a cell-to-cell connector (Qin et al., 2007b).  Thomas and 
Hancock (2009) also proposed that release of eDNA was via bacterial autolysis of a 
subfraction of biofilm cells and their presence might regulate the microcolony 
formation (Thomas & Hancock, 2009).   
 
iv. Maturation and structuring of biofilms  
 
After attachment to a surface and the formation of microcolonies, bacteria undergo 
further adaptation into a mature biofilm consisting of macrocolonies encased by 
EPS and separated by water channels (Sauer et al., 2002).  Several studies 
investigated the bacterial components and external factors regulating biofilm 
maturation and structuring.  PIA is a key component of macrocolonies; however, 
its expression is negatively regulated during the later stage of biofilm formation.  
The LuxS QS response is likely to be the most important factor involved in this 
self-regulating process.  The reaction product of LuxS QS system, AI-2, represses 
the expression of icaADBC (Davies et al., 1998; Soberon-Chavez et al., 2005).  A 
wild type S. epidermidis strain expressing LuxS QS system and its isogenic mutant 
differed in biofilm structure, with the mutant strain forming much thicker and 
unstructural biofilms than the wild type (Xu et al., 2006).  Other global regulators, 
such as SarA, RsbU, and SigB, are also involved in the regulation of biofilm 
maturation.  SarA positively regulates the formation and maturation of biofilm 
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structure of S. epidermidis, by controlling the icaADBC operon transcription in an 
icaR-independent manner (Tao et al., 2006; Tormo et al., 2005b).  Sigma factor B 
and its activator RsbU, exert an important role in the ultrastructure and stability of 
biofilms formed by S. epidermidis, via positive influence on sarA and negative 
regulation of icaR (Goller & Romeo, 2008; Pintens et al., 2008).  Mutants of either 
sigB or rsbU formed biofilms of a small number of cell clusters and almost no PIA 
on the catheter surface (Pintens et al., 2008).  Beside the global regulatory factors, 
bacterial surfactant peptides such as PSMs are also involved in structuring 
staphylococcal biofilm as they provide cell-cell disruptive forces.  Expression of 
PSMs was found to lead to the detachment of cell cluster from the biofilms, which 
consequently leads to the formation of water channels between macrocolony 
structures (Otto, 2008).  Moreover, shear force of the fluid flow, which can be 
found in most natural environments, plays a vital role in the biofilm shaping and 
maturation, by increasing biofilm viscoelasticity and resulting in a denser structure, 
with higher cell densities and stronger attachment (Lee et al., 2008; Rupp et al., 
2005a). 
 
v. Detachment and return to the planktonic growth model 
 
The last stage of biofilm growth is cell detachment and return to the planktonic 
mode.  The detachment could occur as early as 6 h after cell attachment but 
usually occurs after several days depending on conditions.  Constitutive low level 
sloughing as well as active dispersion of biofilm bacteria occurs synchronously in 
the detachment procedure (Stoodley et al., 2005).  Once a biofilm structure is 
formed, under certain environmental cues or self-stress signals, cells on the surface 
exit from the biofilm and re-enter the planktonic state (Bester et al., 2005; Sauer et 
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al., 2002).  Environmental cues to biofilm detachment include: 1) factors 
influencing metabolic activities of bacteria, i.e. starvation of bacteria due to a lack 
of nutrients, limitation in oxygen availability, and sudden change in nutrient or 
oxygen availability in favor of bacterial growth; 2) factors causing lysis of biofilm 
cells or bacterial death such as exposure to antimicrobial agents; 3) factors causing 
loss of biofilm EPS such as extensive biofilm incubation, the presence of surfactant 
produced by CoNS themselves, the presence of shear stress (Donlan, 2002; Hunt et 
al., 2004; Xavier et al., 2005; Ymele-Leki & Ross, 2007).  In addition, 
bacteria-secreting detergent-like molecules, such as PSMs, can disrupt non-covalent 
(such as electrostatic and hydrophobic) interactions and lead to bacterial 
detachment from the substratum (Kong et al., 2006).  In PIA-independent CoNS 
biofilms, exoproteases with low substrate specificity produced by S. epidermidis 
may play an important role in bacterial detachment as they were able to hydrolyze 
the intracellular-connecting proteins in biofilms (Otto, 2009).  Besides the 
environmental factors, self-induced stresses, such as QS systems, also trigger the 
detachment of biofilm cells.  Biofilms that are dysfunctional in the agr QS system 
have a defect in cellular detachment and demonstrated a thicker appearance.  One 
hypothesis is that agr QS system individually controls the production of the 
detergent-like peptides PSMs, such as delta-toxin, which facilitate the bacterial 
detachment (Vuong et al., 2003; Vuong et al., 2004b).    
 
1.3.5.2 Genetics and role of PIA in biofilm formation and virulence 
 
Most genetic studies of CoNS biofilm formation investigated genes responsible for 
the production of PIA.  The ica locus controls the biosynthesis of PIA and the 
expression of the biofilm phenotype in CoNS in most cases (Gad et al., 2009).  
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Synthesis of functionally active PIA requires the involvement of the products of 
four open reading frames (ORFs): icaA, icaD, icaB, and icaC.  IcaA has a 
N-acetylglucosaminyl-transferase activity with UDP-N-acetylglucosamine as a 
substrate.  IcaD is a chaperone that directs the correct folding and membrane 
insertion of the activated N-acetylglucosamine (GlcNAc) monomers, and also acts 
as a link between IcaA and IcaC (Heilmann et al., 1996).  The transmembrane 
protein IcaC is involved in externalization and elongation of the growing 
polysaccharide.  IcaB is a surface-located enzyme protein, and is responsible for 
the exportation and deacetylation of the GlcNAc residues, which introduce positive 
charges that are important for surface binding into the otherwise-neutral polymer 
(Vuong et al., 2004a).  Production of PIA from icaADBC expression is subject to a 
range of genetically regulatory influences, including IcaR, IS256, and a series of 
global regulatory factors, such as sigB, rsbU, sarA, and the LuxS QS system.  IcaR 
is a gene locus located upstream of icaADBC locus and encodes a protein 
negatively regulating ica expression.  The icaADBC regulation via IcaR is further 
controlled by the global regulatory protein SigB and its activator RsbU, through an 
unknown pathway (Handke et al., 2007; Jager et al., 2009).  Although SarA can be 
activated by SigB, SarA directly regulates icaADBC transcription/PIA production in 
a SigB-independent pathway (Handke et al., 2007).  Insertion and excision of the 
insertion sequence element IS256 element can also turn PIA expression off and on 
(Kozitskaya et al., 2004; Ziebuhr et al., 1999).   
 
Biofilm formation, mediated by PIA production, is considered to be the main 
virulence factor of CoNS.  Studies have shown that significantly more invasive 
and less commensal staphylococcal strains carry icaADBC (Li et al., 2009; Rohde 
et al., 2009).  The introduction of the icaADBC genes into S. epidermidis restores 
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the invasiveness of noninvasive strains that lack ica operon (Li et al., 2005).  
Animal studies have also found that S. epidermidis stains which lost the ability to 
produce PIA demonstrated attenuated virulence, in contrast to their parental strains 
(Li et al., 2005; Rupp & Fey, 2001).  Therefore icaADBC has been proposed as a 
genetic marker to distinguish invasive and contaminating strains isolated from 
bloodstreams (Frebourg et al., 2000) and the corresponding icaADBC-negative 
strains were regarded as non-virulent (Li et al., 2005; Zhang et al., 2003b).  
However, several reports concerning the role of icaADBC genes in CoNS 
pathogenesis emerged recently.  Two studies suggested there were no difference in 
icaADBC carriage between the invasive and contaminating blood culture isolates 
(Bradford et al., 2006; Klingenberg et al., 2007).  Other studies also found no 
specific association between the presence of biofilm genes and pathogenecity 
(Nemati et al., 2009).  Moreover, studies using a guinea pig tissue cage model 
showed no difference in virulence between wild S. epidermidis strains 
(biofilm-positive) and their biofilm-negative mutants (Chokr et al., 2007; Francois 
et al., 2003).  Finally it has been reported that even icaADBC-negative CoNS 
could cause biofilm-related persistent infections (Petrelli et al., 2006).   
 
1.3.6 Other factors Influencing CoNS biofilm formation in 
NICUs 
 
1.3.6.1 Properties of medical devices  
 
The adherence of bacteria to medical devices is biomaterial dependent (Lange et al., 
2009).  It is generally agreed that characteristics of inserted catheters, including 
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biomaterial composition, surface topography and hydrophobicity have an important 
role in the formation of CoNS biofilm (Aydinuraz et al., 2009; Ihnen et al., 2010; 
Lauderdale et al., 2009).  Various biomaterials have been used for CVC 
manufacturing, including polyvinyl chloride, polyurethane, polyethylene, nylon, 
silicon and Teflon, among which Teflon and polyurethane are the most commonly 
used in NICUs.  Although all types of biomaterials approved for clinical use are 
prone to CoNS infections (Huebner & Goldmann, 1999), use of Teflon and 
polyurethane is associated with less biofilm-related CoNS infections relative to 
other biomaterials (Sheth et al., 1983). 
 
Physiochemical properties of catheter polymer surfaces, i. e. hydrophobicity, 
surface roughness, presence of proteins and oxygen/nitrogen rich materials, also 
affect the initial adherence and biofilm formation of CoNS (Bruinsma et al., 2003; 
Tang et al., 2009).  Hydrophobicity of the nonpolar surface exerts a strong 
influence on the rate and extent of bacterial attachment.  Most bacteria, including S. 
epidermidis, prefer to attach to low-energy hydrophobic surfaces rather than 
high-energy, hydrophilic surfaces (Bruinsma et al., 2003; Donlan, 2002).  Increase 
of surface roughness and irregularities, which presents as an increased surface area 
and a protection against shear force, is also accompanied by higher bacterial loads 
(Donlan, 2002; Tang et al., 2009).   
 
1.3.6.2 Growth environment of bacteria  
 
The growth environment has a profound effect on biofilm growth.  CoNS are able 
to form biofilm in diverse environments, in which different factors compensate for 
different genetic defects and trigger their biofilm formation procedure.  Changes in 
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environmental conditions can result in switch on/off of biofilm formation and 
different biofilm properties, such as their thickness and antimicrobial resistance 
characteristic.   
 
Following catheter insertion, the introduced CoNS encounter an aqueous 
environment, composed of body fluids, blood and injected solutions.  These in 
vivo conditions provide sufficient nutrients for CoNS to survive and even multiply, 
and favor formation of a highly complex biofilm structure.  This complex in vivo 
situation is difficult to mimic and thus only the importance of in vitro growth media 
on CoNS biofilm formation is discussed here.  Tryptone soya broth has been used 
as the standard growth medium for in vitro CoNS biofilm assay.  Other media, 
such as Mueller-Hinton broth (MHB) and brain heart infusion (BHI), have also been 
used (Fitzpatrick et al., 2005b; Pettit et al., 2005).  However, biofilms produced in 
these media have different characteristics from those in TSB, usually differing in 
the ability to induce biofilm formation or biofilm thickness (Fitzpatrick et al., 
2005b; Pettit et al., 2005).  Nutrient availability is the most important 
growth-medium factor determining biofilm growth.  In general, PIA or biofilm 
production is increased in nutrient-rich conditions, e.g. glucose supplementation 
(Fitzpatrick et al., 2005b).  Other factors, such as incubation length, oxygen 
availability, temperature, presence of other chemicals in the growth media, and iron 
limitation also significantly affected the formation of CoNS biofilms.  Biofilms 
grown for 2-8 h are less mature than overnight biofilms (24-48 h), showing less 
complex structure and being more susceptible to antimicrobial exposure (Monzon et 
al., 2001).  Oxygen and temperature affect biofilm formation of CoNS, though not 
all CoNS strains behave in a similar manner (Fitzpatrick et al., 2002; Fitzpatrick et 
al., 2005a; Fitzpatrick et al., 2005b; Fitzpatrick et al., 2006).  The presence of 
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sodium chloride, ethanol, and antimicrobial agents, possess a modulatory effect on 
CoNS biofilm formation (Fitzpatrick et al., 2002; Fitzpatrick et al., 2006).  The 
influence of these stress factors on biofilms is likely to be species-dependent, for 
example, Staphylococcus capitis strains only produce biofilm under stressed 
conditions such as in the presence of 4% ethanol or 4% NaCl, whereas the presence 
of NaCl and ethanol in the growth medium prevents S. lugdunensis isolates from 
adhering to polystyrene (Frank & Patel, 2007).  Most of these stress stimuli 
regulate CoNS biofilm formation via increasing ica expression and PIA production 
(Otto, 2008).  Some antimicrobials at subinhibitory concentrations, such as 
tetracycline, erythromycin and quinupristin-dalfopristin, vancomycin, and furanone 
also enhance CoNS biofilm formation by stimulating ica expression or with 
unknown mechanisms (Cargill & Upton, 2009; Kuehl et al., 2009; Rachid et al., 
2000).  In contrast, penicillin, oxacillin, chloramphenicol, clindamycin, gentamicin, 
ofloxacin, and teicoplanin had no positive effect (Cerca et al., 2005b; Rachid et al., 
2000). 
 
1.4 Resistance of CoNS biofilms to antimicrobial 
agents 
 
1.4.1 Introduction  
 
Antimicrobial agents play an important role in prevention and treatment of catheter 
related neonatal sepsis.  However, failure has been frequently reported.  There 
have been numerous reports of antimicrobial resistance of CoNS in the literature 
(Jones et al., 1989; Mechin et al., 1999); the most significant characteristics are 
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their resistance to methicillin, intermediate resistance to vancomycin, and the 
extremely high multidrug resistance of CoNS when grown in biofilms.   
 
 
1.4.2 Biofilm formation of CoNS leading to antimicrobial 
resistance 
 
1.4.2.1 The extent of CoNS biofilm resistance to antimicrobial 
agents 
 
When bacteria are grown as biofilms, they become 100-1000 times more resistant 
than their free-living counterparts (Aaron et al., 2002; Ceri et al., 1999).  In vitro 
studies have shown that CoNS in a biofilm mode are highly resistant to killing by 
conventional and newly developed antimicrobial agents, such as methicillin, 
penicillin, gentamicin, vancomycin, imipenem, ampicillin, cefazolin, cefamandole, 
erythromycin, clindamycin, amikacin, netilmicin, tobramycin, sulfamethoxazole and 
even ciprofloxacin (Arciola et al., 2005).  Biofilm-grown CoNS are usually 
susceptible to rifampicin.  Recognized synergistic antimicrobial combinations 
generally failed to eradicate the biofilm-embedded methicillin-resistant CoNS, 
unless rifampicin was included in the combination (Cerca et al., 2005a; Flemming 
et al., 2009).  
 
Comparisons of the antimicrobial susceptibilities of biofilms and planktonic 
cultures have produced different results (Aaron et al., 2002; Spoering & Lewis, 
2001).  Among the reasons for the lack of understanding of biofilm resistance is 
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different methodologies used by investigators.  Different devices were used for 
biofilm growth, including the Modified Robbin’s device, the Calgary Biofilm 
Device (CBD), and the traditional 96-well polystyrene microplate.  Each device 
provides biofilms of different structure, cellular densities and ages, which might 
lead to different antimicrobial susceptibility findings (Aaron et al., 2002).  In 
addition, bacterial suspensions of different growth phase, either planktonic cells at 
log phase or stationary phase, were compared with the biofilm growth mode, and 
different killing targets were used for comparison in these studies.  Minimum 
biofilm eradication concentration (MBEC) of biofilms represents complete bacterial 
killing.  Minimum inhibitory concentrations and minimum bactericidal 
concentrations (MBCs) of planktonic cells stand for bacterial inhibition and 99.9% 
bacterial killing respectively.  Comparisons between biofilm MBECs and 
MIC/MBC of planktonic culture would lead to different conclusions (Aaron et al., 
2002; Ceri et al., 1999; Spoering & Lewis, 2001).  More research is required to 
determine the effective concentration of conventional antimicrobial agents and their 
combinations on CoNS biofilms, to clarify the differences in antimicrobial 
susceptibilities between different growth modes involved in biofilm formation, 
using cells at appropriate stage and equivalent end points for comparison.  
 
1.4.3 Mechanisms of antimicrobial resistance of CoNS  
 
Based on genetic analysis, antimicrobial resistance of CoNS can be either intrinsic 
or acquired (Adair et al., 1969; Adair et al., 1971; Guerin-Mechin et al., 1999; 
Jones et al., 1989; Russell & Furr, 1977; Sutton & Jacoby, 1978).  Based on 
biochemical analysis, mechanisms of antimicrobial resistance of CoNS include 
outer membrane impermeability, increased activity of multidrug efflux, target site 
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alterations, and enzymatic degradation (Poole, 2002; Rice LB, 2003).  None of 
these conventional mechanisms will be discussed in this study. 
 
Biofilm formation is an important factor causing antimicrobial resistance, which is 
considered distinct from the “conventional” antimicrobial resistance (Cochran et al., 
2000).  Antimicrobial resistance of CoNS biofilms is most likely multifactorial, 
including innate resistance of this specific growth mode as well as induced 
resistance by genetic adaption.  A few hypotheses have been raised to explain the 
antimicrobial resistance of bacterial biofilms. 
 
1.4.3.1 Failure of antimicrobial agents to reach the biofilm-grown 
cells 
 
The first hypothesis is the failure of antimicrobial agents to reach a sufficiently 
bactericidal concentration deep in the biofilm.  Early studies reported a retarded 
diffusion of ofloxacin, cefotiam, or a delayed penetration of rifampicin and 
vancomycin through CoNS biofilms (Dunne et al., 1993; Yasuda et al., 1994; 
Zheng & Stewart, 2002).  Failure of antimicrobial agents to reach the 
biofilm-grown cells might be due to: 1) difficulty of antimicrobials of large 
molecular size to penetrate the pore structure of EPS physical barrier; 2) 
electrostatic repulsion or sequestration of antimicrobials by surface polymers of 
biofilms, e.g. positively charged antimicrobials, aminoglycoside, binding to the 
negatively charged exopolymer; and 3) the presence of enzymatic substances in 
biofilm matrix specifically hydrolyzing the antimicrobial agents (Anderl et al., 2000; 
Hope & Wilson, 2004; Mah & O'Toole, 2001; Nichols et al., 1988).  S. 
epidermidis biofilm EPS possesses a neutralizing effect against various 
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antimicrobial agents, including pefloxacin, teicoplanin, vancomycin, teicoplanin, 
ciprofloxacin; this effect results in a substantially lowered efficacy of antimicrobials 
on S. epidermidis biofilms (Souli & Giamarellou, 1998).   Taking these physical 
and ezymatic factors together, the structural EPS of biofilm acts as a formidable 
penetration barrier by which the antimicrobial agents can be deactivated in the outer 
layer faster than it diffuses (Mah & O'Toole, 2001; Stewart et al., 2009).   
However, this barrier effect provided by biofilm EPS could not fully explain 
biofilm resistance to antimicrobial agents (Cochran et al., 2000; Coquet et al., 1998; 
Vandecasteele et al., 2004).  Despite a delayed or weakened penetration and an 
inability to eradicate biofilm-embedded cells, Staphylococcus-active agents such as 
rifampicin, vancomycin and daptomycin are able to permeate S. epidermidis 
biofilms and reach a bactericidal concentration deep in the biofilms, provided 
sufficient exposure time was given (Dunne et al., 1993; Zheng & Stewart, 2002).  
Aaron et al. (2002) challenged P. aeruginosa biofilms of different architecture and 
amounts of EPS with antimicrobial agents and found similar antimicrobial 
behaviors on biofilms (Aaron et al., 2002).  Therefore other mechanisms must also 
be responsible for failure of antimicrobial treatment of biofilms.   
 
1.4.3.2 Altered microenvironment and heterogeneity of biofilm 
grown cells  
 
The second possible explanation for biofilm resistance is the different 
microenvironments within biofilms and the consequential heterogeneity of 
biofilm-grown cells.   
 
Biofilm-embedded bacteria experience general stresses such as nutrient and oxygen 
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limitation, accumulation of metabolic wastes, and changes in osmolarity.  These 
stresses at least partially lead to the alteration of metabolic activity or even the 
growth cessation of bacterial cells embedded in biofilms and promote their 
heterogeneity (Anwar et al., 1992; Borriello et al., 2004; Christensen et al., 1999; 
Sternberg et al., 1999; Stewart & Costerton, 2001).  For example, cells embedded 
in biofilms display dramatic decreases in bacterial metabolism and protein synthesis 
relative to normal planktonic cells or those located in the upper region of the 
biofilm (Vandecasteele et al., 2004).  The heterogeneity of bacterial cells in 
biofilm microenvironments is reflected by different antimicrobial susceptibilities of 
biofilm-embedded cells.  A published study found a top-to-bottom gradient of 
decreasing antimicrobial susceptibility within biofilms (Walters III et al., 2003).  
This could be explained by the fact that the efficacy of some antimicrobials depend 
on active bacterial metabolic activity, such as vancomycin and β-lactam 
antimicrobial agents (Brown et al., 1988).  In addition to the vertical 
heterogenecity, there is also a horizontal heterogenecity which is demonstrated by 
patchy distributions of bacterial survival within apparently identical 
microenvironments (Fux et al., 2005; Huang et al., 1995).  The mechanism of 
formation of horizontal heterogenecity has not been elucidated. 
  
In addition to the influence of biofilm microenvironment on bacteria, it also 
demonstrates an effect on antimicrobials.  A comparatively acidic and anaerobic 
environment of the biofilm matrix, which is produced by the consumption of 
oxygen on the surface and accumulation of acidic waste products deep in the matrix, 
might also antagonize the action of antimicrobial agents against non-growing cells, 
such as ciprofloxacin and rifampicin, since both rifampicin and ciprofloxacin 
demonstrated a less effective when used for biofilms than used against planktonic 
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cultures (Cerca et al., 2005a; Fux et al., 2005). 
 
1.4.3.3 High-cell-density related growth mode and quorum sensing 
response of CoNS 
 
Although it is clear that biofilm-grown cells are more resistant than bacteria grown 
in a free-living mode, there is evidence showing that the difference was due to 
different bacterial densities rather than the growth mode alone (Spoering and Lewis, 
2001).  High-cell-density has also been suggested to play an important role in the 
resistance of Candida albicans to the azole-class drugs fluconazole and 
ketoconazole as well as amphotericin B and caspofungin, and of S. aureus Smith to 
carbapenems (imipenem, panipenem and meropenem) and quinolones 
(pazufloxacin and ciprofloxacin) (Mizunaga et al., 2005; Perumal et al., 2007).  
The role of cell-density in biofilm resistance is likely to be species and 
antimicrobial agent specific as there is no effect of inoculum size on the bactericidal 
activity of fluoroquinolones against P. aeruginosa (Mizunaga et al., 2005).  
Activation of stress responses in response to the high-cell-density related growth 
mode of biofilms might be the mechanism that leads to the resistance to 
antimicrobials.  High-density of bacterial cell population promotes a stress 
response, by activating the alternative sigB regulator RpoS (Anderl et al., 2003; 
Schembri et al., 2003).  RpoS regulates the expression of a wide range of proteins, 
including some antimicrobial agent degrading enzymes and controls the physiology 
of bacteria (Foley et al., 1999).  Agr QS response of Staphylococcus might also be 
the involved in the high-cell-density related antimicrobial resistance of biofilm cells.  
Upon the dilution of QS signaling by transferring the bacteria in fresh media, 
biofilm-grown cells rapidly regained susceptibility (Anwar et al., 1989).  QS 
  45 
response is also thought to be involved in the expression of antimicrobial agent 
hydrolyzing enzymes, and thus plays an important role in the survival of biofilm 
grown bacteria to antimicrobial stress (Hassett et al., 1999).  Further investigation 
should be carried out to clarify the relationship of QS and antimicrobial resistance 
(Schuster et al., 2004; Whiteley et al., 2000).   
 
1.4.3.4 Biofilm specific phenotype due to contact induced gene 
expression  
 
Physiological changes of cells and expression of antimicrobial-degrading enzymes 
regulated by surface attachment might partially explain the lower response of 
biofilm bacteria to the antimicrobial agents.  Bacteria attached to a surface 
generally express different genes than planktonic cells (Cochran et al., 2000; 
Costerton et al., 1999; Mah et al., 2003).  Contact of bacteria with an abiotic 
surface can immediately lead to substantial, genome-wide adaption, including 
up-regulation of the polysaccharide biosynthesis, and down-regulation of basic cell 
processes such as nucleic acid, protein, and cell wall biosyntheses (Davies et al., 
1993; Davies & Geesey, 1995; Yao et al., 2005).  Altered expression of some 
cellular components might protect biofilm bacteria from antimicrobial attack.   
Drenkard and Absubel (2002) found a fraction of P. aeruginosa cells attached to the 
substratum expressed more resistance genes than normal cells.  Vandencasteele et 
al. (2003) compared the gene expression of S. epidermidis planktonic and sessile 
bacterial culture and found a high expression of mecA during the initial stage of 
foreign body infection (Vandecasteele et al., 2003).  Yao et al. (2005) examined 
the gene expression profile of S. epidermidis grown as biofilms and in a 
non-adherent mode and found the up-regulation of some resistance factors, such as 
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antimicrobial resistance determinant Drp35 and zinc resistance protein CzrB (Yao et 
al., 2005).  
  
1.4.3.5 Presence of persister cells in biofilms 
 
Another possible mechanism of biofilm resistance is the presence of “persister 
cells” in a biofilm community.  Persister cells should be differentiated from the 
biofilm specific phenotype induced by contacting a surface.  Although both 
represent subpopulations of bacteria which have differentiated into phenotypically 
resistant state, persister cells, have also been isolated from planktonic cultures at 
stationary phase (Spoering & Lewis, 2001).  Nevertheless gene regulation 
following contacting a surface might contribute to persister cell development, since 
development of persister cells of Candida albicans was associated with mode of 
attachment to the abiotic surface and not to biofilm architecture (LaFleur et al., 
2006).   
 
Spoering et al. (2001) isolated a fraction of antimicrobial-resistant cells from both 
planktonic cultures and biofilms and later termed them as persister cells.  
Production of persister cells was reported to only occur at mid-log phase, stationary 
phase, biofilms, but not the lag phase or early-log phase (Keren et al., 2004a).  
These cells resist antimicrobials killing, and their presence is unrelated to 
antimicrobial concentration and exposure time or induced by the antimicrobial 
exposure (Keren et al., 2004b).   It is believed that more persister cells were 
present in biofilms and stationary phase planktonic cultures than planktonic cultures 
at log phase, but there is no solid evidence presented for a direct correlation 
between biofilm growth mode and the presence of persister cells (Drenkard & 
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Ausubel, 2002; O'Toole, 2002; Spoering & Lewis, 2001).  Moreover, Al-Dhaheri 
and Douglas (2008) claimed that persister cells could not solely account for the 
antimicrobial resistance in Candida biofilms, based on the findings that there were 
no persister cells in biofilms formed by certain strains (Al-Dhaheri & Douglas, 
2008).  The precise role of persister cells in biofilm resistance remains to be 
investigated. 
 
1.4.3.6 Acquired resistance within biofilms 
 
Acquired resistance has also been related to biofilm-grown bacteria.  Most 
previous work investigating induced antimicrobial resistance of biofilm cells were 
done on gram-negative bacteria.  For instance, induction of 
antimicrobial-degrading enzymes and expression of efflux pumps have been found 
in biofilm-grown Pseudomonas aeruginosa (Bagge et al., 2004; Gillis et al., 2005; 
Giwercman et al., 1991).  Concerning antimicrobial-induced resistance in CoNS 
biofilms, supportative evidence is the development of rifampicin resistance in S. 
epidermidis after its exposure to this agent (Svensson et al., 1997; Yu et al., 2005).  
The ease of induction of acquisition of resistance in the biofilm growth mode is 
likely due to: 1) close proximity of bacteria for exchanging resistance genes; 2) 
slow antimicrobial diffusion through the biofilm matrix, which establishes an 
antimicrobial gradient to further enhance acquisition of antimicrobial resistance 
genes. 
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1.5 General laboratory methods for studying biofilm 
phenotypes 
 
1.5.1 In vitro biofilm culture systems  
 
The microtiter plate-based biofilm assays, Congo red biofilm assay, flow chamber 
biofilm assays, agar dish biofilm assays, are among those approaches mostly used 
for in vitro biofilm studies (Ceri et al., 1999; Deighton et al., 1992a; Deighton et al., 
2001; Goeres et al., 2005).  Ideally, an in vitro biofilm culture system should be 
reproducible, repeatable, easy-to-handle and representative of the in vivo biofilm 
phenotype.  The phenotype of the same bacterial biofilms cultured in different 
systems might vary, depending on the time allowed for initial surface colonization, 
incubation temperature, nutrient concentration, and fluid shear stress on the biofilm.   
Different biofilm culturing systems therefore complement each other (Friedman & 
Kolter, 2004; Lemon et al., 2008; O'Toole & Kolter, 1998a).  Animal models of 
biofilm formation have also been established; these include rat subcutaneous 
catheter models and mouse tissue-cage infection models (Kristian et al., 2004; Van 
Wijngaerden et al., 1999), but they are out of the scope of this thesis. 
 
1.5.1.1 Microtiter plate-based biofilm assays 
 
The static microtiter plate-based biofilm assay was developed in the early stages of 
biofilm research and is still widely used because of the presence of well developed 
methods, ease of operation, low cost and wide availability of the resources.  
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Bacterial suspensions of relatively low densities [generally 107 colony forming 
units (CFU)/mL] in growth media are inoculated into a 96-well microtiter plate, 
which has been tissue-culture treated to enhance the initial adherence, and then 
incubated for 18-24 h to allow the biofilm formation.  Two biofilm growth stages 
have been principally investigated; early attachment phase (adherent monolayers) 
and later accumulation and maturation phase (biofilms).  Establishment of an 
adherent monolayer in vitro requires 1-2 h incubation of the bacterial suspension 
with a polymer surface (Aaron et al., 2002; Miyake et al., 1992).  Eighteen to 
twenty-four hours of growth is recommended by many researchers to acquire 
mature biofilms, which is also the preferable time to determine bacterial biofilm 
phenotypes (Christensen et al., 1985; Deighton et al., 2001).  To semi-qualitatively 
determine the amount of biofilms produced by the CoNS, Christensen et al (1986) 
and Deighton et al. (2001) stained the biofilm with crystal violet and measured the 
OD at ~ 600 nm.  The ability of CoNS to form biofilms on polystyrene can be 
categorized into three phenotypes as described later in section 2.2.2.1  In this 
biofilm semi-quantitative assay, crystal violet stains only the bacteria in the biofilm 
matrix, not the surrounding EPS.  Alternatively, alcian blue was used to stain the 
exopolysaccharide material of biofilms, and the amount could also be determined 
by OD or by microscopy (Christensen et al., 1985; Patrauchan et al., 2005).  This 
microplate based biofilm assay is suitable for bacteria which produce biofilms in 
the bottom of microtitre plates, such as CoNS and S. aureus.  For bacteria forming 
biofilms in the air-liquid interface, such as P. aeruginosa and Peudomonas 
fluorescens, this microplate based method has been modified by O’Toole et al. 
(1998, 1999) (O'Toole & Kolter, 1998b; O'Toole et al., 1999).  A high 
concentration of ethanol or acetone (85-100%) is used to solubilise the crystal violet 
at the air-liquid interface.  The solution is then examined by a spectrometer at ~ 
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600 nm.  Both the original and modified microplate based biofilm assays are 
suitable for screening bacterial biofilm phenotypes.  However, these crystal violet 
staining methods measure the mass of the biofilms, rather than exact bacterial 
numbers and viability of the biofilm cells.   
 
The Calgary Biofilm Device was first developed as a relatively easy and 
reproducible assay to test biofilm susceptibilities to antimicrobials (Aaron et al., 
2002; Ceri et al., 1999; Ceri et al., 2001).  The Calgary Biofilm Device employs a 
microtiter plate lid with multiple pegs attached which correspond to 96 wells of a 
microplate.  After bacterial suspensions are incubated in the microplate, bacterial 
biofilms are homogeneously formed on the surface of each peg.  The multi-peg lid 
is then transferred to a new microplate containing challenging agents at serially 
diluted concentrations.  Inhibition and complete killing of biofilm bacteria by 
antimicrobials are determined by examining the bacterial growth in recovery media 
after overnight treatment.  The Calgary Biofilm Device was initially designed for 
gram-negative bacteria, as most predominately form biofilms at the liquid-air 
interface (Ceri et al., 1999).  Most CoNS form biofilm structures at the interface of 
an aqueous phase and a subratratum surface (in the bottom of the microwell) when 
cultured aerobically, thus CBD might not be ideal for CoNS biofilm study.  
 
1.5.1.2 Congo red agar assay  
 
The Congo red agar assay is another rapid, reproducible and qualitative method 
which was developed to examine the biofilm phenotype of staphylococcal strains 
(Freeman et al., 1989).  Congo red agar was prepared with Congo red stain, a 
nutritious agar base, and carbohydrate supplementation (Freeman et al., 1989).  
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Deighton et al. (1992 b) and Helimannn and Gots (1998) used Congo red agar to 
differentiate biofilm-producing staphylococcal strains and their phenotypic variants 
and mutants (Deighton et al., 1992b; Heilmann & Gotz, 1998).  Once the bacteria 
are grown on Congo red agar, the biofilm-positive strains produce black crystalline 
colonies, whereas biofilm-negative strains produce pink colonies with or without 
black centers (Freeman et al., 1989).  However, this method was found to only be 
able to produce reliable results in CoNS, not in S. aureus (Freeman et al., 1989; 
Knobloch et al., 2002); staphylococcal strains considered as moderate or weak 
biofilm producers by other quantitative biofilm assays may present discrepant 
results.  This could be explained that Congo red only stains PIA, the principal 
matrix component of staphylococcal biofilms.  Thus the Congo red assay is not an 
ideal method to examine the biofilm phenotypes of bacteria which have other 
macromolecules rather than polysaccharide as their main biofilm components.  A 
recent study revealed that PIA does not contribute to strong biofilm formation of S. 
aureus (Aaron et al., 2002; Croes et al., 2009), therefore it is not surprising that 
Congo red biofilm assay frequently fail to detect the biofilm-positive S. aureus 
strains. 
 
1.5.1.3 Flow chamber systems  
 
The flow chamber system has also been widely used for investigation of biofilm 
formation of various microorganisms (Anwar et al., 1992; Sternberg et al., 1999).  
This biofilm culture system is engineered to simulate a specific real-world 
environment, by providing shear force and continuous nutrients as in industrial and 
medical environments.  Bacterial biofilms cultured with the flow chamber system 
might differ from those obtained with microplate system such as the CBD in both 
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structure and biological behaviors, being thicker and existing different metabolic 
properties (Goeres et al., 2005).  Recently, Qin et al. (2007) found similar 
microcolony developments occurred in both static microplate system and flow 
chamber system over a 24 h incubation period, however, viability staining of the 
biofilms displayed significantly more dead cells inside the microcolonies of the 
latter system (Qin et al., 2007a).  Difference in cultivation conditions, such as 
nutrient and oxygen abundance, osmolarity and hydrodynamic shear force was cited 
to explain the divergence in biological behavior between these two systems (Qin et 
al., 2007a).  Examples of the flow chamber system include the modified Robbin’s 
device and the CDC biofilm reactor (Goeres et al., 2005; Linton et al., 1999).   
The modified Robbin’s device is a well known flow chamber biofilm system, which 
has been developed to examine the potential of biomaterials to support initial 
attachment, or biofilm formation of different bacterial strains under conditions 
similar to those in the intravascular environment.  The flow chamber system, if in 
combination with CLSM, can be used to monitor and image the structure and real 
time development of biofilms (Coenye et al., 2008).  However, the complexicity of 
this system and the related costs render it unsuitable for most laboratories (Aaron et 
al., 2002).  Moreover, most flow chamber systems cannot be used for 
high-throughput screening study of biofilms such as rapid antimicrobial 
susceptibility testing (Aaron et al., 2002). 
 
1.5.1.4 Colony biofilm assay 
 
The colony biofilm assay has been described by Anderl et al. (2001) and used by 
some others to study biofilm phenotypes (Anderl et al., 2000; Zheng & Stewart, 
2002).  To perform a typical colony biofilm assay, a sterile filter membrane is 
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placed in tryptone soya agar (TSA) plates, and seeded with a drop of overnight 
bacterial culture.  The plate is then inverted and incubated at 37°C for 48 h.  The 
grown colony on the filter membrane is then transferred to a fresh TSA plate every 
12 h for the continuous nutrient supply and avoidance of the accumulation of 
metabolic waste.  The morphology of the complex colonies reflects the ability of 
bacteria to form biofilms.  Other formats of colony biofilm assays include 
immobilized-cell structures such as alginate beads or agar gel layers (Davies, 2003; 
Jouenne et al., 1994).  As for microplate-based biofilm assays, colony biofilm 
assays are amenable to high-throughput screening study. 
 
1.5.2 Microscopic visualization of biofilms 
 
1.5.2.1 Microscopic techniques for biofilm research 
 
Various microscopic techniques have been used to explore biofilm structure, 
composition, physiological activities and viability assessment of constituent cells.  
The most frequently used include phase contrast microscopy, fluorescence 
microscopy, scanning electron microscopy (SEM), transmission electron 
microscopy (TEM), environmental scanning electron microscopy (ESEM) and 
CLSM 
 
Phase contrast microscopy has been used to examine primary attachment, and thin 
mature biofilms cells (Vieira et al., 2004), but is not recommended for biofilms > 1 
µm in thickness (O'Toole & Kolter, 1998b).  Epifluorescence microscope, in 
combination with different fluorochromes, is used to examine composition and the 
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viability of biofilms cells (Davis et al., 2008), but is only useful for examining cells 
at the surface of thick biofilms or for the adherent monolayer stage of biofilms.  In 
addition, the low magnification (up to 1000 ×) of both microscopes is limiting. 
 
Scanning electron microscopy, ESEM, TEM enable imaging of the ultramicroscopic 
structure of the biofilm matrix and single biofilm cells, due to their high power of 
magnification (10,000-1000,000 ×) (Marrie & Costerton, 1984; Surman et al., 
1996).  These techniques facilitate the fine analysis of biofilm cells, including cell 
size, cell membrane and cytoplasmic structure, however, the dehydration step in 
fixation or embedding procedure of both SEM and TEM, may cause distortion or 
collapse of biofilm structures, which is mostly composed of water (Little et al., 
1991; Surman et al., 1996).  Dehydration can be reduced to a minimum level by 
using ESEM, which provides moist conditions during processing and imaging 
samples, however, visualizing biofilm cells, in particular those in the deeper layers 
of the biofilm can be difficult with ESEM as they are immersed in the opaque 
biofilm EPS matrix (Little et al., 1991).  In addition, neither SEM, TEM, nor 
ESEM can differentiate live cells from the dead cells.  These techniques therefore 
are of limited use for evaluating the bactericidal effect of antimicrobial agents on 
biofilm-embedded cells.  
 
Confocal Laser Scanning Microscopy has several advantages over older techniques 
for visualizing bacterial biofilms and for evaluating killing of biofilm cells by 
antimicrobial agents.  CLSM is a microscopic technique which provides direct, 
non-destructive, and three-dimensional visualization of biofilm structures as well as 
single biofilm cells (Harrison et al., 2006).  By performing optical sectioning, 
CLSM acquires in-focus image signals from selected depths.  Through computer 
  55 
analysis of the digital three-dimensional structure,  the optical slices of samples 
can be re-built, mimicking the real biofilm image (Harrison et al., 2006).  CLSM 
provides an enhanced ability to observe and analyze fresh materials in real time 
without disturbing their structure as this technique requires no dehydration 
procedures (Akiyama et al., 2003; Harrison et al., 2006).  It gives clear images of 
microorganisms even if they are overlaid with a thick material, such as the biofilm 
EPS matrix (Akiyama et al., 2003).  By using CLSM, the entire depth of biofilms 
of 90 µm thick can be visualized (Norton TA, 1998).  In conjunction with 
fluorescence dyes, CLSM provides the possibility to visually analyze the 
physiological status of single cells within biofilms, so as to objectively evaluate the 
killing efficacy of antimicrobial agents on preformed biofilms. 
 
1.5.2.2 Fluorescent stains for CoNS biofilms  
 
Different fluorescent stains, including 5-cyano-2,3-ditolyl tetrazolium chloride 
(CTC) and rhodamine 123, Syto-9, propidium iodide, 
tetramethylrhodamine-labelled wheat germ agglutinin (WGA), have been used to 
detect the specific components of CoNS biofilms; live or dead cells, extracellular 
polysaccharide, and eDNA.  Live/dead BacLight bacterial viability kit and 
fluorescent conjugate-labeled WGA are two fluorescent dyes newly introduced to 
study bacterial viability and the presence of polysaccharide in CoNS biofilms.  
 
The Live/dead BacLight bacterial viability kit relies on membrane integrity which 
determines the ability of dyes to enter cells.  Two dyes are used in this kit.  SYTO 
9 is a membrane-permeant DNA labeling dye that labels all cells and fluoresces 
green.  Propidium iodide (PI) is another DNA labeling dye, but is excluded from 
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cells with intact membranes.  If membranes are damaged, PI enters cells and 
quenches SYTO 9, resulting in red fluoresces (Lisle et al., 1999).  Thus, the 
bacterial population will present a fraction of dead cells of red color or/and living 
cells of green color, leaving the background nonfluorescent. 
 
There have been some questions concerning the ability of SYTO 9 and PI to 
penetrate biofilm EPS, however, recent studies have shown that penetration is not 
inhibited in biofilms of S. epidermidis, as 3-dimensional structures rebuilt with 
CLSM revealed fluorescent signals in the deep layers of the biofilm matrix (Qin et 
al., 2007a). 
 
Various lectins have been used to stain biofilm EPS.  Lectins are 
carbohydrate-binding proteins or glycoproteins which are highly specific for their 
sugar moieties.  When used for biofilm staining, two different types fluorescence 
signals are expressed: a signal which defines cell surfaces containing carbohydrates, 
and another signal with a cloud-like appearance which indicates binding of lectin to 
polysaccharide in the biofilm matrix (Neu et al., 2001).  Wheat germ agglutinin 
specifically binds to N-acetylglucosamine and N-acetylneuraminic acid (sialic acid) 
residues, which are major components of CoNS PIA (Thomas et al., 1997).  
Recently, tetramethylrhodamine-labeled WGA has been shown to be effective in 
staining extracellular polysaccharide matrix of CoNS (Cerca et al., 2006; Jager et 
al., 2005).  A newly developed fluorescent conjugate, Alexa Fluor® 555, is 
superior to the tetramethylrhodamine as the conjugate of WGA for CoNS biofilms, 
as it has a similar excitation/emission wavelength while having increased 
photostability, higher extinction coefficient and a brighter image than 
tetramethylrhodamine. 
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1.6 Antimicrobial susceptibility testing of bacteria in 
different growth modes 
 
1.6.1 Conventional MIC/MBC assays against planktonic 
cells 
 
Conventionally, the efficacy of antimicrobial agents against a particular bacterium 
can be assessed by different in vitro methods, including disk susceptibility tests and 
dilution susceptibility tests method, E-tests, and population analysis profiling 
designed for specific bacteria with heteroresistance to specific antimicrobials (CLSI, 
2004).  Methods based on the micro-broth dilution, which measures the MIC and 
MBC, are widely used, as they provide rapid and reproducible results (CLSI, 2004).  
In the conventional micro-broth dilution assay, bacterial suspensions of a standard 
density are cultured in a round-bottom microplate containing 2-fold dilutions of 
antimicrobial agents.  The MIC is defined as the lowest concentration at which 
there is no visible bacterial growth after overnight incubation and MBC was defined 
as the lowest concentration leads to 3 log10 reduction of the bacterial population 
(CLSI, 2004).  Automated methods based on micro-broth dilution assay are widely 
used in clinical diagnostic microbiology. 
 
The MIC/MBC is used to guide antimicrobial therapy for bacterial infections, 
however, in the cases of biomaterial associated infections, in which biofilm 
formation is the main characteristic, conventional MIC only predicts the ability of 
an antimicrobial agent to inhibit the growth of the bacteria released from the 
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biofilm, not the bacterial growth within biofilm matrix (Ceri et al., 2001).  Thus 
MIC/MBC alone is a poor predicter of clinical efficacy for biomaterial associated 
infections.   
 
1.6.2 In vitro antimicrobial susceptibility tests for 
biofilm-grown cells 
 
Assays developed to test the antimicrobial susceptibilities of bacterial biofilms, 
include the biofilm MIC assay, biofilm MBC assay, MBEC assay (Aaron et al., 
2002; Ceri et al., 1999; Cochran et al., 2000; Raad et al., 2003; Wu et al., 2003).  
In biofilm susceptibility testing assays, biofilms are established in a 96 well 
microplates, either on the bottom or on the pegs suspended from the lid.  The 
biofilms are then treated with antimicrobial agents at serial dilutions.  Lack of 
bacterial growth after 24 h is considered as biofilm inhibition; killing of 99.9% of 
biofilm-embedded cells is defined as the biofilm MBC, and no growth on either 
recovery broth or agar plates are considered as biofilm eradication, indicating a 
complete killing.   
 
Most biofilm antimicrobial susceptibility assays are based on recovering and 
enumerating viable cells from biofilms on agar plates after antimicrobial exposure.  
Scraping, vortexing or sonication in combination with viable counts has been 
applied to determine the number of live cells in biofilms grown on the CBDs or 
conventional microplates (Bjerkan et al., 2009; Cerca et al., 2005a; Ceri et al., 
1999).  Sonication of low frequency and power dissociates the biofilm matrix and 
releases single cells with minimum damage to the cells.  Use of sonication baths 
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with lid-attached pegs, although useful as high-throughout methods, vary in 
efficacy of dissociation and is complicated by cross-contamination between 
microwells.  Vortexing and scraping have also been used for bacterial dissociation 
from the biofilms (Garcia-Saenz et al., 2002; Kobayashi et al., 2009; Nishimura et 
al., 2006), however, most of these mechanical methods have low efficacy in 
dissociating the biofilm cells and are time-consuming and labour-intensive.  Viable 
counting not only is labour-intensive and time-consuming, but fails to recover the 
viable but nonculturable bacteria.   
 
An alternative to recovery agar plating is the broth recovery method, which 
qualitatively detects the presence of any live cells after antimicrobial treatment by 
culturing the treated biofilms in nutrient-rich broth followed by turbidity check. 
Antimicrobial carryover after biofilm antimicrobial treatment always remains as a 
problem which would compromise the sensitivity of viable cell detection with the 
broth recovery method.  Other methods used to replace the agar/broth based viable 
cell recovery, are based on using viability indicators to assess the killing efficacy of 
antimicrobial agents.  Bioluminescence assays measure bacterial ATP activity 
during bacterial growth.  The sensitivity of this method for biofilm-grown bacteria 
is low since the level of ATP is low if the growth is slow  (Hendry et al., 2009).  
Tetrazolium salt (e.g. 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) 
carbonyl]-2H-tetrazo-lium hydroxide (XTT)), and alamar blue have been used as 
metabolic indicators of the viable cells within biofilms  (Pettit et al., 2005; Pettit et 
al., 2009; Rodriguez et al., 1992; Wirtanen et al., 2001).  Both XTT and alamar 
blue fluoresce and change color in response to chemical reduction, and the extent of 
the conversion is a reflection of cell viability (Pettit et al., 2005; Rodriguez et al., 
1992; Wirtanen et al., 2001).  These viability indicator-based methods are 
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quantitative, easy to perform and have a high reproducibility.   They provide 
similar results to the more time-consuming viable count based biofilm assays when 
targeting inhibition or 50% killing level (Pettit et al., 2005; Rodriguez et al., 1992; 
Wirtanen et al., 2001).  However, when aiming at a complete killing or a 3 log10 
reduction, these assays demonstrate a low sensitivity as they were reported to detect 
only 90% of the viable cells.  The same problem was found for BacLight 
Live/Dead Viability kit, which only detects 90% of live CoNS.  In addition, most 
of these metabolism-based viability tests, have not been standardized for each 
single bacterial species (Pettit et al., 2009).  Thus, to date the viable count method 
is still the only method that targets complete bacterial killing of biofilm bacteria by 
antimicrobial agents. 
 
1.7 Controlling strategies for CoNS biofilm related 
infections  
 
Various strategies have been developed or are under development to manage 
catheter-related neonatal sepsis caused by CoNS in NICUs.  These strategies were 
designed to cover the issues of how to avoid biofilm formation and how to eradicate 
established biofilms on CVCs.  To prevent biofilm formation, most published 
studies targeted the early adherence stage of CoNS biofilm formation; and for 
biofilm treatment, the strategies aimed at bacterial killing and/or EPS matrix 
removal from established biofilms.  Prophylaxis for biofilm formation and 
methods to eradicate the established biofilms are summarized in below.  However 
their exact efficacies in successfully preventing and treating biofilm-related CoNS 
infections have not been proven in vivo, where a complete killing of the biofilm 
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cells is preferably targeted.  Chapter 6 will compare different antimicrobial agents 
for their efficacies against established CoNS biofilms, with an aim of establishing 
more effective methods for management of catheter-related neonatal sepsis caused 
by CoNS. 
 
1.7.1 Prophylaxes of biofilm-related infections 
 
Attempts at prevention of CoNS infections emphasize the difficulty of eradicating 
established CoNS biofilms with conventional antimicrobials.  Prevention can be 
divided into two categories: preventing the exposure of implanted devices to CoNS, 
and hindering colonization of CoNS if exposure does occur.  
 
1.7.1.1 Compliance of catheter care procedures 
 
Strict adherence to good infection control practice results in a significantly lowered 
incidence of catheter-related sepsis (Harbarth et al., 2003).  Careful selection of  
the insertion site to avoid high density of skin flora, hand disinfection, use of 
maximal sterile barrier precautions, site preparation, skin disinfection, use of 
needleless connectors, disinfection of catheter hubs and injection ports before 
accessing the catheters, and limiting the number of catheter manipulations are 
critical in the prevention of CoNS infections (Berenholtz et al., 2004; O'Grady et al., 
2002; Pronovost et al., 2006; Rogers et al., 2009).  Despite the implementation of 
strict compliance to the standard insertion procedures and maintenance, the 
implanted device can still be contaminated by CoNS and catheter-related CoNS 
infections are still frequently reported.  
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1.7.1.2 Advanced catheter manufacturing techniques 
 
Advances in biomaterial development in CVCs have led to a reduction in 
occurrence of catheter related sepsis, as newer materials have lower affinity for 
CoNS and other bacteria.  As described earlier, Teflon and polyurethane are 
widely used in NICUs, replacing earlier materials such as polyvinyl chloride and 
polyethylene (Sheth et al., 1983).  In vitro adhesion of CoNS on catheter surfaces 
can be reduced by covalently bonding certain chemicals to the polymer surface.  
Examples of surface modification of catheter polymers include using sulfonated 
polyethylene oxide as a surfactant in polyurethane, adding 
glycerophosphorylcholine as a chain extender on polyurethane, and modifying 
polystyrene catheters with a copolymer of polysthylene oxide and polypropylene 
oxide (Baumgartner et al., 1997; Bridgett et al., 1992; Han et al., 1998).   
 
1.7.1.3 Impregnated antibacterial agents 
 
Antiseptic and antimicrobial agents can be impregnated or covalently immobilized 
on implantable medical device surfaces to prevent bacterial growth and biofilm 
formation (Osinska-Jaroszuk et al., 2009).  Catheters coated with chlorhexidin 
with silver sulfadazine, tridodecylmethylammonium chloride, lysostaphin, 
chlorhexidine or benzalkonium chloride, gentian violet, iodine, ponericin G1, and  
some humans non-steroidal anti-inflammatory agents (NSAIDs), such as sodium 
salicylate, have reduced the incidence of catheter related sepsis in clinical trials 
(Arciola et al., 1998; Bandara et al., 2004; Duran et al., 1993; Farber et al., 1995; 
Hell et al., 2009; Maki et al., 1997; Rupp et al., 2005b; Shukla et al., 2009; 
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Veenstra et al., 1999a; Veenstra et al., 1999b).   
 
Antimicrobial agents have also been used to impregnate CVCs.  Catheters coated 
with rifampicin and minocycline were effective in minimizing CoNS infections 
(Darouiche et al., 1999; Falagas et al., 2007; Raad et al., 1997).  Other 
antimicrobials used in experimental studies as effective catheter coating agents 
include ampicillin, cefazolin, ciprofloxacin, clindamycin, dicloxacillin, 
fluocloxacillin, fusidic acid, vancomycin, and teicoplanin (Jang et al., 2010; Rogers 
et al., 2009).  Despite their efficacy in reducing bacterial adherence, the limitations 
of these coating approaches should not be ignored.  Firstly, application of 
antimicrobials on the catheter surface can induce plasmid-encoded resistance that is 
widespread in staphylococci (Otto, 2008).  Secondly, use of antimicrobials as 
catheter-coating agents is still in experimental trial stage, and few of them are 
commercially available.  Finally, studies investigating the efficacy of 
antimicrobial-coating catheter were all designed and developed for adults; few 
studies have been performed for neonates (Kohnen et al., 2003; Maki et al., 1997; 
Raad et al., 1996).  
  
1.7.2 Treatment of catheter-related neonatal sepsis caused 
by CoNS 
 
1.7.2.1 Killing biofilm-associated cells  
 
1.7.2.1.1 Systemic antimicrobial treatment and removal of catheters  
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Conventional treatment of biofilm-related CoNS infections consists of antimicrobial 
therapy appropriate for methicillin-resistant CoNS for 5-7 days with or without 
removal of the implanted catheters (Eggimann et al., 2000; Karlowicz et al., 2002; 
Mermel et al., 2001; Thylefors et al., 1998; Uckay et al., 2009).  The agents 
ideally should have potently bactericidal activities against slow-growing bacteria 
(Spoering & Lewis, 2001).  However, the success rate of conventional 
antimicrobials is relatively low, probably because most conventional antimicrobial 
agents fail to effectively kill the biofilm-grown CoNS (Klingenberg et al., 2005).  
Among conventional antimicrobials, only rifampicin and ciprofloxacin are able to 
eradicate the biofilm cells in vitro, but concentrations required for biofilm 
eradication were beyond the highest serum achievable concentrations (Aggarwal et 
al., 2009; Cerca et al., 2005a).  In addition, the rapid emergence of resistance to 
rifampicin during monotherapy renders it unsuitable for use alone to treat 
biofilm-related infections.  Rifampicin in combination of vancomycin, β-lactam, 
cotrimoxazole, fusidic acid, tigecycline, daptomycin, linezolid, 
quinupristin/dalfopristin, dalbavancin, minocycline, ofloxacin, ciprofloxacin, and 
levofloxacin were tested in vitro or in animal models, and were found efficacious 
against CoNS biofilms (Ein et al., 1979; Gagnon et al., 1994; Monzon et al., 2001).  
Beside the antimicrobial combinations involving rifampicin, Fujimura et al. (2008, 
2009) found a combination of vancomycin and clarithromycin may effectively 
eradicate both in vitro and in vivo staphylococcal biofilms  (Fujimura et al., 2008; 
Fujimura et al., 2009).  In contrast, there are numerous reports presenting the 
failure of antimicrobial combinations, even involving rifampicn, in eradication of 
CoNS grown in biofilms (Uckay et al., 2009).  The failure of conventional 
antimicrobial treatment leaves no choice but removal of the infected medical 
devices (Cervera et al., 2009).  However, removal of catheters is frequently not an 
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option, particularly for long-term catheters or tunneled catheters, because of the 
high cost and difficulty of reinsertion.  
 
1.7.2.1.2 New antimicrobial agents for CoNS biofilm eradication  
 
Examples of novel reagents targeting S. epidermidis biofilms include linezolid, 
tigecycline, daptomycin, lysostaphin and some QS agents (Aksoy & Unal, 2008).  
 
Linezolid is the first commercially available oxazolidinone approved by the US 
Food and Drug Administration (FDA) in 2000.  This protein synthesis inhibitor 
demonstrates excellent activity against S. epidermidis biofilms (Mogenet et al., 
2004; Raad et al., 1998a; Saginur et al., 2006).  This drug has been used as a 
clinical alternative to vancomycin and is generally reserved for staphylococcal 
infections in neonates who cannot tolerate vancomycin, as it has a similar efficacy 
but fewer adverse effects than vancomycin.  However, the high cost of using 
linezolid for infection control and increasing bacterial resistance limit the wide use 
of linezolid (Hong et al., 2007).  Tigecycline is an intravenous glycylcycline 
antimicrobial agent approved by the USA FDA in 2005.  Tigecycline is four times 
more potent than vancomycin and daptomycin against adherent CoNS (Aslam et al., 
2007).   However, its side-effects, in particular those on teeth and bones, limit its 
use in NICUs (Scheinfeld, 2005).  Daptomycin is a novel lipopeptide 
antimicrobial agent used in the treatment of staphylococcal infections.  It was 
approved by the USA FDA and marketed in 2003.  This agent shows great promise 
in treating catheter-related infections caused by Staphylococcus spp. in some in 
vitro studies, probably due to its potency against Staphylococcus and its rapid 
penetration through biofilm matrix (LaPlante & Mermel, 2007; Stewart et al., 2009).  
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In addition to these antimicrobial agents, some other drugs also demonstrated 
excellent anti-staphylococcal potency, including a β-lactam antimicrobial agent, 
ceftobiprole, a dihydrofolate inhibitor, iclaprim, an aminoglycoside arbekacin, and 
some new glycopeptides, i.e. televancin, dalbovancin, and oritavancin (Rouse et al., 
2007; Suzuki, 2003; Trampuz & Widmer, 2006), however, most of these drugs are 
still under an experimental stage, not yet for clinical use (Lemmen et al., 2003; 
Soriano et al., 2005).  Lysostaphin is an endopeptidase derived from 
Staphylococcus simulans which has showed efficacy against S. epidermidis both in 
vitro and in animal studies when combined with either oxacillin or naficillin (Kiri et 
al., 2002; Walencka et al., 2005); however, no clinical data has been provided to 
support the use of lysostaphin in the treatment of staphylococcal infections.   
 
The ability of the agr QS system to negatively regulate Staphylococcus biofilm 
formation affords another novel potential target to control CoNS biofilm related 
infections.  Balaban et al. (2003, 2007) found that RNAIII-inhibiting peptide (RIP) 
could significantly reduce the biofilm formation of S. epidermidis and S. aureus in 
both in vitro model and animal biofilm model.  Moreover low-dose RIP possessed 
a synergistic effect with antimicrobials such as teicoplanin, if used in combination, 
resulted in augmented anti-staphylococcal activity (Balaban et al., 2007).  Others 
also suggested that RIP could be used as a therapeutic or prophylaxis for 
staphylococcal infections (Anguita-Alonso et al., 2007).  However, there are still 
possible limitations of using QS agents as therapeutic targets, including: 1) 
inactivation of agr systems enhances the biofilm growth of staphylococci; 2) 
staphylococcal strains quickly develop resistance to arg antagonistics and agr 
mutants frequently are found in clinical staphylococcal isolates during therapy; 3) 
Different staphylococcal subgroups using different signals might compromise the 
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cross-inhibition effect of QS agents; 4) agr expression is tissue-specific and time 
and cell-density-dependent (Otto, 2004a).  
 
1.7.2.1.3 Catheter lock solutions 
 
Failures of systemic antimicrobials to successfully treat catheter-related neonatal 
sepsis caused by CoNS (Allon, 2004; Benjamin et al., 2001; Berrington & Gould, 
2001; Gagnon et al., 1993), could be due to the inability of most conventional 
antimicrobials to eradicate biofilm-grown bacteria (Donlan, 2000; Klingenberg et 
al., 2005), or to poor access of antimicrobials to the internal surface of the catheter 
lumen when the catheter is in place (Bastani et al., 2000).  However, these 
deficiencies can be overcome by the catheter lock technique (CLT), which involves 
filling the lumen of the catheter with an antimicrobial agent at a high concentration 
(100-1000 times higher than is used systemically) and allowing the compounds to 
dwell for a period of time while the catheter is not in use (Messing et al., 1988).  
When catheter lock technique is used, antimicrobials can easily reach a very high 
concentration, by passing the human serum tolerant limit and gain access to the 
biofilm cells residing on the internal surface of catheter lumen. 
 
A recently published prospective case-series analysis reported that use of 
vancomycin and teicoplannin locks for CoNS venous port-related sepsis had a cure 
rate of nearly 90% (Del Pozo et al., 2009b).  However, earlier studies showed that 
the effectiveness of conventional antimicrobials as catheter lock solutions (CLS) is 
suboptimal, even at very high concentrations (Allon, 2003; Curtin et al., 2003; 
Fernandez-Hidalgo et al., 2006; Kite et al., 2004).  In addition, the application of 
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antimicrobials may be associated with development of resistance, allergic reactions 
and toxicity.  Concentrations of antimicrobials ranging from MIC to 
pharmacological concentrations (the highest concentration without apparent 
precipitation of antimicrobial powder or evaporation of solutions) have been used in 
catheter locks, however, there is no current recommendation regarding the dosing 
and locking time of the antimicrobials (Del Pozo et al., 2009b).  Ethanol is 
extremely effective in the treatment of catheter related bloodstream infections when 
applied as a catheter lock solutions (Metcalf et al., 2004; Onland et al., 2006; Opilla 
et al., 2007), however, there is still a lack of scientific data on the effectiveness of 
ethanol in eradication of biofilm-grown bacteria.  When ethanol and other 
antimicrobial agents were used as CLS in previous studies, their concentrations and 
exposure time were chosen arbitrarily and hence there is much variation in the 
effectiveness reported in different studies (Bailey et al., 2002; Berrington & Gould, 
2001; Lee et al., 2006; Onland et al., 2006; Opilla et al., 2007). 
 
1.7.2.1.4 Degradation of extracellular matrix 
 
Breaking down the extracellular matrix with chemicals is another approach to 
eradicate CoNS biofilms.  Such an approach would allow the penetration of both 
antimicrobials and constituents of human immunity through the biofilm EPS, and 
removal of the seedbed for bacterial growth (Yasuda et al., 1994).   
 
The enzyme, dispersin B, which was first found in Actinobacillus 
actinomycetemcomitans, degrades staphylococcal PIA and destroys the 
staphylococcal biofilm matrix structure (Itoh et al., 2005; Kaplan et al., 2004).  
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Other enzymes including lysostaphin, urokinase, athough non-specific, can also 
greatly facilitate the penetration of the antimicrobial agents into the biofilm matrix 
(Demoulin & Goffin, 2009; Gotz, 2004; Wang et al., 2007a; Wu et al., 2003).  
Some antimicrobial agents, in addition to their anti-bacterial function, can be used 
as EPS-degrading agents.  For instance, clarithromycin possesses an ability to 
eradicate the glycocalyx matrix of biofilms formed by a clarithromycin-resistant S. 
epidermidis strain (Yasuda et al., 1994).  However, the use of EPS-degrading 
agents for catheter related sepsis still remains at an early developmental stage. 
 
1.7.3 Other methods for biofilm control 
 
1.7.3.1 Bioacoustic method as an adjuvant of antimicrobial 
chemotherapy 
 
Bioacoustic effect is a term used by Johnson et al. (1998) to describe the effect of 
ultrasound on biofilms.  In an animal study, ultrasonic waves of 28.48 KHz, were 
found effective in treating CoNS biofilm-related infections when in combination 
with vancomycin (Carmen et al., 2004), but only incomplete killing of biofilm cells 
can be achieved.  Another in vitro study, however, found that ultrasound of 70 kHz 
and low power density (<2 W/cm2) increases the growth rate of S. epidermidis 
adhered to polymer surfaces (Pitt & Ross, 2003).  The mechanisms of ultrasound 
in biofilm killing is still uncertain, likely due to the interruption of biofilm 
structures and promotion of antimicrobial penetration (Carmen et al., 2004).  
Another hypothesis is that ultrasound increases the rate of transport of oxygen and 
nutrients to and waste products away from the biofilm cells, thus enhancing their 
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growth (Pitt & Ross, 2003).   
 
1.7.3.2 Bioelectric effect 
 
The term “bioelectric effect” was initially coined by Costerton et al. (1994).  
These researchers postulated that manipulation of electrical fields that surround 
biofilm bacteria might alter the configuration of the EPS matrix and lead to increase 
of antimicrobial penetration into both biofilm matrix and bacterial envelopes 
(Costerton et al., 1994).  This hypothesis was supported by the later findings that a 
low electric current combined with antimicrobial agents was able to enhance the 
killing of biofilm-associated bacteria, when compared with the antimicrobial agent 
alone (Del Pozo et al., 2009a; Wellman et al., 1996).  A recent in vivo study 
modeling chronic foreign body osteomyelitis also found that an electrical current of 
200 microA was active on S. epidermidis biofilms (Del Pozo et al., 2009c), but 
complete eradication of bacteria could not be achieved.  Moreover, all these works 
were performed in vitro or in animal models and have not been effectively proven 
in clinical situations (Jass et al., 1995; Jass & Lappin-Scott, 1996; van der Borden 
et al., 2005; Wellman et al., 1996).   
 
1.7.3.3 Bacteriophage 
 
The effect of bacteriophage on eradication of bacterial biofilms has been reported 
by a few in vitro studies (Jass et al., 1995; Jass & Lappin-Scott, 1996; van der 
Borden et al., 2005; Wellman et al., 1996).  Cerca et al. (2007) used phage K to 
challenge S. epidermidis biofilms and showed a significant reduction of biofilm 
mass after 24 h (Cerca et al., 2007).  Curtin and Donlan (2006) treated 
  71 
hydrogel-coated silicone catheters with a lytic S. epidermidis bacteriophage 456 and 
found a significant reduction of viable biofilm formation by S. epidermidis over an 
exposure period of 24 h.  These findings suggested the potential of bacteriophage 
for mitigating biofilm formation on indwelling catheters and reducing the incidence 
of catheter-related infections.  However, this approach might be limited due to the 
specificity of phage-staphylococcal interaction, i.e. the requirement for 
staphylococcal phages specific to each infecting staphylococcal strain (Cerca et al., 
2007). 
 
1.7.3.4 Vaccination 
 
Use of PIA as the basis of a vaccine to prevent staphylococcal infections attracted 
much interest over the past 10 years (Gotz, 2004; McKenney et al., 1999).  
Although vaccines against bacterial capsule polysaccharide have been generated for 
other bacterial species, development of effective PIA-based vaccines was generally 
unsuccessful (Prenafeta et al., 2009).  In some published clinical trials, anti-PIA 
antibodies failed to prevent the establishment of catheter-related infections in 
participating patients (Kelly-Quintos et al., 2005; Sadovskaya et al., 2007).  
Neutralizing antisera against other cellular components such as PSMs and surface 
proteins, e.g. fibronectin-binding protein and lipase 2, may be promising as 
immunization strategies (Rennermalm et al., 2001; Xiong et al., 2009), however 
there is still a lack of clinical data to support their effectiveness.   
 
1.7.3.5 Bioactive compounds 
 
In vitro studies reported that bioactive compounds (excretions/secretions) released 
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by Lucilia sericata larvae (maggots) have protease and glucosaminidase activities 
(Harris et al., 2009; van der Plas et al., 2010).  These compounds could disrupt 
biofilm formation of S. epidermidis, via interrupting the biofilm accumulation stage 
(by degrading both PIA and AaP) and increase the bacterial susceptibility to 
antimicrobial agents and the host’s immune system (Harris et al., 2009; van der Plas 
et al., 2010).  It has been shown that adding maggot excretions/secretions to 
conventional incubations resulted in a complete breakdown of staphylococcal 
biofilm (Cheung & Otto, 2010).  Thus these molecules have potential as adjuvants 
for use in controlling biofilm-related infections (van der Plas et al., 2010).  
  
1.7.3.6 Photodynamic treatment 
 
In photodynamic treatment (PDT), photosensitisers such as methylene blue (MB) or 
cationic porphyrin, tetra-substituted N-methyl-pyridyl-porphine (TMP) are released 
to yield receiver compartment concentration.  When MB or TMP is exposed 
simultaneously to visual light or ultraviolet light at certain levels, these compounds 
become phototoxic to various microorganisms, even drug-resistant bacteria, 
normally via oxidative damage (Donnelly et al., 2009; Wainwright, 1998).  If 
combined with an effective drug delivery platform system, such as poly (vinyl 
alcohol)-borate complexes and polyacrylamide (PAA) hydrogel matrix of dynamic 
nanoplatforms and/or in combination with antimicrobial chemotherapy or host 
defense mechanisms such as phagocytosis, PDT would be an effective candidate for 
treatment of some staphylococcal biofilm associated infections (Donnelly et al., 
2009; Wainwright, 1998; Wu et al., 2009a).  Though PDT has the potential to 
become a low-cost approach to the treatment of locally occurring infection, it is still 
at the early developmental stage and has not been applied in clinical situations.  
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Moreover, the PDT method worked more efficiently on young and developing 
biofilms than mature biofilms (Sbarra et al., 2009; Wu et al., 2009a).  
  
1.8 Objectives and specific aims  
 
The objectives of this study were to:  
 
1. Investigate the biofilm resistance phenomenon. Specifically, to examine the 
changes in antimicrobial susceptibilities when CoNS experience biofilm 
development, from a log planktonic phase into early adherent monolayer, mature 
biofilms and then stationary planktonic phase again.  The following questions 
were addressed:  
i.What is the current antibiogram profile of clinical CoNS isolated from RWH 
NICU?  
ii.Are the first line agents used in NICUs and their combinations, at a serum 
achievable concentration, of sufficient potency for the eradication of 
biofilm-grown CoNS?  
iii.Do CoNS exhibit different resistance to conventional antimicrobial agents when 
experiencing the biofilm-development process?  If so, what is the extent of 
these differences?   
 
2. To investigate mechanisms of biofilm resistance to antimicrobial agents 
To examine the roles of a series of factors in biofilm resistance to antimicrobial 
agents, including the general susceptibility characteristics of biofilm-related cells, 
the presence of persister cells, highly densely adherent growth mode, and EPS 
build-up ability.  Specifically, the following questions were answered:  
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i. Do biofilm-embedded cells and biofilm-released cells present the same 
antibiogram profile as normal planktonic cells? 
ii. Are there more “persister cells” in the biofilm growth mode than the other 
growth modes, such as planktonic cultures at log phase and stationary phase?  
iii. Is there a difference in antimicrobial susceptibilities between multilayer 
biofilms formed by “biofilm-positive” CoNS and monolayer biofilms formed by 
their “biofilm-negative” mutant/variant?  
 
3. To establish an optimum strategy to eradicate biofilm-grown CoNS and to cure 
biofilm-related CoNS infections.  Specifically, ethanol and other conventional 
antimicrobials and their combination will be compared for biofilm eradication as 
CLS, and the most optimum agent and the necessary exposure time will be 
determined. 
  
All these investigations aim to minimize the incidence and morbidity of CoNS 
neonatal sepsis in NICUs.
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Chapter 2: General materials and methods 
 
2.1 General materials 
 
Lists of materials, consumables, equipments and their manufacturers or suppliers 
are provided in Appendix A. 
 
2.1.1 Solutions and growth media 
 
A list of recipes for solutions and growth media used in the various experiments is 
provided in Appendix B.  All the solutions and growth media were prepared 
according to the manufacturers’ or published recipes.  
 
2.1.2 Bacterial strains used in this study 
 
Twenty-four CoNS strains isolated from blood cultures of VLBW newborns 
receiving treatments in the RWH NICU were used in this study (Table 2.1).  These 
isolates were identified previously to species level, examined for their ability to 
produce biofilms in TSB with and without supplementation (Bradford et al., 2006).  
They were classified as invasive isolates or probable contaminants based on the 
definition of sepsis in CDC-NNIS guidelines (United States Center for Disease 
Control and Prevention – National Nosocomial Infection Surveillance System) and 
following review of the clinical case histories by a pediatrician Dr. W. 
Uahwatanasakul from the Royal Children’s Hospital (RCH), Melbourne.  Two 
ATCC strains: S. epidermidis ATCC 35984 (RP62a) and S. hominis ATCC 3598
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Table 2.1 Bacterial isolates and biofilm growth media used in this study 
Isolate  Species Status Growth medium for biofilm 
formationa 
   TSB TSB+1% 
glucose 
TSB+4% 
NaCl 
1 S. warneri Invasive  +  
2 S. haemolyticus Invasive -   
3 S. epidermidis Invasive +   
4 S. epidermidis Invasive +   
5 S. epidermidis Invasive +   
6 S. capitis Invasive   + 
7 S. epidermidis Invasive +   
8a S. capitis Invasive   + 
8b S. capitis Invasive   + 
9 S. capitis Invasive   + 
10 S. epidermidis Invasive  +  
11 S. epidermidis Invasive +   
12 S. epidermidis Contaminant  w  
13 S. epidermidis Contaminant +   
15 S. capitis Contaminant  w  
16 S. capitis Contaminant  +  
17 S. capitis Contaminant   + 
18 S. capitis Contaminant   + 
19 S. epidermidis Contaminant -   
20 S. epidermidis Contaminant +   
21 S .epidermidis Contaminant +   
22 S. capitis Contaminant  w  
23 S. epidermidis Contaminant +   
24 S. epidermidis Contaminant  +  
RP62a S. epidermidis Reference +   
SP2 S. hominis Reference -   
ATCC 
25913 
S. aureus  Reference    
a
 Selection of growth medium was based on the medium that produced the highest 
biofilm density for each isolate.  The mass of biofilms produced by each isolate under 
optimal medium was indicated as “+”, “-” or “w”.  “+”: strong biofilm production 
(biofilms stained with Hucker crystal violet, OD600 ≥ 0.24), “w”: weak biofilm 
production (0.12 ≤ OD600 < 0.24), “-”: negative for biofilm production in all media 
(OD600 < 0.12).  Isolates 8a and 8b were from the same baby, collected at different 
episodes of sepsis. 
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(SP2) were used as the controls of biofilm-positive and biofilm-negative strains 
respectively, and S. aureus ATCC 25913 was used as a control of susceptibility 
testing (Table 2.1).  Bacteria were stored at -70°C in TSB with 15% glycerol and 
streaked onto nutrient agar (NA) plates as the working stocks.  These working 
stocks were stored at 4°C and replaced every month.  Before each experiment, the 
bacteria were subcultured onto NA plates and incubated overnight at 35°C. 
 
2.1.3 Antimicrobial agents used in this study 
 
Six anti-staphylococcocal antimicrobial agents of different categories, including 
four commonly used in the RWH NICU for babies with suspected bloodstream 
infections, and two used in other in vitro studies were selected for this study: 
penicillin G (benzyl penicillin) (β-lactam), gentamicin (aminoglycoside), 
vancomycin (glycopeptide), oxacillin (penicillinase resistant β-lactam), ciprofloxacin 
(fluoroquinolone) and rifampicin (rifamycin).   
 
2.2 General procedure and methods 
 
Care was taken to ensure all the practical operations were carried out aseptically.  
Most of the experiments were carried out in a bench physically separated with a 
flaming Bunsen burner or in a biohazard cabinet.  Dedicated pipettes, sterile tips 
and glassware were used to avoid any cross contamination from other projects.  
Disposable gloves were frequently changed to avoid contamination.  
 
Reagents were made from chemicals of an analytical laboratory grade.  Distilled 
water was used as the solvent for most solutions.  Dry chemicals of weights less 
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than 5 g were weighed on a Mettler AE 200 balance.  Dry ingredients weighing 
over 5 g were weighed on an A & D weighing balance, up to a weight limit of 300 g.  
Solutions were dispensed using appropriate Finnpipettes with volumes ranging 
0.5-1.0 µL, 5-40 µL, 10-100 µL, 40-200 µL, 100-1000 µL, 1-5 mL and 1-10 mL.  
For volumes over 10 mL, measuring cylinders were used.  Most of the reagents 
and media were steam sterilized at 121°C for 15 min after thoroughly dissolving 
followed by storing them in a 4°C fridge.  
 
2.2.1 Planktonic bacterial culture at log phase and 
stationary phase 
 
Bacterial suspensions in mid-log phase and stationary phase were prepared as 
described below.  To prepare planktonic cells, three colonies of bacteria from an 
overnight bacterial culture on NA plates were inoculated into 5 mL TSB and 
incubated at 35°C for 4-5 h until the turbidity was equivalent to McFarland 0.5 
(mid-log phase) or for 18 h (stationary phase) with shaking (100 revolutions per 
minute (rpm) to avoid the formation of clumps. 
 
2.2.2 Biofilm bacterial culture  
 
Bacterial biofilm cultures were set up by a modification of an established method 
(Deighton et al., 2001).  Briefly, a bacterial suspension of McFarland standard of 
0.5 (~ 108 CFU/mL) was diluted 1:100 into different diluents, aiming to produce 
maximum amount of biofilms for each individual isolate (Bradford et al., 2006) 
(Table 2.1).  Aliquots of 100 µL of the diluted bacterial suspensions were placed 
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into wells of a 96-well flat bottom polystyrene microplate and the growth was 
allowed to continue for 18-24 h at 35°C without shaking. 
 
2.2.2.1 Biofilm phenotype determination 
 
After overnight incubation, the bacterial suspensions were aspirated out, the wells 
were rinsed twice with 100 µL of phosphate buffered saline (PBS) per well to 
remove nonadherent bacteria.  One drop of Hucker crystal violet (about 50 µL) 
was added into each well for about 1 min to stain biofilms.  The Hucker crystal 
violet in the wells was then discarded and the microplates were washed several 
times to remove excess stain by submerging them in tubs of clean water. The 
microplates were tapped on paper towels to remove excess water in wells and then 
allowed to dry facing down.  The amount of biofilm formed in the wells of 
microplates was read with a plate reader at 590 or 600 nm.  As described by 
Deighton et al. (2001), values of more than 0.24 indicates biofilm positive, values 
between 0.12 and 0.24 indicates weak biofilm production, and values of less than 
0.12 indicates biofilm negative.  The average values obtained from four replicates 
of three repeats for each isolate were calculated and used for biofilm phenotype 
determination. 
 
2.2.3 Adherent monolayer assay 
 
Adherent bacterial culture was established following the method of Miyake et al, 
which involved the addition of 50 µL volumes of 1 x 106 CFU/mL bacterial 
suspensions in TSB into wells of flat-bottomed 96- well microplates (Miyake et al., 
1992).  The microplates were then centrifuged at 20°C for 10 min at 450 x g, 
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followed by incubation at 35°C for 1 h.  Non-adherent bacterial cells were 
removed by gently washing the wells twice with 100 µL PBS. 
 
2.2.4 Antimicrobial susceptibility tests 
 
The MICs of single antimicrobials for planktonic cells in log phase were 
determined with the microdilution method applying the procedures as 
recommended by Clinical and Laboratory Standards Institute (CLSI) (CLSI, 2004).  
Bacterial suspensions at mid-log phase were prepared as described in section 2.2.1.  
The suspensions were then diluted 1:100 to reach a bacterial density of approximate 
1×106 CFU/mL.  Fifty microliters of the diluted bacterial suspension were added to 
an equal volume of two-fold serially diluted antimicrobial solutions, and cultures 
were incubated for 18 h at 35°C for all antimicrobial agents excepted oxacillin and 
vancomycin; incubation for the latter two was extended to 24 h.  The MIC was the 
lowest concentrations of antimicrobial agents that prevented visible turbidity after 
18 or 24-hour incubation.  Muller-Hinton broth (MHB) was used as the growth 
medium for the MIC experiments. When challenging CoNS with oxacillin, MHB 
containing 1% sodium chloride (NaCl) was used instead of MHB (CLSI, 2004).  
 
The MBCs of the antimicrobial agents against planktonic bacteria at log phase were 
determined by the standard method described in CLSI guidelines.  After MICs 
were determined, 10 µL volumes of the solutions from the clear wells were plated 
on NA plates and incubated at 35°C overnight.  The MBCs of antimicrobial agents 
were defined as the lowest concentrations of antimicrobial agents that reduced 
bacterial numbers by 3 log10 when compared with the initial inocula. 
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Chapter 3: Antimicrobial susceptibilities of coagulase- 
negative staphylococci isolated from very-low-birth- 
weight babies: comprehensive comparisons of bacteria 
at different stages of biofilm formation 
 
3.1 Introduction 
 
In NICUs, CoNS, predominantly S. epidermidis, are the most common causative 
agents of neonatal sepsis, a condition related to significant morbidity and mortality 
of newborns (Stoll et al., 2002; Villari et al., 2000).  Biofilm formation has been 
accepted as the main virulence factor of CoNS infections (Childs, 2008; O'Gara & 
Humphreys, 2001).  The presence of a central venous catheter in the VLBW 
babies (< 1000g) is a significant risk factor for biofilm-mediated neonatal sepsis in 
NICUs (Johnson-Robbins et al., 1996; Maas et al., 1998). 
 
Antimicrobial treatment based on standard in vitro susceptibility tests designed for 
planktonic bacteria, such as CLSI methods, frequently failed to clear biofilm-related 
CoNS infections.  It would seem more appropriate to base the treatment on 
susceptibility profile of CoNS grown as biofilms, as studies suggested that bacteria 
grown in biofilms and planktonic cultures behaved differently in their resistance to 
antimicrobial exposure (Blanco et al., 2005; Ceri et al., 1999).  Previous studies 
that compared antimicrobial susceptibilities of biofilm-grown bacteria and 
free-living cells reported inconsistent results (Aaron et al., 2002; Spoering & Lewis, 
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2001).  Most studies using bacteria isolated from adults and older children 
reported that biofilm-grown bacteria were 100-1000 times more resistant than their 
planktonic counterparts (Aaron et al., 2002; Ceri et al., 1999).  Others reported 
that bacteria grown as biofilms had similar or even higher antimicrobial 
susceptibilities than planktonic cells (Blanco et al., 2005; Spoering & Lewis, 2001).  
This inconsistency could be explained by the differences in methodology: 1) 
different biofilm culture devices were used for biofilm antimicrobial susceptibility 
tests, including the modified Robbin’s device, the CBD and its similar products, and 
the traditional 96-well polystyrene microplate (Aaron et al., 2002; Coenye et al., 
2008).  Different biofilm devices provide biofilms of different structural densities 
and ages, which might lead to different antimicrobial susceptibility (Aaron et al., 
2002); 2) planktonic bacterial cultures of different densities were used in 
comparison with the biofilm growth mode.  Previous studies compared 
susceptibilities of planktonic cultures at ~5 × 105 CFU/mL (log phase) or ~5 × 109 
CFU/mL (stationary phase) with mature biofilms, which contain at least ~ 109-10 
CFU/mL of individual bacteria (Aaron et al., 2002; Ceri et al., 1999; Melchior et al., 
2006).  It has been shown that antimicrobial resistance of Staphylococcus spp. is 
inoculum size dependent (Mizunaga et al., 2005); 3) Different killing outcomes 
were targeted in different studies.  Standard MICs that target growth inhibition and 
MBCs aiming at 3 log10 bacterial reduction of planktonic cells have been compared 
with MBECs that target complete bacterial killing of biofilm cells, which would 
lead to incorrect conclusions (Aaron et al., 2002; Ceri et al., 1999; Spoering & 
Lewis, 2001).  
 
As described before, CoNS experience different phases when grown into a biofilm, 
including planktonic culture at log phase, early adherent monolayer, mature 
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biofilms, and probably planktonic cells at stationary phase.  Antimicrobial 
treatment of biofilm- related infections are often unsatisfactory.  Poor response 
could be partly due to differences in bactieral antimicrobial susceptibility at 
different biofilm developmental stages.  Thus it is important to clarify the 
difference in antimicrobial susceptibility of CoNS when they are grown in different 
modes, on the basis of unique cellular densities and killing outcomes. 
 
Distinct bacterial activities are found in different phases of biofilm-related 
infections (Donlan, 2002).  In the febrile phase of biofilm-related infections, large 
numbers of planktonic cells are rapidly shed from the biofilms and present in the 
surrounding tissues or the bloodstream, and are responsible for the acute 
inflammatory response.  This transitory phase is followed by a prolonged chronic 
phase, in which biofilm bacteria are more likely to remain static and cause milder 
clinical symptoms locally (Hall-Stoodley et al., 2004; Kumon, 2000).  When 
immune competence is weakened or antimicrobial stresses subside, biofilms can be 
re-activated and cells can again detach and/or colonize other sites to cause new 
symptoms (Lewis, 2005; Lewis, 2008).  
 
New definitions have been introduced into the susceptibility tests to cover responses 
of bacterial biofilms to antimicrobials, with regards to clinical presentations.  
Biofilm MIC or biofilm inhibitory concentration (BIC) is an in vitro guide to 
antimicrobial use to prevent biofilms from establishing the febrile infections.  This 
term denotes the minimum concentration of antimicrobials to inhibit biofilms from 
releasing planktonic cells, rather than hindering bacterial growth within biofilms 
(Ceri et al., 2001; Moskowitz et al., 2004).  In the chronic phase of biofilm 
infections which are characterized by less active dispersal, concentrations targeting 
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bacterial killing would be more meaningful than the biofilm MICs in predicting the 
clinical response (Ceri et al., 2001).  Biofilm MBC represents the minimum 
concentration of antimicrobials which reduce the number of the biofilm-embedded 
bacteria by at least 3 log10.  However, the MBC for biofilms is not as important as 
that for planktonic cells with regards to its clinical significance.  When an 
immunocompetent host is treated with antimicrobial agents at MBC, 99.9% of 
planktonic bacteria are killed and the remaining 0.1% can be further eradicated by 
human immune responses.  When targeting biofilms, as the biofilm EPS 
compromises the effect of immune responses, the 0.1% “persister cells” can resume 
multiplication once the level of antimicrobials falls, and rebuild the biofilm 
structures (Lewis, 2001; Lewis, 2005).  Therefore the MBEC is clinically more 
important than the biofilm MBC as it targets a complete bacterial killing (Ceri et al., 
1999; Ceri et al., 2001).  In spite of numerous studies of biofilm MBCs and 
MBECs in vitro, the application of either biofilm MBCs or MBECs in clinical 
situations is rare and has not been verified.   In addition, the MBEC might be an 
impractical goal when conventional antimicrobials are used in vitro, but the biofilm 
MBC, which targets 99.9% killing of biofilm-grown bacteria, may be achievable. 
 
Assessments of biofilm antimicrobial susceptibility are generally based on the 
numerical reduction of the viable cells within the biofilm matrix.  The Calgary 
Biofilm Device in combination with a sonication bath has been widely used for 
biofilm susceptibility tests.  However, this device is preferable for gram-negative 
bacteria such as P. aeruginosa and E. coli, not Staphylococcus. spp., as both P. 
aeruginosa and E. coli produced biofilms at the liquid and air interface of 
biomaterials (pegs).  For coagulase-negative staphylococci, biofilms were 
predominantly produced on the bottom of the microwells, when grown under 
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standard conditions (TSB, 35 ºC, 18 h, O2).  Beside the costly features of the 
Calgary biofilm device in susceptibility tests, its combined sonication and/or 
scraping methods are of unknown accuracy and prone to cross-contamination (Ceri 
et al., 1999; Raad et al., 2003).  Sonication and/or scraping are applied to 
dissociate the bacteria from the pegs (Ceri et al., 1999; Ceri et al., 2001).  The 
efficacy of sonication in dissociating biofilm cells was reported to be relatively low.  
Another disadvantage is that the explosive force produced by sonication can easily 
cause cross-contamination by spilling the droplets of bacterial suspension from one 
microwell to another one nearby.  
 
Biofilms produced by CoNS consist principally of PIA, which is encoded by the 
icaADBC operon.  Some antimicrobials at subinhibitory concentrations were 
reported to enhance CoNS biofilm formation by stimulating ica expression (Cerca 
et al., 2005b; Rachid et al., 2000; Rupp & Hamer, 1998).  Most previous studies 
examining the effect of antimicrobials on biofilms were designed to target the stage 
when bacteria switched from a planktonic form to a biofilm (Cerca et al., 2005b; 
Rachid et al., 2000; Rupp & Hamer, 1998); however, the effect of antimicrobials on 
established biofilms is more significant for infections of VLBW infants in NICUs.  
In addition, those studies examined the effect of antimicrobials at subinhibitory 
concentrations; however concentrations achievable in serum would be more 
clinically relevant. 
 
The objectives of this study were to (i) investigate the susceptibilities of 
NICU-acquired CoNS to antimicrobials most commonly used to treat babies, using 
the standard CLSI methodology, (ii) compare the antimicrobial susceptibilities of 
CoNS in different stages of biofilm formation: planktonic cells at log phase, 
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adherent monolayers, mature biofilms and planktonic cells at stationary phases (iii) 
determine any stimulatory effects of the first line antimicrobials used in NICUs on 
preformed CoNS biofilms. 
 
3.2 Materials and methods 
 
3.2.1 Staphylococcal isolates 
 
Twenty-four CoNS isolates (Table 2.1) were examined to obtain an overall view of 
the antimicrobial susceptibility patterns of strains circulating in the unit and to 
determine the effect of antimicrobials at serum achievable concentrations on 
preformed biofilms.  For detailed studies of the antimicrobial susceptibility 
patterns of CoNS in different growth modes, nine representative isolates were 
selected.  These isolates include two biofilm-positive S. epidermidis (Isolates 3 
and 11), one biofilm-negative S. epidermidis (Isolate 19), two biofilm-positive S. 
capitis (Isolates 8a and. 9), two biofilm-weak/negative S. capitis (Isolates 15 and. 
22) and two laboratory reference strains S. epidermidis ATCC 35984 (RP62a), and S. 
hominis ATCC 35982 (SP2), which were used as biofilm-positive and 
biofilm-negative controls respectively.  
 
3.2.2 Antimicrobial agents 
 
Six antimicrobial agents were chosen for this study; penicillin G, gentamicin, 
vancomycin, oxacillin, ciprofloxacin and rifampicin. 
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3.2.3 MICs for planktonic cells at mid-log phase and 
adherent monolayers 
 
The MICs of single antimicrobials for planktonic cells at mid-log phase were 
determined by standard broth microdilution methods (CLSI, as described in section 
2.2.4).    Early adherent monolayers of CoNS were established by following the 
published method (section 2.2.3).  The bacterial numbers of the adherent 
monolayers in four wells (column 12, rows A-D) were determined by a series of 
continuous steps: adding 100 µL PBS into each wells, scraping the wells with 
sterile tips, swabbing the wells with a cotton-tipped swab, mixing the contents, 
pipetting out 10 µL of the contents for serially dilution, and plating 10 µL of the 
diluted solution on NA plates and overnight incubation.  The average bacterial 
count was used to represent all monolayers in the microplates.  To examine the 
MICs of antimicrobial agents for adherent monolayers, 100 µL volumes of twofold 
dilutions of antimicrobials in MHB or MHB plus 1% NaCl (for oxacillin), ranging 
from 128 µg/mL to 0.001µg/mL, were added to microwells with established 
adherent monolayers.  Microplates were incubated at 35°C aerobically for 18 h (all 
antimicrobials except oxacillin and vancomycin) or 24 h (oxacillin and 
vancomycin).  MICs for adherent monolayers were defined as the lowest 
concentration of antimicrobials that prevented visible turbidity after 18 or 24-hour 
incubation at 35°C.   
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3.2.4 MBCs for planktonic cells at mid-log phase and 
adherent monolayers 
 
The MBCs of the antimicrobials against planktonic bacteria at log phase were 
determined by the standard CLSI method, as described in section 2.2.4.  The log10 
reduction for adherent monolayers was calculated by dividing the pre-determined 
viable count in the untreated wells by the viable counts in individual wells after 
antimicrobial exposure.  The MBCs of antimicrobial agents against planktonic 
cells at log phase and adherent monolayers were defined as the lowest 
concentrations that reduced bacterial numbers by 3 log10.  
 
3.2.5 MICs for planktonic cells at stationary phase and 
biofilm-grown bacteria 
 
The MICs of antimicrobials against bacteria at stationary phase could not be tested 
by standard procedures as the maximum cell density had already been reached.  
The method to determine MICs for biofilm-grown bacteria was developed from a 
published method (Ceri et al., 2001).  Biofilms were established in 96-well 
microplates, as described in section 2.2.2.1 and exposed to 100 µL of two-fold 
serial dilutions of antimicrobial agents in MHB or MHB plus 1% NaCl (for 
oxacillin), ranging from 1024 µg/mL to 0.001 µg/mL.  Microplates were then 
incubated at 35°C for 18 or 24 h, depending on the antimicrobials tested.  After 
overnight challenge, the liquid contents in the microplate were carefully transferred 
to a new 96-well microplate without disturbing biofilms, and the turbidity was 
visually assessed.  The biofilm MIC was defined as the lowest concentration of 
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antimicrobial agents at which no visible growth was observed.  When exposed to 
antimicrobials at or above this concentration, the planktonic bacterial population 
could not be established by bacterial shedding from the biofilms. 
 
3.2.6 MBCs for planktonic cells at stationary phase and 
biofilm-grown bacteria 
 
Minimum bactericidal concentrations, rather than MBECs were used to compare 
resistance of biofilms and planktonic cells at stationary phase to antimicrobial 
agents.  
 
Determination of MBCs for biofilms was also based on the reduction in viable 
counts after overnight exposure to antimicrobial agents.  After establishing 
biofilms in 96-well microplates, the bacterial numbers of the biofilms in four wells 
(column 12, rows A-D) were determined following a published method and the 
mean was used to represent all biofilms in the microplates (Gualtieri et al., 2006).  
One hundred microlitres of MHB were added into microwells containing biofilms.  
The biofilm matrix was then scraped with a sterile tip, and sonicated (Branson 450 
sonifier with a microtip) for 8 seconds (4 × 2s) at 11% of the maximum amplitude.  
The suspensions containing biofilm cells was serially diluted with PBS and streaked 
onto NA plates, which were then incubated overnight at 35°C before counting.  
The viable bacteria remaining in biofilms in microwells with antimicrobial 
concentrations above MICs were similarly counted.  MBCs for biofilms were 
calculated by dividing the pre-determined viable count of untreated biofilms by the 
viable counts of specified wells after antimicrobial exposure.  The MBCs of the 
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antimicrobials against planktonic bacteria at stationary phase were determined 
following the CLSI guidelines (2004) except that stationary phase cultures replaced 
log phase cultures.  The MBCs for both planktonic cells at stationary phase and for 
biofilms were defined as the minimum concentration of antimicrobials required to 
reduce bacterial numbers by 3 log10. 
 
3.2.7 Effects of antimicrobial agents at the highest 
concentration achievable in serum on preformed biofilms 
 
To determine the effects of antimicrobials on established biofilms, 100 µL volumes 
of TSB alone and of TSB containing the antimicrobials at the highest serum 
achievable concentration (32 µg/mL for oxacillin, 32 µg/mL for vancomycin, 8 
µg/mL for gentamicin), were added to established biofilms (Murray et al., 2007).  
After incubation at 35 ˚C for 24 h, biofilm quantification was carried out by staining 
with crystal violet (section 2.2.2).  The intra-microplate variability was 
pre-determined by comparing the OD600 of each microwell containing TSB alone.  
Differences between the OD600 values of the test wells and the antimicrobial-free 
wells, if greater than the intra-microplate variability, were considered as an 
enhancement or reduction of the biofilms, depending on the trend of the change.  
After determination of antimicrobial-bacterium combinations that resulted in 
increases in OD600 following antimicrobial challenge, dose-response studies were 
carried out, with biofilms of two representative CoNS strains challenged with the 
antimicrobial at a range of concentrations.  
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3.2.8 Phase contrast microscopy, confocal laser scanning 
microscopy, and epifluorescence microscopy 
 
Phase contrast microscopy was used to examine the morphology of adherent 
monolayers formed by all twenty-four CoNS clinical isolates and two reference 
strains.   
 
Three-dimensional structure of S. epidermidis RP62a biofilms was built-up with an 
upright CLSM (Zeiss LSM 510 Meta CLSM).  Sterile polystyrene pieces (~ 0.5 
cm x 0.5 cm) were aseptically cut from the bottom of a 24-well microplate, with 
extreme caution to avoid any scratch to the tissue culture treated surface.  The 
polystyrene pieces were then transferred to a microwell containing 100 µL of a S. 
epidermidis RP62a suspension (~107 CFU/mL), followed by overnight incubation 
at 35°C.  The polystyrene pieces were then rinsed three times with 0.9% saline to 
remove planktonic bacteria.  The biofilm was stained using Dead/Live BacLight 
viability kit (3.35 µM of Syto-9 and 20 µM of PI) at 22°C for 15 min in dark,  and 
then Alexa Fluor 555 conjugated wheat germ agglutinin) at 22°C for 1 h in dark.  
The structure of biofilm was immediately examined after washing twice with 0.9% 
saline.  To minimize artifacts associated with simultaneous dual wavelength 
excitation, all samples were sequentially scanned, frame-by-frame, first at 488 nm 
and then at 561 nm. A 63 × oil objective was used in all imaging experiments. 
 
Epifluorescence microscopy was carried out to assess whether the increased amount 
of biofilm induced by antimicrobial exposure was due to an increase in the amount 
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of polysaccharide or bacterial cells, and to examine the viability of the biofilm cells 
after antimicrobial challenge.  The enhancement details were further confirmed 
with CLSM.  After overnight exposure to the specific antimicrobial agents, 
microwells containing CoNS biofilms were rinsed with 200 µL volumes of 0.9% 
NaCl three times.  Bacterial attachment and viability was then assayed with the 
LIVE/DEAD BacLight bacterial viability kit, as described above.   In parallel, 
200 µL of a fluorescent dye specific for CoNS polysaccharide, Alexa Fluor 555 
conjugated wheat germ agglutinin (10 µg/mL), were added to untreated and 
antimicrobial treated biofilms, which were stained for 1 h in the dark.  The 
biofilms were then examined by a Nikon Diaphot inverted fluorescence microscope 
(general observation of the biofilm enhancement) and by a Nikon Eclipse Ti 
inverted microscope equipped with Nikon A1R Fast Laser Scanning Confocal 
system (detailed observation of biofilm enhancement).  Nikon Diaphot inverted 
fluorescence microscope was equipped with B2 filter sets and G-2A filter sets.  B2 
filter set has a medium excitation filter of 450-490 nm, longpass dichromic mirror 
of 500 nm and longpass barrier filter of 515 nm.  G-2A filter set has an excitation 
filter of 510-560 nm, longpass dichromic mirror of 565 nm and longpass barrier 
filter of 590 nm.  B2 filter set was used to observe the live cell (stained with 
SYTO-9) and G-2A was used for detection of dead cells (stained with PI) and EPS 
(stained with Alexa Fluor 555 conjugated wheat germ agglutinin).  CLSM was 
used to confirm the results of epifluorescence microscopy.  In CLSM experiments, 
samples were scanned frame-by-frame, at 488 nm to observe the live cells and at 
561 nm for detection of dead cells and polysaccharide.  A representative area in 
the centre of microwells was chosen for both epifluorescence microscopy and 
CLSM imaging.     
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3.2.7 Data analysis 
 
All MIC and MBC experiments were repeated on three different occasions, and a 
fourth test was performed if the values were not identical.  The geometric mean 
(log2) was calculated and used for comparisons.  Based on the acceptable range of 
MIC for S. aureus ATCC 25913 (CLSI 2004), an increase of >2 x log2 in MIC and 
MBC for oxacillin, vancomycin, ciprofloxacin and rifampicin, and an increase of 
>3 x log2 for MIC and MBC for penicillin and gentamicin, were considered 
significant.  Experiments for the effects of antimicrobials on preformed biofilms 
were performed in triplicate.  One way analysis of variance (ANOVA) or the 
non-parametric method Mann-Whitney test was used for two-set comparisons, for 
data falling in a normal distribution or not, and a p value of < 0.05 was considered 
significant. 
 
3.3 Results 
 
3.3.1 Confirmation of adherent monolayer structure by 
phase contrast microscopy 
   
Establishment of adherent monolayers of all 26 CoNS isolates in 96-well 
microplates was confirmed with 40 × 10 phase-contrast microscopy (Fig. 3.1).  A 
microcolony structure characteristic of biofilms was observed when incubation time 
was extended to 2 h for biofilm-positive CoNS. 
 
  94 
3.3.2 Confirmation of biofilm structure of S. epidermidis 
RP62a by CLSM 
 
S. epidermidis RP62a biofilms formed on polystyrene pieces mainly contained live 
bacteria and polysaccharide.  Twenty-four-hour S. epidermidis RP62a biofilms on 
polystyrene pieces were approximately 20 µm in thickness, with polysaccharide 
throughout the whole biofilm matrix.  The bacteria accumulated mostly in the 
center of biofilms.  Hole-like channels were found connecting distributed bacterial 
aggregates (Fig. 3.2). 
 
 
3.3.3 Susceptibilities of CoNS to antimicrobial agents  
Antimicrobial susceptibilities of the planktonically grown CoNS to six 
antimicrobials (penicillin, gentamicin, vancomycin, oxacillin, ciprofloxacin, and 
rifampicin) are presented in Table 3.1.  According to the CLSI MIC interpretive 
breakpoints (penicillin: susceptible (S) ≤ 0.12, resistant (R) ≥ 0.25; gentamicin: S ≤ 
4, R ≥ 16; oxacillin: S ≤ 0.25, R ≥ 0.5;  vancomycin: S ≤ 4, R ≥ 32; ciprofloxacin: 
S ≤ 1, R ≥ 4; rifampicin: S ≤ 1, R ≥ 4), most CoNS were resistant to penicillin 
(100%), gentamicin (83.3%), and oxacillin (91.7%), and remained susceptible to 
vancomycin (100%), ciprofloxacin (100%) and rifampicin (79.2%) (Table 3.2).  
There was no significant difference in susceptibilities when the comparisons were 
made between invasive and contaminating strains (p ≥ 0.05) (Table 3.3). 
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Fig. 3.1 Adherent monolayer of S. epidermidis RP62a.  A single layer of RP62a 
cells strongly attached to the polystyrene surface; a few bacterial clumps composed 
of ~5-20 cells presented in the adherent monolayer (40×10 phase-contrast 
microscope). 
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Fig. 3.2 CLSM of a S. epidermidis RP62a biofilm.  Biofilm were stained with 
both Dead/Live BacLight bacterial viability kit (live cells stain green and dead cells 
stain red) and Alexa Fluor 555 conjugated wheat germ agglutinin (polysaccharide 
stains red).  The red staining mainly indicates the presence of polysaccharide, as a 
parallel CLSM image using only Dead/Live BacLight bacterial viability kit 
suggested that there were few dead cells in freshly prepared biofilms. 
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Table 3.1 MICs and MBCs of single antimicrobial agents based on the CLSI microdilution method (µg/mL) 
Isolate Species Status Penicillin Gentamicin Oxacillin Vancomycin Ciprofloxacin  Rifampicin 
   MIC MBC MIC        MBC MIC MBC MIC MBC MIC MBC MIC MBC 
1 S. warneri Invasive 32 32 8 8 0.25 0.25 2 2 0. 25 0. 25 0.015 0.03 
2 S. haemolyticus Invasive 8 8 0.5 0.5 32 64 1 1 0.12 0.12 0.008 0.03 
3 S .epidermidis Invasive 8 16 0.25 0.25 0.25 0.25 2 4 0.12 0.25 0.008 0.015 
4 S. epidermidis Invasive 2 4 0.25 0.25 4 16 1  1 0.25 0.25 0.002 0.002 
5 S. epidermidis Invasive 8 16 64 128 32 128 2 2 0.12   0.12 128 >128 
6 S. capitis Invasive 32 64 64 64 8 16 2 4 0.12 0.25 0.015 0.06 
7 S. epidermidis Invasive 8 16 64 64 16 64 2 2 0.25 0.25 0.004 0.008 
8a S. capitis Invasive 128 128 32 32 8 8 1 2 0.25 0.25 0.008 0.03 
8b S. capitis Invasive 64 64 32 32 4 8 1 1 0.12 0.25 0.008 0.015 
9 S. capitis Invasive 32 64 32 32 8 16 1 2 0.25 0.25 0.015 0.03 
10 S. epidermidis Invasive 32 128 >128 >128 32 128 2 2 0.25 0.25 0.004 0.004 
11 S. epidermidis Invasive 8 8 64 128 32 64 1 1 0.06 0.12 128 >128 
12 S. epidermidis Contaminant 32 32 64 64 2 2 2 4 0.25 0.25 0.002 0.002 
13 S. epidermidis Contaminant 16 16 64 128 2 8 2 2 0.25 0.25 0.002 0.008 
15 S. capitis Contaminant 128 128 32 64 16 32 4 4 0.25 0.25 0.015 0.03 
16 S. capitis Contaminant 64 128 64 64 16 64 1 2 0.25 0.25 0.015 0.03 
17 S. capitis Contaminant 64 64 32 64 8 32 2 2 0.25 0.25 0.015 0.03 
18 S. capitis Contaminant 64 128 32 64 4 4 2 2 0.12 0.25 0.008 0.015 
19 S. epidermidis Contaminant >128 >128 64 64 2 8 2 2 0.25 0.25 0.008 0.015 
20 S. epidermidis Contaminant 8 16 128 >128 16 32 1 1 0.12 0.12 128 >128 
21 S .epidermidis Contaminant 8 8 64 128 32 64 2 2 0.12 0.12 128 >128 
22 S. capitis Contaminant 128 >128 64 64 8 16 4 4 0.12 0.25 0.015 0.03 
23 S. epidermidis Contaminant 4 4 128 128 16 32 2 2 0.25 0.25 0.008 0.008 
24 S. epidermidis Contaminant 8 8 128 128 16 64 1 1 0.12 0.12 >128 >128 
Values are geometric means of the results of at least nine independent measurements, taken to the closest doubling dilution.    
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Table 3.2 Percentages of CoNS isolates susceptible/resistant to single antimicrobial agents 
  
Penicillin Gentamicin Oxacillin Vancomycin Ciprofloxacin Rifampicin 
Invasive Contaminating Invasive Contaminating Invasive Contaminating Invasive Contaminating Invasive Contaminating Invasive Contaminating Isolates 
(n=12) (n=12) (n=12) (n=12) (n=12) (n=12) (n=12) (n=12) (n=12) (n=12) (n=12) (n=12) 
Susceptible 0 
 
0 
 
3 
 
0 
 
2 
 
0 
 
12 
(100%) 
12 
(100%) 
12 
(100%) 
12 
(100%) 
10 
(83.3%) 
9 
(75%) 
Intermediate 
 
NA NA 1 0 NA NA 0 0 0 0 0 0 
Resistant 12 
(100%) 
12 
(100%) 
8 
(66.7%) 
12 
(100%) 
10 
(83.3%) 
12 
(100%) 
0 0 0 0 2 
(16.7%) 
3 
(25%) 
NA: not available
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Table 3.3 Comparison of antimicrobial susceptibilities of invasive and contaminating CoNS  
Mean MIC for planktonic bacteria   
Penicillin Gentamicin Oxacillin Vancomycin Ciprofloxacin Rifampicin 
Invasive isolates  
24.08±1.68 
 
23.75±3.47 
 
22.75±2.49 
 
20.5±0.52 
 
2-2.58±0.67 
 
2-5.33±4.31 
Contaminating 
isolates 
 
25±1.95 
 
26±0.74 
 
23 ±1.41 
 
20.92±0.67 
 
2-2.42±0.51 
 
2-3.33±6.54 
 
P-value a 
 
0.230 
 
0.074 
 
0.817 
 
0.175 
 
0.644 
 
0.507 
a P-values were obtained based on the comparison of means of MICs of individual antimicrobial agents for invasive isolates and contaminating isolates.  
Statistics analysis was carried out with one-way ANOVA or nonparametric Mann-Whitney test, depending on the data distribution.  If MIC values were >128 
µg/mL, they were recorded as 256 µg/mL for data analysis. 
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3.3.4 Comparison of antimicrobial susceptibilities of CoNS 
grown in different modes 
 
3.3.4.1 Adherent monolayers compared with planktonic cultures at 
mid-log phase 
   
There were generally no significant differences in antimicrobial susceptibility 
between planktonic cells at mid-log phase and early adherent monolayers 
(determined by MIC and MBC).  Two exceptions were: 1) MBCs of penicillin 
were 16 times 
 
higher for monolayer-grown S. epidermidis RP62a and S. hominis 
SP2 than planktonic cells, 2) MICs and MBCs of oxacillin were 8 times 
 
higher for 
monolayer-grown cells of isolate 8a than for planktonic cells (see underlined values 
in Tables 3.4 and 3.5).  
 
3.3.4.2 Biofilms compared with planktonic cultures at mid-log 
phase and adherent monolayers 
   
Differences between susceptibilities of biofilm-grown cells and planktonic cells at 
mid-log phase were strain and antimicrobial dependent.  The CLSI and biofilm 
MICs of gentamicin, ciprofloxacin, and rifampicin were similar for most CoNS 
isolates studied; however, the MICs of three cell wall active antimicrobial agents 
(penicillin, oxacillin, and vancomycin) were significantly higher for biofilm cells 
than for planktonic cells at log phase for most isolates (32-256 times for penicillin 
G for 7 of 9 CoNS isolates, 8-32 times for oxacillin for 6 of 9 isolates, and 8 times 
for vancomycin for 5 of 9 isolates) (see bolded values in Tables 3.4 and 3.5).  The 
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Table 3.4 Antimicrobial susceptibilities of five biofilm-positive isolatesa grown in different modes 
Penicillin 
(µg/mL) 
Gentamicin 
(µg/mL) 
Oxacillin 
(µg/mL) 
Vancomycin 
(µg/mL) 
Ciprofloxacin 
(µg/mL) 
Rifampicin 
(µg/mL) 
Isolate and mode 
of growth  
Initial bacterial 
density (CFU/mL) 
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC 
RP62a 
 
 
 Log Planktonic (2.6-7.3)×105 8 8 16 32 64 64 2 2 0.06 0.12 0.008 0.03 
Monolayer (6-15.6) ×105 32 128c 64 64 16 64 2 8 0.12 0.12 0.002 0.008 
Stat Planktonic (0.215-0.47) ×109 b >1024  1024  >1024  32  ≤1  32 
Biofilm (0.895-1.86) ×109 1024e >1024 64 >1024 64 >1024 16 >1024d 0.25 >1024 0.004 0.015 
Isolate 3  
Log Planktonic (2.9-8.25) ×105 8 16 0.25 0.25 0.25 0.25 2 4 0.12 0.25 0.008 0.015 
Monolayer (5-11) ×105 32 64 0.25 0.5 0.12 0.5 2 8 0.25 0.5 0.002 0.004 
Stat Planktonic (0.575-2.19) ×109  >1024  32  >1024  >1024  1024  256 
Biofilm (2.55-13.4) ×108 >1024 >1024 16 16 0.25 2 16 16 0.25 2 0.5 4 
Isolate 8a  
Log Planktonic (2.6-5.5) ×105 128 128 32 32 8 8 1 2 0.25 0.25 0.008 0.03 
Monolayer (6.4-11.1) ×105 >128 >128 32 64 64 64 1 8 0.12 0.5 0.004 0.015 
Stat Planktonic (4.4-4.85) ×108  >1024  >1024  >1024  >1024  1024  2 
Biofilm (0.6-1.8) ×108 1024 >1024 256 >1024 256 >1024 8 >1024 0.12 1024 0.004 4 
Isolate 9         
Log Planktonic (3.1-5.2) ×105 32 64 32 32 8 16 1 2 0.25 0.25 0.015 0.03 
Monolayer (4.6-10.8) ×105 128 >128 32 128 16 32 2 8 0.25 0.5 0.004 0.015 
Stat Planktonic (0.7-0.79) ×109  >1024  >1024  >1024  >1024  >1024  256 
Biofilm (1.1-1.73) ×109 1024 >1024 64 >1024 128 >1024 8 >1024 0.25 >1024 0.008 4 
Isolate 11  
Log Planktonic (2.65-8.5) ×105 8 8 64 128 32 64 1 1 0.06 0.12 128 >128 
Monolayer (3.2-17.8)×105 32 64 128 >128 32 64 1 2 0.06 0.12 128 >128 
Stat Planktonic (0.81-1.57) ×109  >1024  >1024  >1024  >1024  512  1024 
Biofilm (1.7-5.85) ×108 1024 >1024 256 >1024 256 >1024 8 >1024 0.25 16 64 >1024 
a Biofilm-positive isolates (OD600 > 0.24). 
b
 MICs for CoNS at stationary phase are not provided as the values could not be determined by standard methods. 
c
 Values underlined indicate a significant increase in the MICs or MBCs between log-planktonic and adherent monolayer modes of growth   
d
 Values in italic indicate a significant change in the MBCs between stationary-planktonic and biofilm modes of growth. 
e
 Values in bold indicate a significant increase in MICs or MBCs between log-planktonic/adherent monolayer and biofilm modes of growth.  
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Table 3.5 Antimicrobial susceptibilities of four biofilm-negative isolatesa grown in different modes 
a Biofilm-negative isolates included biofilm-weak producer (0.24 > OD600 ≥ 0.12) and biofilm-negative producer (OD600 < 0.12). 
b
 MICs for CoNS at stationary phase are not provided as the values could not be determined by standard methods. 
c Values underlined indicate a significant increase in the MICs or MBCs between log-planktonic and adherent monolayer modes of growth.  
d
 Values in italics indicate a significant change in the MBCs between stationary planktonic and biofilm modes of growth. 
e Values in bold indicate a significant increase in MICs or MBCs between log-planktonic/adherent monolayer and biofilm modes of growth. 
Penicillin 
(µg/ml) 
Gentamicin 
(µg/ml) 
Oxacillin 
(µg/ml) 
Vancomycin 
(µg/ml) 
Ciprofloxacin 
(µg/ml) 
Rifampicin 
(µg/ml) 
Isolate and 
mode of growth 
Initial bacterial 
density (CFU/ml) 
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC 
SP2  
Log Planktonic (1.15-4.1) ×105 0. 5 0. 5 8 8 0.06 0.06 1 2 0.12 0.12 0.008 0.03 
Monolayer (2.6-4.7) ×105 2 8c 16 16 0.12 0.12 0.5 1 0.12 0.12 0.004 0.008 
Stat Planktonic (3.5-9.5) ×107 b >1024  1024d  2  4  2  0.008 
Biofilm (1-3.15) ×107 128 >1024e 8 32 0.12 2 2 4 0.12 2 0.002 0.008 
Isolate 15         
Log Planktonic (2.2-5.5) ×105 128 128 32 64 16 32 4 4 0.25 0.25 0.015 0.03 
Monolayer (5.2-16.4) ×105 >128 >128 32 64 16 64 4 8 0.12 0.25 0.004 0.008 
Stat Planktonic (3.7-7.9) ×108  >1024  >1024  >1024  >1024  >1024  64 
Biofilm (6.6-9.25) ×107 >1024 >1024 256 >1024 256 >1024 16 >1024 0.25 512 0.004 0.008 
Isolate 19  
Log Planktonic (2.85-7.4) ×105 >128 >128 64 64 2 8 2 2 0.25 0.25 0.008 0.015 
Monolayer (3.2-14.6) ×105 128 >128 64 128 2 8 2 8 0.12 0.25 0.002 0.008 
Stat Planktonic (0.6925-1.45) ×109  >1024  >1024  >1024  >1024  1024  2 
Biofilm (1.415-2.18) ×108 1024 >1024 64 >1024 64 >1024 4 >1024 0.25 4 0.008 0.06 
Isolate 22  
Log Planktonic (2.75-5.6) ×105 128 >128 64 64 8 16 4 4 0.12 0.25 0.015 0.03 
Monolayer (4.8-16.25) ×105 >128 >128 32 128 32 32 2 8 0.12 0.25 0.004 0.008 
Stat Planktonic (0.5125-0.74) ×109  >1024  >1024  >1024  >1024  >1024  256 
Biofilm (1.55-1.82) ×108 1024 >1024 128 >1024 128 >1024 16 >1024 0.25 1 0.008 0.03 
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MBCs of all antimicrobials except rifampicin were significantly higher for 
isolates grown as biofilm cells than planktonic cells at mid-log phase.  Five of 
nine isolates were equally susceptible to killing by rifampicin as biofilms and 
planktonic cells in mid-log phase.  The comparisons of MICs and MBCs 
between adherent monolayers and biofilms showed similar trends (see bold 
values in Tables 3.4 and 3.5). 
   
3.3.4.3 Biofilms compared with planktonic cultures at stationary 
phase 
   
The MBCs of most antimicrobial agents were above the upper limit of detection 
(≥ 1024 µg/mL) for most CoNS isolates grown as either planktonic culture at 
stationary phase or biofilms.  This rendered the comparison between these two 
growth modes impossible for most antimicrobial agents.  For the combinations 
of isolates and antimicrobials that could be compared between these two growth 
modes (n = 22), planktonic cells at stationary phase were either equally resistant 
to (n = 7) or more resistant than (n = 13) biofilm cells (Tables 3.4 and 3.5). 
 
Regarding the percentage of isolates showing increases in antimicrobial 
resistance as biofilm developed (planktonic to adherent monolayer to biofilms), 
no differences were found between the isolates of biofilm-positive and 
biofilm-negative phenotypes for most antimicrobials (Table 3.6).  However, 
most biofilm-positive, but few biofilm-negative isolates were more resistant to 
vancomycin (increased MICs) and rifampicin (increased MBC) in the biofilm 
mode than planktonic cells or adherent monolayers (Tables 3.4 and 3.5)
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Table 3.6 Number of isolates showing a significant change in the MIC or MBC when growth modes changed 
a
 Indicates that nine strains were tested; four strains were compared and 0 strain showed a significant increase of MIC when the growth modes changed from 
log-planktonic to monolayer; five strains could not be compared because of indefinite values, i.e. >128 µg/mL, >1024 µg/mL, and ≤1 µg/mL.   
b
 MICs could not be tested in stationary phase as there was no further bacterial growth in this specific phase.   
c
 Most of the strains in both growth modes had MBCs>1024 µg/mL.  
d
 “-” Indicates the number of isolates whose planktonic growth mode was more resistant than their biofilms, and the“+”vice-versa. “(-2+1)/4” means in four 
isolates that could be compared, two isolates were more resistant in stationary planktonic growth mode, one isolate was more resistant in biofilm growth mode, and 
one isolate was similarly resistant in both modes. 
Log-planktonic to monolayer Log-planktonic to biofilm Monolayer to biofilm Stationary-planktonic to biofilm  
MIC (n=9) MBC (n=9) MIC (n=9) MBC (n=9) MIC (n=9) MBC (n=9) MIC (n=9) MBCc (n=9) 
Biofilm 
phenotype Positive Negative Positive Negative Positive Negative Positive Negative Positive Negative Positive Negative Positive Negative Positive Negative 
Penicillin 0/4a 0/1 1/3 1/1 4/5 2/4 5/5 2/2 3/5 1/3 3/3 1/1 NAb NA 0/0 0/0 
  
        
Gentamicin 0/5 0/4 0/4 0/4 1/5 0/4 5/5 3/4 1/5 0/4 4/4 3/4 NA NA 0/1 -1/1 
  
        
Oxacillin 1/5 0/4 1/5 0/4 3/5 3/3 5/5 4/4 2/4 2/3 4/5 4/4 NA NA -1/1 0/1 
  
        
Vancomycin 0/5 0/4 0/5 0/4 5/5 0/4 4/5 3/4 4/5 1/4 4/5 3/4 NA NA (-1+1)/2  0/1 
  
        
Ciprofloxacin 0/5 0/4 0/5 0/4 0/2 0/2 5/5 3/4 0/2 0/0 4/5 3/4 NA NA (-2+1)/4d -2/3 
  
        
Rifampicin 0/5 0/4 0/4 0/4 1/5 0/4 3/4 0/4 1/5 0/4 3/4 1/4 NA NA -3/4 -3/4 
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3.3.5 Effects of antimicrobial agents at the highest 
serum-achievable concentration on preformed CoNS 
biofilms 
 
The effects of oxacillin, gentamicin, vancomycin and their combination on the 
overnight CoNS biofilms are presented in Table 3.7.  Vancomycin and its 
combination with both oxacillin and gentamicin were the most effective in reducing 
the density of preformed CoNS biofilms (40% for biofilm-negative CoNS and 
63.3% for biofilm-positive strains), followed by oxacillin (0% for biofilm-negative 
CoNS and 36.7% for biofilm-positive strains) and gentamicin (0% for 
biofilm-negative CoNS and 10.5% for biofilm-positive strains).  Exposure to 
oxacillin at the highest concentration achievable in serum resulted in increases in 
biofilm densities for two S. capitis isolates (isolates 15 and 22), converting these 
biofilm-negative isolates (OD600 < 0.12, when grown with TSB) into weak biofilm 
producers (0.12 ≤ OD600 < 0.24) or even biofilm-positive phenotypes (OD600 ≥ 0.24) 
(Fig. 3.3).  S. epidermidis isolate 19 also showed enhancement of biofilm in the 
presence of oxacillin but the difference did not quite reach statistical significance (P 
= 0.074).  Similar findings were obtained when 1% glucose was added into TSB as 
the medium for biofilm growth (data now shown).  A dose-response study 
confirmed that oxacillin at concentrations ranging from 0.5 µg/mL to 128 µg/mL 
enhanced the biofilm growth of these isolates, with peak enhancement occurring 
around 8 to 32 µg/mL (Fig. 3.4). 
 
There was a discrepancy between the antimicrobial susceptibility of CoNS and the 
efficacy of antimicrobials at the highest serum-achievable concentration in controlling
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Table 3.7 Numbers of CoNS isolates of different biofilm phenotypes showing reduction or 
enhancement in biofilm densities after exposure to antimicrobials 
 Gentamicin Oxacillin Vancomycin Antimicrobial 
combinationa 
Biofilm 
phenotype Negative Positive Negative Positive Negative Positive Negative Positive 
Reduction 0 2 0 7 2 12 2 12 
Enhancement 0 0 3 0 0  0 0 
No effect 5 17 2 12 3 7 3 7 
Total 5 19 5 19 5 19 5 19 
a
 Antimicrobial combination: oxacillin of 32 µg/mL, vancomycin of 32 µg/mL, and gentamicin of 8 µg/mL.
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established biofilms.  All isolates were susceptible to vancomycin, yet vancomycin 
reduced the density of the biofilms in only 58% of isolates.  The corresponding 
figures for gentamicin were 83% versus 8% and for oxacillin were 92% versus 29%.  
This suggests that conventional MICs are not suitable for antimicrobial 
susceptibility testing once the bacteria grow into biofilms. 
 
3.3.6 Microscopic analysis of the CoNS biofilm 
enhancement by oxacillin  
 
In the crystal violet staining assay, exposure to oxacillin at 32 µg/mL increased the 
thickness of biofilms of both isolates 15 and 22 (Fig. 3.5).  In both epifluorescence 
microscopy and CLSM imaging experiments, for both isolates, oxacillin stimulated 
the production of polysaccharide (Fig. 3.5 a and c), and the multiplication of living 
cells attached to the polystyrene surface (Fig. 3.5 b and d). 
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Fig. 3.3 Enhancement of biofilm-mode growth of CoNS cells by oxacillin at the 
highest serum-achievable concentration.  Solutions of gentamicin, oxacillin, 
vancomycin or the three agents in combination in TSB at the highest concentrations 
achievable in serum, were added to biofilm grown cells of two S. capitis isolates; 15 
(biofilm-negative, ica-weak), and 22 (biofilm-negative, ica-positive).  After 
overnight incubation, bacterial growth was stained with crystal violet and the OD600 
was measured.  Error bars represent standard errors of at least 3 individual 
experiments in triplicate. *: P = 0.004; ** P < 0.001. 
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Fig. 3.4 Enhancement of the biofilm-mode growth of CoNS by oxacillin at different concentrations.  a: isolate 15, b: isolate 22.  
Overnight biofilms of isolates 15 and 22 were treated with oxacillin at concentrations ranging from 0 to 128 µg/mL, stained with crystal violet, 
and the quality of the biofilm grown in the centre of microwell was spectrometrically assessed. 
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 a b c d 
Fig. 3.5 Enhancement of the biofilm growth of isolate 15 by oxacillin at the highest achievable serum concentration 
As isolate 15 and 22 showed similar responses, only the results for isolate 15 are shown. a and c: stained with Alexa Fluor 555 conjugated 
wheat germ agglutinin; red signal indicates the presence of polysaccharide. b and d: stained with Live/Dead BacLight bacterial viability kit; 
green signal indicates the presence of live cells and red signal indicates the presence of dead cells. 
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3.4 Discussion 
 
The main findings of this study were: 1) standard MICs/MBCs do not predict 
biofilm resistances 2) planktonic cells at log phase generally have similar 
antimicrobial susceptibilities to early adherent monolayers 3) planktonic cells at 
stationary phase and biofilm cells behave in a similar manner in antimicrobial 
resistance 4) oxacillin enhances the biofilm growth of some S. capitis strains. 
 
The prevalence of antimicrobial resistance of planktonically-grown CoNS isolated 
from VLBW infants in the NICU at RWH, was similar to that of a previous study 
(100%, 93%, 80% and 0% resistant to ampicillin, methicillin, gentamicin and 
vancomycin respectively) (Villari et al., 2000).  Invasive isolates and contaminants 
exhibited similar susceptibilities.  The same group of invasive and contaminating 
isolates showed no differences in biofilm production or possession of the ica genes 
(Bradford et al., 2006), suggesting that resistant strains are acquired initially as skin 
flora and subsequently cause invasive infections in susceptible infants. 
 
This is the most comprehensive study so far to compare antimicrobial 
susceptibilities of bacteria in different growth modes.  Planktonic cultures at 
mid-log phase, early adherent monolayers, mature biofilms and planktonic cultures 
at stationary phase were assessed for their susceptibilities to multiple antimicrobials.  
The rationale was to challenge bacterial cultures at different stages and modes of 
growth with the same amount of antimicrobial agent.  In particular, the 
susceptibilities of biofilm-grown cells and planktonic cells of the same cell densities 
were compared.  
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In agreement with the study of Labthavikul et al. (2003), MICs and MBCs in this 
study were found generally similar when CoNS are grown planktonically or as 
adherent monolayers (Labthavikul et al., 2003).  The few exceptions encountered 
were three isolates that were more resistant in the early adherent monolayer form to 
ß-lactam agents, such as penicillin and oxacillin.  Other studies found that S. 
aureus, E. coli and P. aeruginosa were significantly more resistant to both growth 
inhibition and killing of antimicrobials in the adherent form than in the planktonic 
form (Aaron et al., 2002; Miyake et al., 1992).  Different methodologies used for 
monolayer formation might also be responsible for the different findings in these 
studies.  Early adherent monolayers have been established by scientists using 
different bacteria and incubation times.  Miyake and colleagues (1992) grew S. 
aureus monolayer with one hour incubation while Aaron et al. (2002) extended the 
incubation time to two hours for P. aeruginosa (Aaron et al., 2002; Miyake et al., 
1992).  In the present study, an one-hour-incubation period was chosen because 
preliminary work using phase-contrast microscopy showed that most 
biofilm-positive CoNS had formed many microcolonies by two hours.  
Microcolonies represent early stage of biofilm formation and demonstrate some 
properties of biofilms (Donlan, 2002).  It is likely that Aaron et al. (2002) obtained 
early-stage biofilms rather than early adherent monolayer in their study.  However, 
the possibility that the difference was due to the different kinetics of biofilm 
formation between P. aeruginosa and Staphylococcus spp. cannot be discounted.   
 
Conventional MICs have been used to guide the treatment of biofilm-related 
infections at the febrile stage (Ceri et al., 2001).  Reported differences between the 
conventional MICs and biofilm MICs were attributed to lack of standardization of 
initial inocula and to the presence of small colony variants (Ceri et al., 2001).  Ceri 
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et al. (2001) suggested that viable counts could resolve this problem.  In the 
present study, MICs of cell wall active agents (vancomycin, oxacillin and penicillin) 
were frequently higher for biofilm–grown bacteria than planktonic cultures, despite 
using the viable count method.  This is consistent with studies by Moskowitz et al. 
(2004) and Melchior et al. (2006), who reported that biofilm MICs of β-lactam 
agents, but not other agents, were much higher than the conventional MICs for P. 
aeruginosa and S. aureus respectively (Melchior et al., 2006; Moskowitz et al., 
2004).  These results are not surprising given that cell wall active antimicrobial 
agents mainly affect rapidly growing bacteria.  Biofilm released cells are likely to 
be less active than dividing planktonic cells, probably because they have recently 
undergone a switch from a biofilm mode of growth to a free-living mode, similar to 
cells at lag-phase growth, and require a change in gene expression to adapt to the 
new environment. 
 
The MBCs of penicillin G, gentamicin, oxacillin, ciprofloxacin and vancomycin for 
CoNS in biofilm mode were significantly higher than conventional MBCs.  
Although conventional MBCs of some of these agents were below concentrations 
achievable in serum, biofilm MBCs were generally >1024 µg/mL, which is above 
achievable concentrations in serum.  Administration of single antimicrobial agents 
to newborns with catheter-associated infections, based on the results of in vitro 
susceptibility tests designed for planktonic bacteria at mid-log phase, is therefore 
unlikely to reach an effective concentration to eradicate the bacteria adherent to 
catheters.  This explains the frequent failure of treating CoNS infections with 
conventional antimicrobial agents in VLBW infants when the CVCs are not 
removed.   
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The MBCs of most antimicrobial agents were similar for CoNS at stationary phase 
and in the biofilm mode of growth.  However, the MBCs of rifampicin and 
ciprofloxacin were generally higher for planktonic cells at stationary phase than 
their biofilm-grown counterparts.  Other studies have shown that stationary phase 
cultures are equally or more resistant than biofilm-grown bacteria. The resistance 
was attributed to the presence of phenotypically more resistant “persister cells” in 
dense cultures (Harrison et al., 2005; Spoering & Lewis, 2001).  Studies reported 
in Chapters 3 and 4 found that there was higher percentage of persister cells in 
biofilms and stationary phase culture than planktonic cultures at log phase.  In this 
study, rifampicin behaved similarly on both log-planktonic and biofilm growth 
modes of almost half CoNS isolates, which supports previous reports that 
rifampicin was the most common constituent of  combinations active against 
staphylococcal biofilms (Gagnon et al., 1994).  
 
No significant difference was found in the response to antimicrobials between 
biofilm-negative and biofilm-positive phenotypes in different growth modes.  
However, it is important to note that isolates classified as biofilm-negative (OD600 < 
0.12), if grown under biofilm assay conditions, do produce densely-grown 
microcolonies (Christensen et al., 1985).  This information, together with our 
finding that there was little difference in susceptibility between biofilm-grown 
bacteria and planktonic-grown bacteria of the same density, suggests that a densely 
adherent growth mode is likely to be an important determinant of biofilm resistance.   
 
To my knowledge, this is the first study to investigate whether the commonly used 
antimicrobials at the highest concentration in serum are able to stimulate further 
growth of established biofilms or biofilm-mode grown adherent cells.  It is also the 
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first study which visually demonstrates the enhancing effect of external stimuli on 
two principal components of biofilms; polysaccharide and bacteria.  Other studies 
focused on the effect of antimicrobials at subinhibitory concentrations on 
development of biofilms (Rachid et al., 2000; Wu et al., 2003).  Rachid et al. 
(2000) showed that oxacillin at subinhibitory concentration did not induce the 
expression of ica operon and biofilm formation.  Different subspecies/strain and 
concentration of oxacillin used by these investigators might explain the lack of 
biofilm enhancement by oxacillin.  Cerca et al. (2005) reported that exposure to 
subinhibitory dicloxacillin, an agent structurally similar to oxacillin, could stimulate 
the polysaccharide synthesis in S. haemolyticus, not S. epidermidis.  In this study, 
oxacillin at the highest achievable serum concentration (32 µg/mL) enhanced 
biofilm growth of two biofilm-negative S. capitis (both ica-positive, oxacillin MIC 
= 16 µg/mL).  Biofilm enhancement in both S. capitis isolates was related to an 
increase both of bacterial numbers and in the amount of polysaccharide produced.  
The exact mechanism of oxacillin enhancing biofilm formation of S. capitis 
requires further investigation.  Biofilm production in S. capitis can be induced by 
external stresses such as a high NaCl level through induction of ica expression by 
repression of tricarboxylic acid cycle (Goller & Romeo, 2008; Moretro et al., 2003).   
It is likely that the positive influence of oxacillin on biofilm production 
demonstrated in this study is also via the stress-induced ica expression.  The 
enhancement of biofilm production by oxacillin might explain some treatment 
failures, as flucloxacillin is frequently used to treat infections caused by sensitive 
CoNS. 
 
This study was designed to investigate the effect of antimicrobials on various stages 
of biofilm development.  Upon initial attachment to a polymer surface, CoNS may 
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be susceptible to antimicrobials, but resistance increases as the biofilm develops.  
These findings highlight the importance of early recognition and treatment of 
catheter-related CoNS infections.  Success is possible with the widely used 
first-line antimicrobials guided by conventional susceptibility tests at the early 
attachment stage.  However it should be noted that some CoNS are more resistant 
to β-lactam antimicrobial agents in the early adherent monolayer phase.  Once 
biofilms have developed, cell-wall active antimicrobials often fail to resolve the 
febrile phase of infections, as these antimicrobials at the MIC cannot reliably 
prevent biofilms from releasing free-living cells.  Moreover, only rifampicin and, 
in some cases ciprofloxacin, consistently displayed activity against biofilm-grown 
bacteria.  Finally, examples are presented of the enhancement of CoNS biofilms by 
clinically achievable concentrations oxacillin, representing the commonly used 
β-lactamase resistant penicillins.  
 
A limitation of this study was the use of a small sample size.   Nine representative 
isolates were used to compare the antimicrobial susceptibilities of different growth 
modes.  Labour intensity of the sonication and viable count based method rendered 
it impossible to use a large sample size.  Another limitation was the assessment of 
killing of biofilm bacteria using the biofilm MBC, which leaves 0.1% of the 
challenged cells out of our consideration.  This remaining 0.1% population might 
contain “persister cells”, which have been considered as an important mechanism of 
biofilm resistance (Spoering & Lewis, 2001).  While the endpoint of complete 
killing may be more desirable, MBECs of representatives of the first-line 
antimicrobial agents used in NICUs were far above the upper detection limit used in 
this study (1024 µg/mL). 
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Chapter 4: Antimicrobial susceptibilities of biofilm 
-isolated cells and the role of the persister cells in 
biofilm resistance 
 
4.1 Introduction 
 
The previous chapter determined the high resistance of CoNS grown as biofilms.  
This chapter investigated the contribution of single cells to biofilm related 
antimicrobial resistance. 
  
Research aiming to determine the mechanisms of biofilm resistance has been 
carried out in the past (Aaron et al., 2002; Ceri et al., 1999; Spoering & Lewis, 
2001).  Most of those studies focused on the antimicrobial resistance of the entire 
biofilm matrix.  No insight has been gained about the single biofilm cells with 
regards to their antimicrobial susceptibilities.  Lack of research on single biofilm 
cells might be due to the difficulty in isolating them from the biofilm matrix, and 
the difficulty in separating the effect of cells and polysaccharide matrix from other 
factors causing the high tolerance of biofilms to antimicrobial agents.  Mechanical 
methods which are widely used to release single cells from biofilms, such as 
scraping, vortexing and sonication, tend to produce a mixture of cellular clumps and 
single cells, rather than purely single planktonic cells, and could damage the surface 
properties of the bacteria (Bruinsma et al., 2001).  Research directly investigating 
the biofilm-related antimicrobial resistance, based on the pure cellular aspect, is still 
lacking. 
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Persister cells are a small fraction of cells that exist in most bacterial populations, 
including bacteria in mid-log phase, stationary phase, or within biofilms (Keren et 
al., 2004a; Lewis, 2007; Spoering & Lewis, 2001).  This fraction of cells are 
suggested to specifically remain in a third physiological phase, apart from either log 
phase or stationary phase (Shah et al., 2006).  They were considered to be neither 
defective cells, nor cells produced in response to the presence of antimicrobials, and 
they neither grew nor died in the presence of bactericidal antimicrobial agents 
(Keren et al., 2004a).   
 
The presence of persister cells has been suggested as a cause of multidrug tolerance 
of various bacteria in the planktonic mode, including E. coli, P. aeruginosa and 
Staphylococcus spp., although the exact mechanisms involved were not completely 
clarified (Keren et al., 2004a; Keren et al., 2004b).  One possible mechanism of 
persister cell-mediated antimicrobial resistance is the over-expression of 
toxin-antitoxin (TA) modules (Keren et al., 2004b).  TA modules comprise an 
inhibitor (toxin) that interfere with important bacterial cellular functions such as 
translation and replication, and the corresponding repressor (antitoxin), which forms 
an inactive complex with toxin in persister cells.  Once the translation or 
replication process is inhibited, target functions, such as protein synthesis or DNA 
replication are shut down.  This would prevent antimicrobial agents from 
functioning on their cellular targets and lead to multidrug tolerance of persister cells 
(Keren et al., 2004b).  Examples of TA modules proposed or validated for E. coli 
persister cells include proteins encoded by ygiUT, yafQ/dinJ, yoeB/yefM, relBE, 
hipAB, mazEF (Keren et al., 2004b; Lewis, 2005; Shah et al., 2006).  
  
                                                                                                        
 
119
The presence of persister cells has also been proposed as an explanation for high 
resistance of bacterial biofilms to antimicrobial agents (Lewis, 2005; Roberts & 
Stewart, 2005).  Although this theory has been verified by a mathematical model, 
there is still a lack of experimental evidence to directly support its effect on CoNS 
biofilms (Roberts & Stewart, 2005).  Lewis et al. (2001) compared the number of 
persister cells in biofilms and in planktonic culture at mid-log phase and reported 
that biofilms produced more persister cells than the corresponding planktonic 
populations.  However, their study counted the persister cells within 
polysaccharide-surrounded biofilms, and did not take into account the presence of 
polysaccharide matrix and the highly accumulated hydrolytic enzymes, which could 
affect the performance of antimicrobials used for isolation of persister cells (Mah & 
O'Toole, 2001; Stewart, 2002).   
 
The methodology used to isolate the persister cells from different bacterial 
populations varied in previous studies.  Most studies exposed bacterial cultures to 
antimicrobials at 5-10 x MIC for either 3 h or 24 h, in order to kill normal cells, 
while retaining the persister cells.  However, exposure of bacteria to antimicrobials 
at these levels for such a short term could not ensure complete killing of all 
members of the normal population in cultures with density of ~ 108 CFU/mL, which 
was the density of bacterial cultures commonly used for persiter cells studies.  
Therefore specified antimicrobial concentrations and exposure times targeting 
complete killing of normal cells are required.  These factors should be pre-tested 
for individual strains for different antimicrobial agents to successfully isolate 
persister cells.   
 
The aims of this study were: 1) to determine the antimicrobial susceptibilities of 
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single cells derived from biofilms in order to investigate the antimicrobial 
susceptibility of biofilms at the single-cell level; 2) to compare the percentage of 
persister cells in different bacterial populations;  planktonic cells in mid-log phase 
and stationary phase, biofilm-embedded cells and biofilm-released cells, thus to 
reveal the role of persister cells in the high antimicrobial resistance of biofilms; 3) 
to investigate antimicrobial susceptibilities of persister cells isolated from each 
population, to reveal the intrinsic characteristics of persister cells. 
 
4.2 Materials and methods 
 
4.2.1 Bacterial strains and antimicrobial agents  
 
Two biofilm-positive strains; S. epidermidis RP62a and a clinical strain isolate 3 
(OD600=1.89±0.06) were used in this study.  Six antimicrobial agents were chosen 
for the susceptibility tests; penicillin G, gentamicin, oxacillin, vancomycin, 
ciprofloxacin, and rifampicin.  Penicillin G and gentamicin were excluded from 
persister cell studies as S. epidermidis RP62a was highly resistant to them. 
 
4.2.2 Preparation of single cells from planktonic bacterial 
cultures 
 
Bacterial suspensions in mid-log phase and stationary phase were prepared as 
described in section 2.2.1.  Bacterial suspensions were then centrifuged at 4500 × 
g for 10 min, washed with sterile phosphate buffered saline (PBS), and then 
resuspended with MHB to McFarland 0.5 standard (1 ×108 CFU/mL). 
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4.2.3 Collection of single biofilm-released cells and 
biofilm-embedded cells  
 
Biofilm-released cells were isolated as follows: after preparing and washing 
biofilms, 1 mL of MHB was added and the plate was incubated at 35°C for 90 min 
with shaking at 100 rpm.  The supernatants were then collected into a sterile tube, 
vortexed at high speed for 30 seconds four times to break up any large clumps.  
The bacterial suspensions were then filtered through a 1.2 µm Acrodisc syringe 
filter to remove any further bacterial clumps. 
 
Single biofilm-embedded cells were prepared after collection of biofilm-released 
cells.  Biofilms were washed with PBS to remove the loose or non-adherent cells.  
One milliliter of MHB was then added to the wells, and the wells were scraped 
thoroughly with sterile tips.  The resulting suspensions were mixed well by 
pipetting several times and transferred into a sterile tube.  The wells were then 
swabbed with a sterile pre-moistened cotton-tipped swab to collect the remaining 
adherent cells on the well-bottom.  The cotton tip of the swab was put into the tube 
with cells obtained by scraping.  The tube was vortexed at a high speed to dislodge 
the bacteria from the swab and to break up the bacterial clumps (30″×4).  The 
suspensions were filtered with 1.2 µm Acrodisc syringe filter as described earlier 
and viable counts were performed. 
 
Growth curves of the cell suspensions released from S. epidermidis RP62a biofilms 
and planktonic cells of the similar initial density were set up to assess whether the 
biofilm-released cells were shed from the biofilms or the result of multiplication 
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during collection.  One milliliter of fresh MHB was added into the well containing 
a biofilm.  The microplate was incubated at 35°C with gentle shaking (100 rpm) 
for 90 min to obtain suspensions of biofilm-released cells.  Planktonic cell cultures 
of similar initial cell densities (~ 5 x 107 CFU/mL) were prepared by diluting an 
overnight bacterial suspension 1:20 with fresh MHB.  The bacterial suspensions of 
planktonic cells were then incubated under the same conditions as for the 
suspension of biofilm-released cells.  Viable counts were performed on both sets 
of suspensions at times 0 h, 0.5 h, 1 h, 1.5 h, and 2 h.   
 
To validate the use of 1.2 µm Acrodisc syringe filters to remove bacterial clumps, 
100 µL aliquots were removed from the suspension before and after filtration, 
followed by viable counting.  The ratio of post-filtration CFUs to pre-filtration 
CFUs was used to calculate the proportion of cells passing the 1.2 µm Acrodisc 
syringe filter.  Viable counts would likely under-estimate the bacterial density of 
the pre-filtration suspensions, as there were both single cells and bacterial clumps.  
As the number of single cells in the pre-filtration suspension was likely to far 
exceed the number of bacterial clumps in the suspension, the CFU before the 
filtration was used to approximate the number of single cells. 
 
4.2.4 Antimicrobial susceptibility tests for bacterial 
cultures at the standard density and higher densities 
 
MICs and MBCs
 
of single antimicrobial agents for planktonic cells from different 
growth phases (mid-log planktonic, biofilm-released and biofilm-embedded), were 
determined by broth micro-dilution method described in CLSI guidelines (CLSI, 
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2004), except MHB instead of MHB with 1% NaCl was used for oxacillin.  This 
was to avoid any influence of NaCl on the further persister cell isolation studies.  
Antimicrobial MIC and MBC for planktonic cells at densities of 107~ 108 CFU/mL 
were also tested.  These values were defined as MIChigh and MBChigh respectively.  
They were chosen for this study as bacterial cultures at higher bacterial densities 
(~108 CFU/mL) were frequently used to quantify the persister cells in published 
studies and likely showed different antimicrobial susceptibility from CLSI defined 
planktonic cultures (5 x 105 CFU/mL).  
 
4.2.5 Time-dependent bacterial killing and lytic curves of 
cells in different growth phases  
 
Time-dependent kill curves were prepared to determine the incubation time with 
different antimicrobials required to isolate persister cells.  Time-dependent lytic 
curves were also performed to determine the most appropriate antimicrobial agents 
and their exposure times to isolate persister cells for SEM studies.  Lytic curves 
were prepared because dead bacteria selected by time-kill experiments might still 
retain their intact morphology, which would confuse the SEM results.  
Antimicrobial agents at concentrations of 8 or 16 × MIChigh were used for these 
experiments provided this concentration was beyond MBChigh.  The kill curves for 
both CoNS isolates in the presence of oxacillin, vancomycin, ciprofloxacin, and 
rifampicin were determined.  Initial inocula used for time-kill curves and 
time-dependent lytic curves were planktonic cells at mid-log phase (also 
representing biofilm-released cells) and planktonic cells at stationary phase (also 
representing biofilm-embedded cells).  After preparation of planktonic bacterial 
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cultures, they were resuspensed to McFarland 0.5 standard (~ 1 × 108 CFU/mL).  
Nine milliliters of the bacterial suspensions were added into a 10 mL sterile tube 
containing 1 mL of the designated antimicrobial solution at a concentration of × 80 
MIChigh to reach a final concentration of × 8 MIChigh for the antimicrobial agent.  
Suspensions were incubated at 35°C on a shaker (200 rpm).  One milliliter 
volumes were removed at time points 0 h, 4 h, 8 h, 12 h, 16 h, 24 h, and 48 h.  The 
lytic activities of these antimicrobial agents were monitored by OD measurements.  
The time-kill activities were monitored along by plate counting (Herigstad et al., 
2001). 
 
4.2.6 Isolation of persister cells 
 
A published method was used for isolation of persister cells; a specific method has 
also been developed for this study, as deficiencies were found in the published 
method (Keren et al., 2004a; Keren et al., 2004b).  Referring to the published 
method, persister cells in mid-log planktonic cultures, biofilm-embedded 
populations, and biofilm-released populations, were isolated by exposure of 
suspensions of single cells at densities of ~ 108 CFU/mL to antimicrobials at 8 × 
MIC for 3 h with vigorous shaking (200 rpm) (Keren et al., 2004a; Keren et al., 
2004b).  By following the developed method, suspensions of cells at mid-log 
phase and stationary phase, cells embedded in biofilms, and cells released from 
biofilms were exposed to antimicrobial agents at 8 × MIChigh with shaking.  
Exposure times for the developed method were based on the results of time-kill 
curves.  Viable counts were performed and the ratio of bacterial survival (bacterial 
density after antimicrobial treatment) in the initial culture (bacterial density before 
antimicrobial treatment) (x 100) was estimated, as the percentage of persister cells 
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in different bacterial populations.  Log10 % survival is a logarithmic format of the 
percentage of persister cells for statistical analysis.  For example, log10 % survival 
of -2 stands for approximately 1% (10-2) of the original population persisting the 
antimicrobial exposure.  The lower the log10 % survival is, the fewer persister cells 
the corresponding cell population produces. 
 
4.2.7 Antimicrobial susceptibilities of “persister cells”  
 
In order to determine whether the persister cells are phenotypically or genotypically 
resistant to antimicrobial agents, susceptibility tests were performed for “persister 
cells” isolated with the published and developed methods.  After the persister cells 
were isolated, the fresh growth on NA plates obtained by the viable count procedure 
were inoculated into MHB broth and grown for 5-7 h.  The resulting suspensions 
were adjusted to McFarland 0.5 standard for the MIC tests, following the standard 
CLSI guideline, except MHB instead of MHB with 1% NaCl was used for oxacillin.   
 
4.2.8 Scanning electron microscopy 
 
Scanning electron microscopy was employed to examine the morphology of 
“normal” biofilm cells and the presence of bacterial clumps before and after 
filtration with 1.2 µm Acrodisc syringe filters.  Biofilm “persister” cells isolated 
with the published method and the developed method were also examined.  After 
isolating biofilm-embedded cells and selecting persister cells with oxacillin (8 MIC 
X 3 h), ciprofloxacin (8 MIC X 3 h), oxacillin (8 MIChigh X 24 h) and vancomycin 
(8 MIChigh X 48 h) respectively, 100 µL of the suspensions were filtered using a 
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0.45 µm filter membrane and air-dried overnight.  The samples were sputter 
coated with 200 angstroms of gold using a Magnetron sputter coater (Dynavac, 
SC100M); the trapped cells were viewed and imaged on a scanning electron 
microscope (XL30, Philips).  
 
4.2.9 Statistical analysis 
 
Assays to determine antimicrobial susceptibilities of bacteria and to isolate persister 
cells after antimicrobial exposure were carried out in three repeated triplicates (9 
assays).  One way ANOVA was used to compare the persister cell percentages in 
different growth modes.  On some occasions, a non-parametric method 
(Mann-Whitney) was applied if the data did not fall in a normal distribution.  A 
P-value of 0.05 was accepted as the significant level.  
 
4.3 Results 
 
4.3.1 Scanning electron microscopy to confirm the isolation 
of single cells 
 
Most single S. epidermidis RP62a cells from biofilms, had sizes of 0.8-1.0 µm in 
diameter (Fig. 4.1).  Few cells were found to possess sizes above 1.2 µm.  Cells 
of isolate 3 had a similar size (data not shown).  Under the high resolution SEM, a 
few bacterial clumps of 5-10 cells were observed, if biofilm cells were only isolated 
by scraping and vortexing.  Few bacterial clumps were found after the biofilm 
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bacterial suspension was filtrated with 1.2 µm syringe filter (Fig. 4.2).  Only single 
cells from S. epidermidis biofilms could pass the 1.2 µm syringe filter and any 
bacterial clumps (> 1.2 µm in size) would be excluded from the filtered suspension. 
 
4.3.2 Release and recovery of single cells from           
S. epidermidis RP62a biofilms  
 
Incubation of biofilms with fresh MHB for 90 min with gentle shaking (100 rpm) 
resulted in continuous release of the cells from the biofilm matrix, as indicated by 
viable counts.  During the 90-min incubation, bacterial densities of the suspension 
surrounding the biofilm, increased from ~8 x 107 to ~ 5 x 108 CFU/mL (Fig. 4.3).  
In contrast, planktonic cultures of the same age and initial density only doubled in 
cellular densities (Fig. 4.3).  When incubation was extended to 120 min, the 
bacterial density of biofilm-released cells continued to increase at the same rate, 
while the corresponding planktonic cell population entered the logarithmic growth 
phase.  These results suggested that 90 min incubation with gentle shaking (100 
rpm) would be an appropriate method for the acquisition of biofilm-released cells.   
 
Viable counts performed before and after filtering with a 1.2 µm syringe filter 
showed that about 50% of the CFUs present in the original suspension passed 
through the filter (51% for biofilm-embedded cells and 54% for biofilm-released 
cells based on three assays).   
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Fig. 4.1 S. epidermidis RP62a biofilm cells (before filtration).  Cells were 
dissociated by scraping and vortexing.  0.45 µm filter membrane was used as the 
supporting platform. Most cells measure 0.8-1.0 µm in diameter.  Bacterial clumps 
consisting of up to 10 cells were found. 
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Fig. 4.2 S. epidermidis RP62a biofilm cells (after filtration).  Cells were 
dissociated by scraping and vortexing, and followed by filtration with 1.2 µm 
syringe filter.  Few bacterial clumps were found. 
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Fig. 4.3 Time-dependent increase of density of cells released from S. 
epidermidis RP62a biofilms and planktonic cells of the same age.  The increase 
of bacterial density of biofilm cells is most likely due to continuous release from 
biofilms and multiplication.  The increase of bacterial density of a planktonic 
culture followed a normal growth curve due to bacterial multiplication.          
* 6.00E+08 stands for 6.00 x 108 CFU/mL. 
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4.3.3 MICs and MBCs of antimicrobial agents for CoNS 
from different growth modes  
 
There were no significant differences of the antimicrobial susceptibilities between 
planktonic cells in mid-log phase, biofilm-released cells and biofilm-embedded 
cells for both S. epidermidis RP62a and isolate 3, when they were tested at a 
standard density of ~ 5 x 105 CFU/mL, by following CLSI instruction (Table 4. 1). 
 
 
4.3.4 Development of criteria for the developed method to 
isolate persister cells  
 
4.3.4.1 Determination of antimicrobial concentrations for isolation 
of persister cells  
 
To determine the concentration of antimicrobials required to select persister cells 
while killing other bacteria, MICs and MBCs were performed using log phase and 
stationary phase cells at high densities of 107-108 CFU/ml (MIChigh and MBChigh). 
Based on results presented in Table 4.2, 8 × MIChigh was selected as the persister 
cell selecting concentration in most cases, except that oxacillin and vancomycin at 
16 x MIChigh were used for S. epidermidis RP62a planktonic culture at mid-log 
phase.  This was to ensure that planktonic cultures in both log phase and stationary 
phase of S. epidermidis RP62a received the same level of antimicrobials.
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Table 4.1 Antimicrobial susceptibilities of single CoNS cells isolated from different growth modesa 
a
 Values are numbers of micrograms per milliliter. Each value is the geometric mean of three triplicates (9 data points)  
 
 
 
Penicillin Gentamicin Oxacillin Vancomycin Ciprofloxacin Rifampicin Isolate and mode 
of growth MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC 
S. epidermidis RP62a  
Planktonic log phase 16 16 16 64 4 8 2 2 0.12 0.12 0.008 0.03 
Biofilm-embedded 32 32 32 32 4 16 2 2 0.12 0.12 0.004 0.008 
Biofilm-released 32 32 32 32 4 16 2 4 0.12 0.12 0.004 0.008 
Isolate 3  
Planktonic log phase 8 16 0.25 0.25 0.12 0.25 2 2 0.12 0.12 0.008 0.008 
Biofilm-embedded 16 32 0.12 0.25 0.12 0.12 2 4 0.25 0.25 0.008 0.008 
Biofilm-released 8 16 0.25 0.25 0.12 0.12 2 4 0.25 0.12 0.008 0.008 
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Table 4.2 Antimicrobial susceptibilities of CoNS at high densities, and the concentrations of antimicrobials used to isolate persister cells 
Oxacillin (µg/mL) Vancomycin (µg/mL) Ciprofloxacin (µg/mL) Rifampicin (µg/mL) 
Bacterial 
isolates MIChigh MBChigh 
Concentration 
to isolate  
persisters 
MIChigh MBChigh 
Concentration 
to isolate  
persisters 
MIChigh MBChigh 
Concentration 
to isolate  
persisters 
MIChigh MBChigh 
Concentration 
to isolate  
persisters 
 Planktonic culture at mid-log phase 
S. epidermidis 
RP62a 128 128 2048 4 4 64 0.5 0.5 4 0.008 0.12 0.064 
Isolate 3 0.25 0.25 4 4 8 64 0.5 0.5 4 0.008 0.03 0.064 
 Planktonic culture at stationary phase 
S. epidermidis 
RP62a 256 256 2048 8 16 64 0.5 0.5 4 0.008 0.015 0.064 
Isolate 3 0.25 1 4 8 8 64 0.5 0.5 4 0.008 0.12 0.064 
                                                                                                        
 
134
4.3.4.2 Time-dependent lytic and killing curves of CoNS at mid-log 
phase and stationary phase 
 
A significant decrease in turbidity with a concomitant decrease in viability in both 
isolate 3 and S. epidermidis RP62a were observed in presence of oxacillin and 
vancomycin.  Oxacillin had the most potent lytic effect, with a complete lysis of 
most cells in both log and stationary culture within 24 h.  An additional 24 h was 
required for vancomycin to achieve complete lysis of both S. epidermidis RP62a 
and isolate 3.  In the presence of 8 × MIChigh of ciprofloxacin and rifampicin, the 
lysis of bacterial cells was incomplete.  After 8 h exposure to rifampicin, dramatic 
increases in optical density were found (Fig. 4.4).  Time-kill curves were also 
determined by antimicrobial agents and bacterial growth phases.  Stationary phase 
cells required at least 16-24 h exposure to oxacillin or ciprofloxacin to eradicate 
most bacteria, while 48 h was required for vancomycin.  Log phase cells were 
killed more rapidly by these antimicrobials.  Cells in both phases were rapidly 
killed by rifampicin after 4-8 h, but there was a sharp increase in bacterial number 
afterward, in spite of continuous antimicrobial exposure. 
 
Based on the above findings, 24 h exposure to oxacillin (8 or 16 × MIChigh) or 
ciprofloxacin (8 × MIChigh), 48 h exposure to vancomycin (8 or 16 × MIChigh), or  
8 h exposure to rifampicin (8 × MIChigh), were used for isolation of persister cells.  
The same periods were used for bacteria grown in different modes and growth 
phases to enable valid comparisons to be made.  
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Fig. 4.4 Time-dependent lytic curves of S. epidermidis after exposure to various antimicrobial agents at 8 or 16 x MIChigh 
a. S. epidermidis RP62a at stationary phase. 
b. S. epidermidis RP62a at log phase. 
c. Isolate 3 at stationary phase. 
d. Isolate 3 at log phase. 
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Fig 4.5 Time-kill curves of S. epidermidis after exposure to various antimicrobial agents at 8 or 16 x MIChigh 
e. S. epidermidis RP62a at stationary phase 
f. S. epidermidis RP62a at log phase 
g. Isolate 3 at stationary phase 
h. Isolate 3 at log phase 
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4.3.5 Estimation of the percentage of the persister cells in 
different growth modes 
 
4.3.5.1 “Persister” cells isolated by the published methodology 
 
After exposure to oxacillin, vancomycin, ciprofloxacin, or rifampicin for three 
hours, there were differences in the percentages of “persister cells” recovered 
between the three populations all at ~ 108 CFU/mL (biofilm-released cells, 
biofilm-embedded cells and planktonic cells at log phase) (Fig. 4. 6 a & b).   
 
All three populations studied showed a decrease of the bacterial densities when 
exposed to antimicrobials for 3 h, with a mean log10 % survival of -2.02, ranging 
from -0.33 to -3.63 for individual isolate and antimicrobial agent (Fig. 4. 6 a & b).  
For both S. epidermidis RP62a and isolate 3, biofilm-embedded cell populations 
produced higher percentage of “persister cells” (lower mean log10 % survival) than 
the other two growth modes when exposed to oxacillin, vancomycin, and 
ciprofloxacin (P < 0.05).  However, in the case of rifampicin, the percentage of 
persister cells was similar for biofilm-embedded cells and planktonic cells of both 
strains (P>0.05).  In general, the biofilm-released population yielded the lowest 
percentage of persister cells (Fig. 4. 6 a and b). 
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Fig. 4.6 Quantitative comparisons of persister cells of S. epidermidis RP62a and isolate 3 in three different growth modes by using the 
published methodology. 
a. Isolation of S. epidermidis RP62a persister cells grown in different modes (3 h, 8 x MIC) 
b. Isolation of isolate 3 persister cells grown in different modes (3 h, 8 x MIC) 
Log10 % survival is a logarithmic format of the percentage of survivor cells for statistical analysis.  For example, log10 % survival of -2 
stands for approximately 1% (10-2) of the original population persisting the antimicrobial exposure.  The lower the log10 % survival is, the 
fewer survivor cells the corresponding cell population produces. 
 
                                                                                                        
 
139
4.3.5.2 Persister cells isolated by the developed methodology  
 
Using more stringent conditions for isolation of persister cells, there were few 
differences between, but greater variation in the percentages of persister cells 
isolated from populations of different growth modes (Fig. 4.7)  The few 
statistically significant differences were: 1) when ciprofloxacin was used against S. 
epidermidis RP62a, planktonic cells in stationary phase showed more persister cells 
than biofilm-embedded populations (Fig. 7a and Table 4.3); 2) when isolate 3 was 
treated with oxacillin, biofilm released population grew the most persister cells, 
followed by that at stationary phase, then that at log phase; 3) when ciprofloxacin 
was used against isolate 3, planktonic cells in stationary phase showed more 
persister cells than biofilm-embedded populations (Fig. 7b and Table 4.3).  When 
oxacillin and vancomycin were used to isolate persister cells from all growth modes 
of S. epidermidis RP62a, the log10 % survival reached a level close to the detection 
limit.  In addition, significantly fewer viable cells were recovered by this method 
than were obtained with the published method.    
 
 
4.3.6 Antimicrobial susceptibilities of persister cells derived 
from different populations of S. epidermidis RP62a 
 
The persister cells isolated from different populations and grown on NA plates for 
viable counting were tested for antimicrobial susceptibilities, using the CLSI 
microdilution method.  There was no difference in MICs of any antimicrobial 
agents when 3 h “persister cells” from different populations were tested.
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Fig. 4.7 Quantitative comparisons of persister cells of S. epidermidis RP62a and isolate 3 in different growth modes by using the 
developed methodology. 
a. Isolation of S. epidermidis RP62a persister cells grown in different modes.  
b. Isolation of isolate 3 persister cells grown in different modes.  
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Table 4.3 P-values of the quantitative comparisons of persister cells of S. epidermidis in different growth modes 
The highlighted values indicate a significant difference (P < 0.05). 
Bacterium Oxacillin Vancomycin Ciprofloxacin Rifampicin 
S. epidermidis 
RP62a 
Planktonic- 
log 
Planktonic
-stationary 
Biofilm- 
embedded 
Planktonic- 
log 
Planktonic- 
stationary 
Biofilm- 
embedded 
Planktonic- 
log 
Planktonic- 
stationary 
Biofilm- 
embedded 
Planktonic
-log 
Planktonic- 
stationary 
Biofilm- 
embedded 
Planktonic- 
stationary 1.000   0.396   0.269   0.741   
Biofilm- 
embedded 0.225 0.396  1.000 0.225  0.291 0.010  0.216 0.006  
Biofilm- 
released 1.000 1.000 0.396 0.684 0.823 0.497 0.802 0.362 0.122 <0.001 < 0.001 <0.001 
Isolate 3             
Planktonic- 
stationary < 0.001   0.451   0.080   < 0.001   
Biofilm- 
embedded <0.001 0.064  0.277 0.664  0.849 0.007  0.031 0.07  
Biofilm- 
released <0.001 0.001 0.860 0.876 0.434 0.272 0.165 0.102 1.000 0.963 <0.001 0.001 
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Furthermore, there was no difference in MICs between these persister cells and 
their parent strains (Table 4.4).  
 
After 24 or 48 h of challenge with antimicrobial agents at higher concentrations (8 
or 16 × MIChigh), S. epidermidis RP62a persister cells selected by oxacillin, 
vancomycin and ciprofloxacin, if present, had the same MICs as their ancestors 
(Table 4.5).  However, cells selected by rifampicin exhibited a higher MICs 
compared with their ancestors, by more than 10 log2.   
 
4.3.7 SEM of S. epidermidis RP62a persister cells  
 
Using the published method, cells selected with either oxacillin or ciprofloxacin (3h, 
8 × MIC) were variable in size, and showed many large swollen cells, suggesting 
killing with incomplete lysis.  Some cells were in the process of cell division, 
indicating the presence of live and growing bacteria.  A large amount of cellular 
debris or EPS materials was found on the filter membranes, showing shadows there.  
Cells isolated with the developed method were not available for SEM study as no 
persister cells were isolated from bacterial populations in most experimental 
repeats. 
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Table 4.4: Antimicrobial susceptibilities (MICs) of S. epidermidis RP62a persister cells selected by the published method 
Bacterial origin  Oxacillin 
32 µg/mL 
Vancomycin 
16 µg/mL 
Ciprofloxacin 
1 µg/mL 
Rifampicin 
0.03 µg/mL 
Initial Planktonic 4a 2 0.06 0.008 
Planktonic-log 4 2 0.06 0.008 
Biofilm-embedded 4 2 0.06 0.008 
Biofilm-released 4 2 0.06 0.008 
 a
 Values are numbers of micrograms per milliliter. Each value is the geometric mean of three triplicates. 
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Table 4.5 Antimicrobial susceptibilities (MICs) of S epidermidis RP62a persister cells selected by the developed methodsa 
a
 Each value is the geometric mean of three triplicates. 
b
 No persister cells isolated from bacterial populations in most experimental repeats. 
Bacterial origin  Oxacillin 
2048 µg/mL 
Vancomycin 
64 µg/mL 
Ciprofloxacin 
4 µg/mL 
Rifampicin 
0.064 µg/mL 
Initial Planktonic 4 2 0.06 0.008 
Planktonic-log /b / 0.06 >128 
Planktonic-stationary 4 2 0.06 >128 
Biofilm-embedded / / 0.06 >128 
Biofilm-released / 2 0.06 >128 
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a b 
Fig. 4.8 SEM of persister cells isolated with the published method. 
a. S. epidermidis RP62a “persister cells” isolated from biofilms by oxacillin (3 h, 8 x MIC) 
b. S. epidermidis RP62a “persister cells” isolated from biofilms by ciprofloxacin (3 h, 8 x MIC) 
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4.4 Discussion  
 
To my knowledge, this is the first study to date to successfully isolate single cells 
from bacterial biofilms.  Methods to obtain single bacteria from biofilms were 
developed and validated in this study.  Incubation of biofilms in fresh media at 
35°C for 1.5 h with gentle shaking led to an approximate six-fold increase in 
bacterial density.  Planktonic cells of the similar density incubated under the same 
conditions showed less than two-fold increase.  As both types of cells were 
derived from stressed cultures (stationary phase planktonic cultures or biofilms), 
these results suggest that most of the biofilm-released cells were acquired from 
biofilm-shedding, rather than bacterial multiplication.  A combination of scraping, 
pipetting, swabbing, and vortexing was used to break up the biofilm matrix and to 
isolate biofilm-embedded single cells, as all these steps were reported to have 
negligible effects on the physiological properties of the bacterial cells (Bruinsma et 
al., 2001).  Single planktonic or biofilm-grown CoNS cells had cellular sizes 
ranging from 0.8 µm to 1.0 µm, which enables the 1.2 µm syringe filter to separate 
them from bacterial clumps.  Using a 1.2 µm syringe filter, some biofilm cells 
were apparently trapped by the filter as only ~ 50% of the CFUs were recovered.  
This is most likely due to the presence of diplococci and small clumps within the 
biofilm.  However, single cell suspensions containing bacteria of up to 107-108 
CFU/mL were finally achieved, which were adequate for antimicrobial 
susceptibility tests and persister cell studies.  Other researchers obtained 
biofilm-released cells by simply incubating biofilms in fresh media, and obtained 
biofilm-embedded cells by sonication or scraping (Ceri et al., 2001; Leitch & 
Willcox, 1999).  It is likely that bacterial clumps, which behaved more like biofilm 
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cells, were acquired by these researchers. 
 
Biofilm-embedded cells and biofilm-released cells had similar susceptibilities 
(shown by MICs and MBCs) to log-planktonic cells, suggesting that the 
biofilm-growth mode, not the genetic traits of most cells, contribute to biofilm 
resistance.  These results are consistent with a microarray study that found few 
genes showing differential expression between planktonic cells and 
biofilm-embedded cells of P. aeruginosa, despite the striking differences in their 
lifestyles (Whiteley et al., 2001).   
 
The MIC and MBC values do not account for the presence of persister cells.  Since 
the MBC targets 99.9% killing, one in 1000 cells in the bacterial population would 
remain out of the consideration of conventional antimicrobial susceptibility tests.  
A number of influential factors have been carefully considered and controlled when 
designing the experiment to isolate persister cells from different populations.  First, 
persister cells undergo a phenotypic switch when the culture conditions favor their 
growth (Shah, et al., 2006, Balaban et al., 2004).  In this study, antimicrobial 
agents prepared in fresh MHB were used to select and retain the persister cells, 
since exposure to antimicrobial agent containing fresh medium reduces the chance 
of switching (Keren et al., 2004b).  The second factor is the concentration used to 
isolate the persister cells.  Most other studies exposed bacterial cultures of 107-108 
CFU/mL to antimicrobials at 5 to 10 x MIC.  However, this level may not be 
sufficient to kill all vulnerable bacteria if densities of bacterial cultures are higher 
than that used in standard MIC determination.  This study used up to × 16 MIChigh 
to isolate persister cells in an attempt to kill the majority of bacteria in populations 
of 107-108 CFU/mL.  The third factor is the exposure time used to isolate persister 
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cells.  Most other studies exposed bacterial cultures to antimicrobials for 2.5 - 3 h 
to select persister cells, however, no evidence has been provided to confirm killing 
or lysis of all vulnerable cells by 3 h (Keren et al., 2004a).  In this study, 24 h was 
chosen when oxacillin and ciprofloxacin were used as the selecting agents and 48 h 
was chosen for vancomycin.  The choice of these treatment times was based on 
pre-determined lytic and kill curves, which showed that most susceptible bacteria 
were destroyed in those times.  
 
A higher percentage of persister cells was found in biofilms than its corresponding 
planktonic growth modes when exposure to antimicrobials at 8 x MIC for 3 h were 
used to isolate persister cells.  This finding is consistent with the conclusion from 
other published studies (Lewis, 2005; Spoering & Lewis, 2001).  The presence of 
persister cells in biofilms or other cell populations has been widely reported 
(Harrison et al., 2005; Lewis, 2005; Spoering & Lewis, 2001), and it has been 
proposed that the high tolerance of biofilms to antimicrobials may be partially due 
to the presence of relatively more resistant cells within biofilms than in planktonic 
cultures (Spoering & Lewis, 2001).   However, SEM results from this study 
showed that the antimicrobial regimen used in the published method was 
insufficient to kill all the vulnerable cells.  This suggested that cell selecting 
conditions should be regulated to ensure that cells isolated are persister cells.  
 
Different results were obtained when antimicrobial concentrations and treatment 
times based on time-kill curves were used to isolate persister cells.  Under the 
more stringent conditions, fewer persister cells were isolated and there was 
generally no significant difference in the percentage of persister cells, regardless of 
growth modes.  Moreover, the production of persister cells seemed to be 
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antimicrobial agent dependent; biofilms treated with vancomycin and oxacillin 
produced very few persister cells, almost reaching the detection limit, however, 
there were a certain number of persister cells in different populations when 
ciprofloxacin was used.  Besides the possibly high potential of vancomycin and 
oxacillin in eradication of persister cells, the lack of persister cells is also likely to 
be due to that vigorous shaking during the selection procedure which caused 
persister cells to switch back to normal cells and become vulnerable to cell-wall 
active antimicrobials such as vancomycin and oxacillin.  Stability of persister cells 
could possibly be enhanced both by increasing the antimicrobial concentrations and 
omitting this shaking step in the selection procedure. 
 
Taken together, this study suggests that biofilms contain a tolerant population in 
addition to persister cells, in which there is a delay in killing by antimicrobials.  
These tolerant cells are more numerous in biofilms than planktonic cultures, but 
they are still vulnerable to extensive killing.  Thus there might be three fractions of 
cells in a biofilm cellular population.  A fraction of normal cells is rapidly killed 
by antimicrobials.  The second comparatively larger fraction of cells has a slower 
response to bacterial killing by antimicrobials, but can be eventually eradicated by 
antimicrobials if higher concentrations are used for a longer time.  The third 
fraction is the persister cells, which is resistant to high concentration of 
antimicrobial agents over extended periods of time (Keren et al., 2004a; Lewis, 
2005).  However, the presence of persister cells and their number are both 
antimicrobial agent and bacterial strain dependent.  When certain cell-wall active 
antimicrobials were used at a high concentration for an adequate time, persister 
cells were apparently eradicated to an undetectable level.  Both persister and 
tolerant cells had the same antimicrobial susceptibilities as normal cells and their 
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ancestors, suggesting that there were no genotypically resistant traits involved in 
their tolerance or resistance.  
 
Ideally, treating biofilm related CoNS infections should target persister cells.  
Vancomycin generated the lowest number of persister cells among four 
antimicrobial agents during a 24 - 48 h period.  Oxacillin was also effective, 
although resistance of S. epidermidis to methicillin is widespread.  Ciprofloxacin 
had lower ability to eradicate persister cells, while exposure to rifampicin resulted 
in selection of resistant mutants.  This in vitro study also supports the use of a 
combination of vancomycin and rifampicin for treatment of catheter-related CoNS 
infections.   Rifampicin is effective in killing normal cells as well as tolerant cells 
in biofilm population in a short term, while vancomycin can eventually eradicate 
persister cells and does not appear to generate resistant mutants.  
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Chapter 5: Adherent growth mode, rather than 
extracellular polymer substance matrix build-up 
ability, contributes to high resistance of S. epidermidis 
biofilms to antimicrobial agents  
 
5.1 Introduction 
  
As described in Chapter 3, adherent monolayers/biofilms formed by 
“biofilm-negative” and “biofilm-positive” CoNS both show high resistance to 
multiple antimicrobial agents.  When the bacterial growth changed from 
log-planktonic to early adherent monolayer, then to the biofilm mode, biofilm 
positive and negative strains behaved similarly with respect to increases in 
antimicrobial resistance.  Since biofilm-negative CoNS strains form dense layers 
of cells on the substratum, this chapter investigates the role of densely adherent 
growth and the ability to build up the EPS matrix in the resistance of biofilm 
bacteria to antimicrobial agents. 
 
The ability of CoNS to form biofilms has been previously categorized into three 
groups: biofilm-positive, biofilm-weak, and biofilm-negative, based on the 
measurement of the optical density after staining with Hucker crystal violet 
(Christensen et al., 1985; Deighton et al., 2001).  It is generally believed that the 
thicker EPS matrix the biofilm cells build up, the higher resistance they gain to 
multiple antimicrobials.  The terms, monolayer biofilm and multilayer biofilm, 
have been recently proposed to describe bacterial biofilms, based on the abilities of 
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bacteria to establish EPS and the biofilm structures they present 
(Entcheva-Dimitrov & Spormann, 2004; Karatan & Watnick, 2009; Smit et al., 
2000; Van Dellen et al., 2008).  The former corresponds to isolates classified as 
biofilm-negative strains or weak biofilm producers and the latter refers to 
biofilm-positive isolates (Karatan & Watnick 2009).    
 
To date, most biofilm research concerning antimicrobial resistance focused on the 
“biofilm-positive” phenotype or the multilayer biofilms (Dales et al., 2009; Hajdu 
et al., 2009; Olson et al., 2002; Presterl et al., 2009; Spoering & Lewis, 2001).  
Numerous genetic studies performed in vitro also targeted strategies to control the 
build-up of the EPS matrix of multilayer biofilms (Johnson et al., 2008; Sadykov et 
al., 2008).  There is a lack of studies of antimicrobial susceptibility of the 
“biofilm-negative” phenotype or monolayer biofilms. 
 
In the previous chapter, it was shown that there is no significant difference in the 
number of persister cells between biofilms and planktonic cultures at log phase.  In 
this chapter, these findings are extended to compare monolayer and multilayer 
biofilms for the presence of persister cells, with a modified method of using more 
stringent conditions to ensure the stability of persister cells. 
 
The aims of this study were to use paired strains that form multilayer and 
monolayer biofilms to: 1) evaluate the role of the adherent growth mode and 
biofilm EPS build-up in biofilm resistance to antimicrobials; 2) determine whether 
adherent growth mode or biofilm EPS build-up ability are significant virulence 
factors of CoNS; 3) re-assess various mechanisms leading to biofilm resistance to 
antimicrobials. 
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5.2 Materials and methods 
 
5.2.1 Bacterial isolates and growth conditions 
   
Four S. epidermidis strains were used in this study; S. epidermidis M187 sp11, S. 
epidermidis M187 sn3, S. epidermidis RP62a, and S. epidermidis epidermidis 
RP62aCRV.  S. epidermidis M187 mutants sp11 and sn3 were kindly donated by Dr. 
Gene Muller (previously in the Channing Laboratory).  S. epidermidis M187 is a 
“biofilm-positive” strain and was isolated from a patient with dialysis-associated 
peritonitis.  Both S. epidermidis M187 sp11 and sn3 were produced by a single 
insertion of Tn917-LTV1 into the parent bacterium (Higashi et al., 1998; Thomas et 
al., 1997).  The strain M187 sp11 is phenotypically identical to M187 and M187 
sn3 is a biofilm-deficient mutant.  Both strains were maintained on NA plates 
containing chloramphenicol at 5 µg/mL and erythromycin at 1 µg/mL.  S. 
epidermidis RP62aCRV was also donated by Dr. Gene Muller.  It was previously 
selected from S. epidermidis RP62a and appeared to have a “biofilm-negative” 
phenotype (Table 5.1). 
 
 
5.2.2 Antimicrobial agents 
   
Representatives of four classes of antistaphylococcal antimicrobial agents were 
chosen for this study; oxacillin, vancomycin, ciprofloxacin, and rifampicin.   
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Table 5.1 S. epidermidis strains used in this study a 
Strains Adherence Polysaccharide intracellular adhesin  Biofilm formation Other information 
RP62a Strong Positive Positive ATCC 35984 
RP62aCRV Weak Not Known Negative Congo Red Variant of RP62awt 
M187 sp11 Strong Positive Positive Transposon mutant of M187 
M187 sn3 Weak Negative Negative Transposon mutant of M187 
a Adopted from Thomas et al. (1997). 
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5.2.3 Biofilm assays. 
 
Biofilms were established in 96-well polystyrene microplates with TSB, as 
described in section 2.2.2.  Biofilms produced by each S. epidermidis strain was 
quantitated by measuring OD595 after staining with Hucker crystal violet (Deighton 
et al., 2001). 
 
5.2.4 Antimicrobial susceptibilities of S. epidermidis in a 
planktonic mode 
 
Susceptibilities of four S. epidermidis strains to antimicrobials were evaluated by 
determining the MICs and MBCs, according to CLSI guidelines (section 2.2.4)  
 
5.2.5 MICs and MBCs for monolayer/multilayer biofilms   
 
MICs for biofilm-grown bacteria were measured as described in section 3.2.5.  
Three different methodologies were used to define MBCs of antimicrobials for S. 
epidermidis monolayer biofilms or multilayer biofilms.  
 
The first methodology was referred to as the viable count-based MBC (Gualtieri et 
al., 2006; Polonio et al., 2001).  The number of bacteria in established 
monolayer/multilayer biofilms was pre-determined before antimicrobial treatment 
as described in section 3.2.6 (Gualtieri et al., 2006; Villain-Guillot et al., 2007).  
The bacterial numbers after antimicrobial treatment were similarly determined.  
The minimum concentration of antimicrobials which reduced bacterial numbers by 
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at least 3 log10 (99.9%) was taken as the viable count-based MBC. 
 
The second and third MBC methodologies were based on a published broth 
recovery method, with and without a modification (Tomihama et al., 2007; Zhang 
& Mah, 2008).  After the biofilms were treated with antimicrobials at a series of 
concentrations overnight, the antimicrobial solutions were removed and the 
microwells were washed 3 times with sterile PBS.  The microwells were then 
processed with 1) broth recovery-based method; 200 µL of TSB was added into 
each well and the microplates were then incubated for a further 48 h with shaking 
(100 rpm), and 2) modified broth recovery-based method; 200 µL of TSB and 0.2 g 
antimicrobial agent-removal resin beads (Amberlite XAD-16) were added into each 
well and the microplates were then incubated for a further 24 h with shaking (100 
rpm).  The supernatants were carefully transferred to a new 96-well microplate, 
and the turbidity of the contents was visually assessed.  The minimum 
concentrations of antimicrobials that resulted in no visible bacterial growth in the 
suspensions were defined as broth recovery-based MBC and modified broth 
recovery-based MBC respectively.   
 
5.2.6 MBECs for biofilms   
 
After the broth recovery-based MBCs were determined, the remaining biofilms 
were then swabbed with a cotton-tipped swab, cultured on a NA plate, and 
incubated for 3 days at 35º C (Dales et al., 2009).  The MBEC was the minimum 
concentration resulting in no bacterial growth. 
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5.2.7 CLSM 
 
Multilayer biofilms of S. epidermidis RP62a and S. epidermidis M187 sp11, 
monolayer biofilms of S. epidermidis RP62aCRV and S. epidermidis M187 sn3 were 
grown in 96-well microplates.  The microwells were then rinsed three times with 
0.9% saline to remove non-adherent bacteria.  One of the following treatments was 
applied to the S. epidermidis biofilms for 24 h: a) MHB, as an untreated biofilm 
control; b) 2560 µg/mL oxacillin; c) 1280 µg/mL vancomycin; d) 128 µg/mL 
ciprofloxacin; and e) 32 µg/mL rifampicin.  The treated monolayer/multilayer 
biofilms were then stained with LIVE/DEAD BacLight viability kit and the 
viability of biofilm cells were examined immediately with a Nikon A1R Laser 
Scanning Microscope equipped with Nikon Eclipse Ti fluorescence microscope, as 
described in section 3.2.8.   
 
5.2.8 Bacterial densities of monolayer/multilayer biofilms 
 
The calculation of bacterial densities of monolayer/multilayer biofilms was based 
on the formula:  
Biofilm Bacterial Density = Viable Count of Biofilms / Volume of Biofilms 
Bacterial numbers of biofilms were determined by performing scraping, sonication, 
swabbing, and viable count, as described earlier.  The volume of biofilms was 
calculated by following the formula:  
Biofilm Volume = Average Biofilm Thickness x Average Biofilm Area 
Biofilm thickness was measured after constructing a 3-dimensional structure of 
biofilms using CLSM.  The mean of nine thickness values from three different 
biofilms was used to represent the overall biofilm thickness.  The area covered by 
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attached cells was quantified using the area of the microwell bottom and the 
percentage of bacterial coverage of the microwell bottom (Image J software, 
National Institute of Health, USA).  The mean of nine individual values from three 
different biofilms was used as the overall biofilm area. 
 
5.2.9 Isolation and quantification of persister cells in 
planktonic cultures at log phase, and from monolayer/ 
multilayer biofilms     
 
To isolate persister cells, bacterial suspensions of biofilm cells and planktonic 
culture at log phase were prepared as described in previous chapter (sections 4.2.2 
and 4.2.3).  Persister cells from each population were isolated, by following the 
previously developed method (section 4.2.6), except that the broth recovery-based 
MBC replaced the 8 or 16 × MIChigh and the tube was incubated statically rather 
than with shaking.  Broth recovery-based biofilm MBCs were generally higher 
than 8 or 16 × MIChigh.  Modification with a higher concentration of antimicrobials 
and omitting of shaking over the method developed in Chapter 4 were to ensure the 
stability of persister cells in selecting procedure.  The antimicrobial exposure 
times were 24 h for oxacillin, ciprofloxacin, and rifampicin or 48 h for vancomycin, 
based on preliminary bacterial lytic curve for S. epidermidis RP62a.  Before 
enumeration of persister cells, one gram of the antimicrobial agent-removal resin 
beads (Amberlite XAD-16) was added into the tube, followed by vortexing and 
incubation for at least 15 min (Wright et al., 2002; Zabinski et al., 1993).  The 
ratio of bacterial survival (bacterial density after antimicrobial treatment) in the 
initial culture (bacterial density before antimicrobial treatment) (x 100) was 
estimated, as the percentage of persister cells in the corresponding bacterial 
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populations.  
 
5.2.10 Scanning electron microscopy 
 
Scanning electron microscopy was carried out for S. epidermidis persister cells 
isolated in this study, as descried in section 4.3.7. 
 
5.2.11 Data analysis   
 
Antimicrobial susceptibility experiments were repeated at least three times.  A 
fourth repeat was performed if the results were inconsistent.  The geometric mean 
(log2) was calculated and used for comparison.  Persister cell experiments were 
repeated twice in triplicate.  The paired T-test was used to compare the percentage 
of persister cells in different populations, and a P-value < 0.05 was considered as a 
significant level. 
 
5.3 Results  
 
5.3.1 Re-confirmation of biofilm phenotypes 
 
After overnight growth, S. epidermidis RP62a showed a multilayer biofilm 
phenotype (conventionally biofilm-positive), and S. epidermidis RP62aCRV, showed 
a monolayer biofilm phenotype (conventionally biofilm-negative).  S. epidermidis 
M187 sp11, demonstrated strong biofilm-producing ability (multilayer biofilm); 
while its mutant, S. epidermidis M187 sn3, had a very weak biofilm-formation 
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ability (monolayer biofilm) (Table 5.2).  All these biofilm phenotypes were 
confirmed with CLSM (Fig. 5.1). 
 
5.3.2 Antimicrobial susceptibilities of S. epidermidis isolates  
 
Both S. epidermidis RP62a and its biofilm-negative variant RP62aCRV, and  S. 
epidermidis M 187 mutants sp11 and its biofilm-negative mutant sn3 had the same 
susceptibilities to oxacillin, vancomycin, ciprofloxacin, and rifampicin respectively, 
based on their CLSI MIC and MBC results (Table 5.3). 
 
5.3.3 Antimicrobial susceptibilities of monolayer/multilayer 
biofilms 
 
In general, there were no significant differences in the biofilm MIC, broth 
recovery-based MBC, modified broth recovery-based MBC or MBEC of 
antimicrobials between multilayer biofilms of S. epidermidis RP62a and monolayer 
biofilms of its “biofilm-negative” variant, RP62aCRV, or between that of S. 
epidermidis M187 sp11 and its “biofilm-negative” counterpart, M187 sn3 (Table 
5.3).  The biofilm MICs of rifampicin and ciprofloxacin were generally similar to 
the CLSI MICs for planktonic cultures; however, biofilm MICs of oxacillin and 
vancomycin were significantly greater than CLSI MIC in the case of the two S. 
epidermidis M187 strains.  Modified broth recovery-based biofilm MBCs and 
MBEC were much higher than CLSI MBCs, with most values beyond the detection 
limit (640 µg/mL for rifampicin and 2560 µg/mL for the other agents).  In addition, 
biofilm MBCs obtained with the modified broth recovery-based method were 
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Table 5.2 Biofilm phenotypes of S. epidermidis isolates used in this study 
Bacteria OD595a Conventional Category New Category 
S. epidermidis RP62a 3.14 ± 0.41 Biofilm-positive Multilayer biofilm 
S. epidermidis  RP62aCRV 0.04 ± 0.01 Biofilm-negative Monolayer biofilm 
S. epidermidis M187 sp11 2.90 ± 0.18 Biofilm-positive Multilayer biofilm 
S. epidermidis M187 sn3 0.14 ± 0.03 Biofilm-weak Monolayer biofilm 
a OD595 was measured after the biofilms were stained with Hucker crystal violet.
    162 
Table 5.3 Antimicrobial susceptibilities of monolayer biofilms and multilayer biofilms (µg/mL) a 
 
a All MIC, MBC and MBEC values are geometric means of the results of at least three independent measurements, taken to the closest doubling 
dilution. 
Antimicrobials Oxacillin Vancomycin Ciprofloxacin Rifampicin 
Bacteria RP62a  RP62a CRV
  
M187 
sp11  
M187 
sn3  RP62a  
RP62a 
CRV
 
M187 
sp11  
M187 
sn3  RP62a  
RP62a 
CRV
   
M187 
sp11  
M187 
sn3  RP62a  
RP62a 
CRV
  
M187 
sp11  
M187 
sn3  
CLSI MIC 64 64 0.5 0.5 1 1 1 1 0.12 0.12 0.12 0.12 0.004 0.004 0.004 0.004 
CLSI MBC 64 64 1 1 2 2 1 2 0.12 0.12 0.12 0.12 0.008 0.008 0.004 0.004 
Biofilm MIC 128 320 64 128 4 4 8 4  0.25 0.25 0.5 0.5  0.002 0.002 0.004 0.004 
Viable 
count-based 
MBC 
>2560 640 >2560 128 >2560 64 >2560 32 128 0.5 1280 1 0.03 0.015 320 0.25 
Broth 
recovery-based 
MBC 
>2560 >2560 >2560 >2560 640 1280 64 128 128 64 128 64 64 16 32 32 
Modified broth 
recovery-based 
MBC 
>2560 >2560 >2560 >2560 >2560 >2560 2560 >2560 1280 640 >2560 2560 128 64 >640 > 640 
 
MBEC >2560 >2560 >2560 >2560 >2560 >2560 >2560 2560 >2560 1280 >2560 > 2560 > 640 > 640 > 640 > 640 
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Fig. 5.1 Survival of biofilm cells from antimicrobial exposure.  Biofilms of S. epidermidis RP62a, RP62aCRV, M187 sp11, and M187 sn3 
were treated with antimicrobials at 1’000 x MIC or higher except for the combination oxacillin/RP62a, then stained with Syto-9 (bright green 
for live cells) and popidium iodide (red for dead cells). 
Bacteria Control Oxacillin 2560 µg/mL Vancomycin 1280 µg/mL Ciprofloxacin 128 µg/mL Rifampicin 32 µg/mL 
S. epidermidis  
RP62a 
     
S. epidermidis  
RP62a CRV 
     
S. epidermidis  
M187 sp11 
     
S. epidermidis  
M187 sn3 
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generally higher than those by the previously published broth recovery method. 
Although there were generally no significant differences between broth 
recovery-based MBCs of any antimicrobials for multilayer and monolayer biofilms, 
there were significant differences in viable count-based MBCs.  Multilayer 
biofilms showed a much higher resistance to all four antimicrobial agents than 
monolayer biofilms, when the analysis was based on viable count-based MBCs 
(Table 5.3). 
 
5.3.4 Bacterial densities of monolayer/multilayer biofilms 
 
Though multilayer biofilms after overnight incubation in TSB in a 96-well 
microplate contain more bacterial cells in total number than the corresponding 
monolayer biofilms (~108 CFU versus ~107 CFU), they had a similar bacterial 
density of 1011-12 CFU / mL (1011.9±0.1 CFU/mL for S. epidermidis RP62a, 1011.7±0.1 
CFU/mL for S. epidermidis M 187 sp11, 1011.5±0.1 CFU/mL for S. epidermidis 
RP62aCRV, and 1011.1±0.1 CFU/mL for S. epidermidis M 187 sn3 respectively). The 
bacterial densities of both multilayer and monolayer biofilms were much higher 
than those of planktonic cultures at either log phase (106-8 CFU / mL) or stationary 
phase (109-10 CFU / mL).  
 
5.3.5 CLSM 
 
The CLSM study showed that even exposed to a very high concentration of 
antimicrobials, a small fraction of bacteria in both monolayer biofilms and 
multilayer biofilms still survived antimicrobial killing (Fig. 5.2).   
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5.3.6 Quantification of persister cells in monolayer 
/multilayer biofilms 
 
After exposure to antimicrobials at broth recovery-based MBC for a pre-determined 
period, there were no persister cells surviving in planktonic cultures at log phase.  
In contrast, 1-0.01 % of cells remained viable in the biofilm populations (Fig. 5. 2).  
The percentage of persister cells in biofilms appeared to be strain and antimicrobial 
dependent.  There was no significant difference in the percentage of oxacillin 
persister cells present in monolayer biofilms and multilayer biofilms.  When 
selected with vancomycin or ciprofloxacin, multilayer biofilm formed by S. 
epidermidis M187 sp11 had significantly more persister cells than monolayer 
biofilm of M187 sn3 (P values, 0.005 and < 0.001 respectively); however, less 
persister cells were found in multilayer biofilms of S. epidermidis RP62a than the 
corresponding monolayer biofilms of S. epidermidis RP62aCRV (P values, 0.014 and 
0.007).  Selection of persister cells by rifampicin was not successful due to the 
emergence of mutant strains after overnight exposure.  
 
5.3.7 Scanning electron microscopy 
 
When exposed to oxacillin for 24 h, or vancomycin for 48 h, cellular debris were 
found on the supporting filter membranes, along with a few intact bacteria ranging 
in size from 0.8-1.0 µm in diameter.  They were round in shape, possessing a 
smooth surface.  No spore-like or small cells were found.  There were no 
significant morphological difference between the persister cells isolated from 
biofilm populations, and the normal bacteria grown in a planktonic culture or 
biofilms.
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 Fig. 5.2 Survival of the persister cells in S. epidermidis multilayer biofilms 
(RP62a and M187 sp11) and monolayer biofilms (RP62aCRV and M187 sn3).  
Log10 % survival is a logarithm format of the percentage of persister cells for 
statistical analysis.  The lower the log10 % survival is, the less persister cells the 
corresponding cell population can produce. 
+: P> 0.05; *: P <0.05; **: P< 0.01; ***: P <0.001.
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Fig. 5.3 SEM of persister cells selected with modified method used in this study 
a. S. epidermidis RP62a persister cells isolated from biofilms after exposure to oxacillin 
b. S. epidermidis RP62a persister cells isolated from biofilms after exposure to vancomycin 
 
 
a b 
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5.4 Discussion 
 
In this study, pairs of “biofilm-positive” S. epidermidis strains and their 
“biofilm-negative” mutants (or variants) were used to show that at least for S. 
epidermidis, once grown in an adherent mode, the bacteria become highly resistant 
to antimicrobials, regardless of their abilities to build up an EPS matrix.  There 
was no significant difference in antimicrobial resistance defined by the biofilm MIC, 
broth recovery-based MBC, modified broth recovery-based MBC, and MBEC 
between the monolayer biofilms produced by those so called “biofilm-negative” 
strains and multilayer biofilms established by “biofilm-positive” strains.  The 
CLSM study also suggested that, after exposure to high concentrations of 
antimicrobial agents (1000 X MIC or higher except for the combination 
oxacillin/RP62a), viable cells still remained in both types of biofilms.  Results 
from this study are supported by a recent study that showed that strains of 
Pseudomonas syringae pv. Theae with different biofilm-production abilities had 
similar susceptibilities to bactericides (Tomihama et al., 2007).  In addition, it has 
been reported that no correlation exists between the amount of slime produced and 
antimicrobial susceptibility of S. epidermidis (Edmiston et al., 2006; Labthavikul et 
al., 2003).  It should be questioned whether the conventionally defined “biofilm 
formation” is a true virulence factor of CoNS, as the biofilm build-up ability is not 
directly related to antimicrobial resistance.  Since most CoNS isolates are able to 
attach to a substratum and form monolayer or multilayer biofilms, it is likely that 
the adherent growth mode, rather than the ability of bacterial strains to produce EPS 
matrix or to form a typically “conventional” biofilm, is responsible for CoNS 
biofilm resistance to various antimicrobial agents.  Consequently it is proposed the 
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adherent growth mode is a major virulence factor of CoNS in regard to 
antimicrobial resistance.  EPS build-up ability of CoNS mainly contributes to the 
tolerance of biofilm bacteria to innate immune defenses of human body (Otto, 
2009). 
 
In contrast to resistances defined by biofilm MICs, broth recovery-based MBCs, 
modified broth recovery-based MBC, and MBECs, viable count-based MBCs were 
significantly different between multilayer and monolayer biofilms.  Multilayer 
biofilms demonstrated significantly higher viable count-based MBCs than 
monolayer biofilms.  This could be explained by the different stress that most cells 
in monolayer and multilayer biofilms encounter.  It is proposed that there are three 
subpopulations in a bacterial biofilm: a small fraction of normal cells, a large 
fraction of stressed cells with variable tolerance to antimicrobials, and a small 
fraction of persister cells.  This proposal is supported by the bacterial kill curve of 
biofilm cell populations in Chapter 4.  The tri-phasic curve consisted of an initially 
small but sharp drop in viable count, followed by a gradual drop, and then a level 
plateau of viable cells, corresponding to the normal cells, tolerant-but-killable cells 
and persister cells respectively.  Conventional MBC, modified broth 
recovery-based MBCs and MBEC target these three populations respectively.  In a 
multilayer biofilms, cells are stressed by a series of factors, including a high cellular 
density, the lack of oxygen and nutrient, and accumulated waste products from 
biofilm cells.  These stressed cells have an overall high resistance to antimicrobials.  
In contrast, cells in a monolayer biofilm are mostly stressed by the growth at 
high-density, and present a comparatively low resistance to antimicrobials.  Thus, 
it is not surprising those viable count-based MBCs, which target most but not all of 
the stressed cells (99.9% of the total population), would be higher for multilayer 
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biofilms than for monolayer biofilms.  On the other hand, the modified broth 
recovery-based MBCs and MBECs for both monolayer and multilayer biofilms 
were similar, indicating the same level of antimicrobial susceptibility of the mostly 
stressed cells and persister cells in both populations.    
 
In this study, re-incubation of the treated biofilms in broth medium for 48 h at 37°C 
was used to recover live cells in the biofilm matrix after treatment.  A more 
common method used in association with both the CBD and modified Robbins 
device was direct scrape-sonication followed by plating cells on recovery agar 
plates (Raad et al., 2007).  However, the results achieved by the scrape-sonication 
method did not match those obtained in the present study by the broth recovery 
method.  This could be explained by the detection limit of 1-3% biofilm cells 
using the sonication method, or/and the inability of this method to recover shocked 
cells, which were alive but not culturable (Polonio et al., 2001; Shah et al., 2002).  
 
Broth recovery-based MBCs obtained with the previously published methods were 
generally lower than those by the modified method using resin beads described in 
this study, suggesting the presence of antimicrobial carryover effects in biofilms 
after antimicrobial exposure.  This difference could be explained by the slow 
diffusion of antimicrobials such as vancomycin and rifampicin through biofilms 
(Darouiche et al., 1994; Dunne et al., 1993; Jefferson et al., 2005; Zheng & Stewart, 
2002).  Any trapped antimicrobial agents would continue to destroy biofilm 
bacteria unless bound with resin beads. 
 
Resin beads were added to compromise the antimicrobial carryover effects.  
Carryover of antimicrobials after antimicrobial treatment is problematic in time-kill 
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or MBC studies, especially when antimicrobial agents have been tested at very high 
concentrations.  Resin beads have been used to avoid this side-effect as they 
exhibit an effective absorbance of antimicrobial agents.  Amberlite XDA-16 is a 
non-ionic polymeric adsorbent to adsorb hydrophilic molecules from polar solvent.  
This excellent cross-linked resin has been used for antimicrobial neutralization.  
Although there were inadequate reported data about the efficacy of Amberlite 
XAD-16 in removal of antimicrobials, its structurally similar, however functionally 
weaker product, Amberlite XAD-4 has been reported to be able to successfully 
reduce the carryover of various antimicrobials, including aminoglycoside, penicillin, 
macrocide, ciprofloxacin and vancomycin from bacterial cultures.  The percentage 
of removal by resin beads was reported not related to the concentrations of the 
drugs prior to removals (Hyatt et al., 1994; Zabinski et al., 1993).  Moreover, these 
resin beads had no effect on bacterial growth (Hyatt et al., 1994; Zabinski et al., 
1993).   
 
CLSM in combination with LIVE/DEAD BacLight viability kit has been 
successfully used to examine the efficacy of antimicrobial agents on S. epidermidis 
biofilm eradication (Qin et al., 2007a; Qin et al., 2007c).  According to the 
manufacturer, once stained with LIVE/DEAD BacLight viability kit, the dead cells 
in a bacterial population present bright red colour while live cells display bright 
green colour, leaving the background nonfluorescent.  This theory is consistent 
with results in this study when cell-wall active antimicrobials, such as oxacillin and 
vancomycin were tested (Fig. 6. 2: b & c).  However, when antimicrobial agents 
with intracellular targets or more complex killing mechanisms were examined, the 
dead cells presented a reduced green colour or displayed an orange colour, 
indicating only partial quenching of SYTO-9 by PI or simultaneous staining of cells 
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by PI and SYTO-9 had occurred.  Similar results were obtained in a previous study 
by Berney et al. (2007).  These authors found that E. coli with intact outer 
membrane showed strong green fluorescence intensity and those cells with 
cytoplasmic membrane damage displayed decreased green fluorescence intensity.  
An incomplete replacement and quench of SYTO-9 fluorescence by PI has been 
proposed to explain this phenomenon (Berney et al., 2007).  Based on the report 
by Berney et al. (2007) as well as current study, reduction of green fluorescence 
density, but not the absolute absence of green signal, should be used as indicators of 
bacterial killing when BacLight kit are used to examine the viability.  This theory 
is more significant when antimicrobial agents with intracellular targets rather than 
cell-wall active mechanism are tested, i.e. ciprofloxacin.  The incomplete 
replacement could be explained by the poor effect of these antimicrobial agents on 
the membrane integrity in Staphylococcus spp. (O'Neill et al., 2004), the much 
lower fluorescent intensity of PI compared with SYTO 9 (8:300) when excited 
(Stocks, 2004), or by the presence of viable but non-culturable cells in the biofilms 
after antimicrobial exposure (Alam et al., 2007). 
 
This study found that both monolayer and multilayer biofilms of S. epidermidis 
contain persister cells, but no persistent cells were found in planktonic cultures, 
suggesting an important role of persister cells in biofilm resistance.  Finding no 
persister cells in log phase culture is in agreement with recently published studies 
(Al-Dhaheri & Douglas, 2008; Singh et al., 2009), but other studies reported the 
presence of persister cells in planktonic cultures at log phase (Keren et al., 2004b; 
Spoering & Lewis, 2001).  The contradiction could be explained by the different 
methods used to isolate persister cells.  Studies presented in Chapter 4 and by 
others have shown that exposure to antimicrobials at 8-10 X MICs for 3 h is 
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insufficient in selecting the persister cells (Al-Dhaheri & Douglas, 2008).   
 
In this study, approximate 0.01-1% of biofilm cell populations persisted the 
bacterial killing of vancomycin or oxacillin.  No persister cells were isolated from 
biofilm cell populations with the same antimicrobial agents using the method 
described in Chapter 4.  The difference could be explained by the deficiencies of 
the developed method used in Chapter 4.  As described in Chapter 4, 
pre-determined concentrations and exposure times based on time-kill curves were 
used to isolate the persister cells, however it seems incubation in fresh broth media 
with vigorous shaking under the insufficient stress of antimicrobials failed to 
stabilize the persister cells.  Suppression of persister cells from recovery by the 
antimicrobial carryover effect might also compromise the results obtained in 
Chapter 4.  The method described in Chapter 4 was further modified in this 
chapter, by omitting the vigorous shaking during incubation and using more 
stringent antimicrobial selection in an attempt to stabilize persister cells (using 
broth-recovery based biofilm MBC), and then adding resin beads into the broth 
before recovering any of the persister cells.   
 
Some studies suggested that persister cells are spore-like and smaller in size than 
normal cells (Drenkard & Ausubel, 2002; Spoering & Lewis, 2001).  However, 
SEM showed no significant differences in morphology between the persister cells 
and normal cells in this study.  S. epidermidis small colony variants are small cells 
with rough cellular surfaces; persister cells isolated by antimicrobial selection in 
this study are different from SCVs.    
 
Antimicrobial resistance of CoNS biofilms has been attributed to multiple causes. 
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(Anderson & O'Toole, 2008; Stewart, 2002)   Based on the present study, neither 
the diffusion of antimicrobials into the biofilm matrix, nor the unfavorable 
micro-environment, appeared to play a major role in the antimicrobial resistance of 
biofilms, as the monolayer biofilms and multilayer biofilms showed the similar 
antimicrobial susceptibilities.  If these factors contributed significantly to biofilm 
resistance, it would be expected that multilayer biofilms would be consistently more 
resistant than monolayer biofilms, regardless of the methodology used.  It is well 
known that persister cells play an important role in biofilm tolerance to 
antimicrobials.  In this study, despite the different number of persister cells, 
monolayer and multilayer biofilms showed a generally similar response to 
antimicrobials.  Therefore it is proposed that the presence of persister cells, rather 
than the quantity of persister cells in biofilm bacterial populations, is likely to be the 
key of the biofilm resistance.  Both monolayer and multilayer biofilms were found 
to be densely populated with bacteria.  Thus activation of high density related 
stress responses is probably another important cause of biofilm resistance.  In 
addition, as the monolayer biofilms presented high resistance to antimicrobials, 
expression of resistance genes induced by contact with a surface (adherent growth 
mode) cannot be excluded from factors causing biofilm resistance (Vandecasteele et 
al., 2003; Yao et al., 2005).  The genotypic resistance of biofilm cells was not 
considered as a major factor leading to biofilm-resistance to antimicrobials as 
planktonic culture, monolayer and multilayer biofilms all produced resistant 
mutants after exposure to rifampicin, but not to other antimicrobial agents. 
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Chapter 6: Comparison of various antimicrobial 
agents for catheter lock: preference of ethanol in 
eradication of CoNS biofilms 
 
6.1 Introduction 
 
As described in previous chapters, biofilm formation of CoNS is a major problem 
encountered in NICUs, as this specific growth modes render the bacteria highly 
resistant to multiple antimicrobial agents.  Different strategies have been 
developed to treat biofilm-related infections.  However, few successes have been 
achieved by these strategies when targeting a level of eradicating biofilm cells.  
Moreover, most strategies were studied in vitro or in animal models, and their 
efficacies have not been proven in clinical application.  This chapter aimed to 
investigate the most effective strategy which has been applied in clinical situations 
to treat biofilm-related infections. 
 
Long-term catheters are often used in hospitalized or home patients to provide 
access for special therapies, such as parenteral nutrition, cancer chemotherapy and 
haemodialysis (Ackoundou-N'guessan et al., 2006; Onland et al., 2006; Opilla et al., 
2007).  Intraluminal colonization of long-term catheters by CoNS, and subsequent 
biofilm formation on the interior surface of the catheter lumen, have been reported 
as a significant cause of catheter-related neonatal sepsis in NICUs.  Neonatal 
sepsis often resists systemic antimicrobial treatment and frequently requires 
withdrawal or replacement of the inserted catheters (Bansal et al., 2004; Maas et al., 
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1998; von Eiff et al., 2005).  Withdrawal of catheters may have some undesired 
outcomes, such as incapability to reinsert the catheter, failure to find an alternative 
insertion site, increased expense, and delay in therapy.  As removal or replacement 
of catheters is not feasible or desired, salvage of the inserted catheters has become a 
reasonable alternative.   
 
The catheter lock technique was introduced as an effective therapeutic option for 
catheter-related neonatal sepsis, in particular that caused by organisms of low 
virulence, such as CoNS and gram-negative bacteria (O'Grady et al., 2002; Raad & 
Hanna, 2002).  Application of a catheter lock aims to kill the biofilm-embedded 
bacteria and/or to remove the biofilm-related occlusion within the catheter lumen 
(Shanks et al., 2006).  This chapter principally focuses on the eradication of 
biofilm cells by catheter locks, rather than clearing the catheter occlusion.   
 
The CLT has a higher effectiveness and lower toxicity in comparison with systemic 
antimicrobial treatment.  Various antimicrobial agents have been evaluated as 
CLSs, including conventional antimicrobial agents, newly developed antimicrobials 
and disinfectants such as ethanol (Bailey et al., 2002; Opilla et al., 2007).  In the 
case of antimicrobials, conventional and newly developed agents have their 
limitations of the poor effectiveness and the unavailability respectively.  Examples 
of conventional antimicrobials that have been used for catheter lock include 
vancomycin, gentamicin, minocycline and ciprofloxacin, used as single agents or in 
combination with rifampicin (Bailey et al., 2002; Garland et al., 2005; Metcalf et 
al., 2004; Opilla et al., 2007).  Although successful salvage of catheters has been 
reported in some clinical cases, there were a number of failures, even at 
concentrations as high as 1000 times of MICs for planktonic cells 
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(Fernandez-Hidalgo et al., 2006).  Some newly developed antimicrobials such as 
taurolidine, linezolid and eperezolid, were found be more effective than the 
conventional antimicrobials (Curtin et al., 2003; Lee et al., 2006; Percival et al., 
2005; Raad et al., 2007), however, most of these agents are not used routinely in 
clinical settings or unavailable for intravenous administration (Allon, 2003; Curtin 
et al., 2003; Kite et al., 2004; Opilla et al., 2007).  In addition, it is well known 
that application of antimicrobial agents is always accompanied by other undesirable 
side-effects, including high cost, development of resistance, and vestibular toxicity. 
 
Ethanol was first used as the catheter lock solution in 1987 and has proven to be 
effective and safe in various clinical or in vivo studies (Metcalf et al., 2004; Onland 
et al., 2006; Opilla et al., 2007; Pennington & Pithie, 1987).  Ethanol is an 
antiseptic agent with broad spectrum bactericidal activity and limited side effects 
(McDonnell & Russell, 1999).  Although there is still a lack of information on the 
effectiveness of ethanol in eradication of biofilm-cells, it has been found to be 
extremely effective in the treatment of catheter-related infections, when applied as a 
catheter lock.  Moreover, unlike antimicrobial agents, there is no report of 
development of resistance to ethanol concerning medically significant bacteria.  
The main limitation of ethanol application is the catheter structural degradation.  
Degradation of the catheter biomaterial was reported when high concentration of 
ethanol (95% V/V) was used (Guenu et al., 2007).  In contrast, when exposed to < 
60-70% ethanol, no degradation of the biomaterial or impairment of the 
integrity/function of catheters was found, even with prolonged exposure (Bell et al., 
2006; Crnich et al., 2005; Guenu et al., 2007; Metcalf et al., 2004).  Another 
reported disadvantage was occlusion of the catheter lumen when ethanol was used, 
however, it only relates to the application of 100% ethanol (Laird et al., 2005). 
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Although the effectiveness of various antimicrobial agents used in catheter locks to 
prevent or to treat neonatal sepsis have be compared in numerous studies, there is 
still a lack of solid data on the most effective antimicrobial agents, their optimum 
concentrations and exposure times when applied for CLT (Bouza et al., 2007; Lee et 
al., 2006; Onland et al., 2006; Opilla et al., 2007).  Of the antimicrobial agents 
studied, most investigators selected the concentration and exposure time arbitrarily 
and there is much variation of these parameters between previous studies. The aims 
of this chapter were to evaluate different antimicrobial agents as catheter locks for 
treatment of CoNS biofilms and to determine their optimum concentration and 
exposure times.  The specific aims were to: 1) examine the effectiveness of single 
antimicrobial agents and various antimicrobial combinations as catheter lock 
solutions; 2) determine the optimum concentration and dwell time of ethanol when 
applied as catheter lock solutions; 3) establish and validate an in vitro method to 
evaluate the effectiveness of antimicrobial agents for catheter salvage. 
  
6.2 Materials and methods 
 
6.2.1 Bacterial strains and growth media 
 
Eight CoNS isolates were used in this study; two reference strains (S. epidermidis 
RP62a and Staphylococcus hominis SP2) and six invasive clinical CoNS isolates.  
The isolates were: a biofilm-positive S. epidermidis isolate 3, a biofilm-weak S. 
epidermidis isolate 4, another biofilm-positive S. epidermidis isolate 5 and three 
Staphylococcus capitis isolates which only produce biofilms under stress induced 
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by sodium chloride or ethanol (isolates 6, 8 and 9). The icaA gene was found in all 
the biofilm-positive S. epidermidis and S. capitis isolates, except the biofilm-weak 
isolate S. epidermidis isolate 4 (Bradford et al., 2006).  
  
Biofilms were developed in TSB in 96-well microplates as described in section 
2.2.2.1.  Since S. capitis only produces biofilms when stressed with salt or ethanol, 
TSB with 4% (W/V) sodium chloride was used for biofilm production of S. capitis 
isolates 6, 8 and 9. 
 
6.2.2 Antimicrobial agents 
 
Representatives of five different classes of antimicrobial agents and one disinfectant 
were chosen for the catheter lock experiments: oxacillin, gentamicin, vancomycin, 
ciprofloxacin, rifampicin and ethanol.  To compare the effectiveness of single 
antimicrobial agents in catheter lock experiments, dilutions were prepared with 
sterile saline, starting from very high concentrations used in CLT as previously 
reported (Lee et al., 2006; Mermel et al., 2001; Onland et al., 2006; Opilla et al., 
2007; Sherertz et al., 2006).  The selected high concentrations were also consistent 
with published guidelines for the management of catheter-related bloodstream 
infections (Mermel et al., 2001). The starting concentrations were 10 mg/mL for 
gentamicin and rifampicin, 5 mg/mL for oxacillin, vancomycin and ciprofloxacin 
and 80% (V/V) for ethanol.  These concentrations are defined as pharmacological 
concentrations, at which no apparent precipitation of antimicrobial powder or 
evaporation of solutions occurs.   
 
The double or triple combinations of conventional antimicrobials, were chosen 
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based on their reported effectiveness against CoNS biofilms (Saginur et al., 2006). 
Therapeutic concentrations were used for individual antimicrobials in the 
combinations that were defined by CLSI for determining resistance (Table 6. 1). 
 
6.2.3 In vitro model to predict the efficacy of catheter lock 
solutions.   
 
The efficacy of single antimicrobials, antimicrobial combinations, and ethanol 
against CoNS biofilms was examined.  Preformed 24-hour biofilms were exposed 
to different concentrations and combinations of antimicrobial agents in saline for 24 
h as follows: two hundred microliters of single agents at concentrations ranging 
from 4 µg/mL to 5 or 10 mg/mL, double or triple antimicrobial combinations at 
therapeutic concentrations (Table 6.1), or ethanol (10% to 80%), were added to the 
biofilms.  After 24 h of exposure, biofilms were washed three times with saline to 
remove the residual antimicrobial agents.  Sterile resin beads (0.2 g/well) 
(Amberlite XAD 16) were then added to minimize the chance of antimicrobial 
carryover.  Two hundred microliter volumes of TSB were then added to each well 
and microplates were incubated at 37°C for a further 48 h.  A microplate shaker 
(speed 2) was used to facilitate the multiplication and release of any live cells 
remaining in the biofilms.  After 48 h, 150 µL of the contents in each well in the 
microplate was transferred to a U-bottom microplate and examined visually for 
turbidity.  The lowest concentration of antimicrobial agent corresponding to clear 
wells was defined as the MBEC for successful use in CLT.  This method was 
defined as the broth recovery method, in contrast to the plate recovery method, 
which employs agar plates to recover live cells after treatment. 
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6.2.4 Optimum concentration and duration of ethanol 
exposure for catheter lock applications   
 
Two hundred microliters of ethanol at concentrations ranging from 10% to 80% 
were added to 24 h CoNS biofilms and allowed to remain in contact for 1 min, 15 
min, 1 h, 4 h, 8 h and 24 h respectively.  After the specified contact time, the 
MBECs of ethanol were determined as described in section 5.2.6, but without 
adding resin beads to the wells.  The ethanol-treated biofilms of RP62a and SP2 in 
the original microplate were then collected with sterile cotton-tipped swabs, and 
cultured on nutrient agar plates to detect any viable cells embedded in the biofilms, 
which could not be detected by the broth recovery method.   
 
6.2.5 CLSM   
 
S. epidermidis RP62a biofilms were grown on sterile polystyrene pieces as 
described in section 3.2.8.  The biofilm-grown pieces were then rinsed three times 
with 0.9% saline to remove planktonic bacteria.  One of the following treatments 
was applied to the S. epidermidis RP62a biofilms: a) 0.9% saline for 24 h, as a 
untreated biofilm control, b) 5 mg/mL of oxacillin for 24 h, c) 5 mg/mL of 
vancomycin for 24 h, d) 256 µg ciprofloxacin ml-1 for 24 h, e) 40% ethanol for 1 h, 
and f) 40% ethanol for 4 h.  The treated biofilms were then stained with 
LIVE/DEAD BacLight viability kit and the viability of biofilm cells were 
immediately examined by a Zeiss LSM 510 Meta confocal Laser scanning 
microscope with Zeiss Axioplan upright microscopes, as described in 3.2.8.  
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Table 6.1 Antimicrobial combinations and the test concentrations of 
individual agents 
a
 G: gentamicin; O: oxacillin; V: vancomycin; C: ciprofloxacin; R: rifampicin.   
b
 16:4: 16 µg/mL of Gentamicin + 4 µg/mL of Rifampicin 
Combinationsa Therapeutic concentrations (µg/mL) 
G:R 16:4b 
O:R 0.5:4 
V:R 32:4 
C:R 4:4 
G:O:R 16:0.5:4 
G:V:R 16:32:4 
G:C:R 16:4:4 
O:V:R 0.5:32:4 
O:C:R 0.5:4:4 
V:C:R 32:4:4 
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6.2.6 Data analysis   
 
All experiments were duplicated and repeated at least three times.  A fourth 
duplicate was performed if the results were inconsistent.  
 
6.3 Results 
 
6.3.1 Comparison of the effectiveness of antimicrobial 
agents and ethanol as catheter locks 
 
6.3.1.1 Efficacy of single antimicrobial agents against CoNS 
biofilms 
 
Ethanol was found to be the most efficient of the antimicrobial agents examined for 
eradication of the CoNS biofilms after 24 h exposure.  A low concentration (20% 
ethanol) killed all cells embedded in the biofilms after overnight exposure.   
Gentamicin, oxacillin and vancomycin, even at very high pharmacological 
concentrations (10 mg/mL, 5 mg/mL, and 5 mg/mL respectively), failed to eradicate 
the biofilm cells of most CoNS isolates.  The only exceptions were two 
gentamicin-sensitive strains S. epidermidis isolates 3 and 4, which responded to 
gentamicin.  In addition, ciprofloxacin and rifampicin did achieve biofilm killing 
of all isolates when saline was used as growth media and exposure lasted for 24 h, 
but only at relatively high concentrations (32-128 µg/mL and 256-512 µg/mL 
respectively) (Table 6.2).  
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There was no significant difference in the MBEC of single antimicrobial agents for 
strains with different biofilm-formation abilities.  For the biofilm-negative S. 
hominis strain, SP2, the concentrations of single antimicrobial agents required to 
eradicate the adherent cells were as same as that required for S. epidermidis RP62a 
biofilms; though the latter formed much thicker biofilms than the former (Table 
6.2). 
 
6.3.1.2 Efficacy of antimicrobial combinations against CoNS 
biofilm 
 
Ten combinations of either two or three antimicrobials at therapeutic concentrations 
failed to eradicate the biofilms formed by most strains, indicating a limitation of 
conventional antimicrobial combination in the salvage of catheters (Table 6.3).  
Combinations containing gentamicin were effective against biofilms of S. 
epidermidis isolate 4, unless they contained oxacillin (Table 6.3). 
 
All combinations at pharmacological concentration eradicated the CoNS biofilms; 
however all combinations contained rifampicin at the pharmacological 
concentration, which was effective alone in killing bacteria in pre-existing biofilms.   
 
 
6.3.2 Optimum concentration and duration of treatment 
of ethanol for catheter lock 
 
Biofilm cells of all isolates were killed within one minute of exposure to 60-80% 
ethanol and in one hour of exposure to 40% ethanol.  Exposure for >1h was 
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Table 6.2 Minimal biofilm eradication concentrations of single antimicrobial agents against 24 h CoNS biofilms a 
Antimicrobial agents  
Strain identity   Gentamicin 
(mg/mL) 
Oxacillin 
(mg/mL) 
Vancomycin 
(mg/mL) 
Ciprofloxacin 
( µg/mL) 
Rifampicin     
(µg/mL) 
Ethanol 
(%) 
S. epidermidis RP62a > 10 > 5 > 5 64 512 20 
S. hominis SP2 > 10 5 > 5 32 512 20 
S. epidermidis isolate 3 0.128 > 5 > 5 64 512 20 
S. epidermidis isolate 4 0.008 > 5 > 5 128 256 20 
S. epidermidis isolate 5 > 10 > 5 > 5 128 512 20 
S. capitis isolate 6 > 10 > 5 5 64 512 20 
S. capitis isolate 8 > 10 > 5 5 128 512 20 
S. capitis isolate 9 > 10 > 5 5 64 512 20 
a Values are geometric means of at least 3 duplicates and variation between 3 duplicates was less than 4-fold in all instances. 
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Table 6. 3. Regrowth of biofilm bacteria after exposure to double and triple combinations of antimicrobials at therapeutic concentrationsa 
Strain identity  R:G b R:V R:O R:C R:G:O R:G:V R:G:C R:O:V R:O:C R:V:C 
S. epidermidis RP62a  + c + + + + + + + + + 
S. hominis SP2 + + + + + + + + + + 
S. epidermidis isolate 3 + + + + + + + + + + 
S. epidermidis isolate 4 - + + + + - - + + + 
S. epidermidis isolate 5 + + + + + + + + + + 
S. capitis isolate 6 + + + + + + + + + + 
S. capitis isolate 8 + + + + + + + + + + 
S. capitis isolate 9 + + + + + + + + + + 
a
 Results were obtained by the broth recovery method.  Therapeutic concentrations of individual antimicrobials refer to Table 1.  
b
 R: rifampicin; G: gentamicin; V: vancomycin; O: oxacillin; C: ciprofloxacin.  
c +: Regrowth; -: No regrowth
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required only for 20% ethanol and no further advantage was achieved by increasing 
the dwell time beyond 4 h (Fig. 1). 
 
Good correlations were found between the qualitative determinations of presence of 
living cells by two recovery methods: the recovery method using 48 h incubation 
with TSB under shaking and inoculating the biofilms on nutrient agar plates after 
regrowing the biofilm in TBS for 48 h (Table 6.4).  
 
 
6.3.3 CLSM 
 
The CLSM study revealed exposure to 40% ethanol for 1-4 h, or 256 µg ml-1 of 
ciprofloxacin for 24 h was most efficient in biofilm cell killing (Fig. 6. 2 d, e & f).  
Exposure to the first line conventional antimicrobials, such as oxacillin and 
vancomycin at very high concentrations, did not kill all biofilm cells (Fig. 6. 2, b & 
c). 
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Table 6.4 Exposure of biofilms to ethanol: comparison of the MBECs obtained by two recovery methods 
 MBECs for S. epidermidis RP62a 
(% ethanol) 
MBECs for S. hominis SP2 
(% ethanol) 
Exposure time 1 m 15 m 1 h 4 h 8 h 24 h 1 m 15 m 1 h 4 h 8 h 24 h 
Broth recovery a 60% 30% 30% 20% 20% 20% 50% 30% 20% 20% 10% 10% 
Agar recovery b 60% 30% 30% 20% 20% 20% 50% 30% 20% 20% 10% 10% 
a Broth recovery method used in this study.  After biofilms were treated with antimicrobial agents, they were incubated with TSB with  
shaking for 48 h, and the turbidity of solutions represents the presence of living cells.  
b
 Agar recovery method used by published studies. After biofilms were treated with antimicrobial agents, they were incubated with  
TSB for 48 h, and then biofilms were inoculated onto NA for viable counts. 
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Fig. 6.1 Concentrations and exposure times of ethanol required to kill all CoNS residing in biofilms.   
Experiments were repeated in duplicate three times and the data were identical.
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Fig. 6.2 Biofilms of S. epidermidis RP62a treated with antimicrobial agents.  
Antimicrobial agent treated biofilms stained with Syto-9 (brightly green for live cells) and popidium iodide  
(red or orange, or loss of bright green for dead cells). 
 
 
 
(a) Untreated control (b) 5 mg/mL oxacillin x 24 h (c) 5 mg/mL vancomycin x 24 h 
 
 
 
(d) 256 µg/mL ciprofloxacin x 24 h (e) 40% ethanol X 1 h (f) 40% ethanol X 4 h 
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6.4 Discussion 
 
Conventional antimicrobial agents commonly used in NICU were found to have 
low effectiveness in completely killing biofilm cells, even at pharmacological 
concentrations, indicating unsuitability of these conventional antimicrobial agents 
as catheter locks.  This was supported by the frequently encountered failures of 
applying vancomycin, oxacillin, gentamicin in clinical situations to treat catheter 
related sepsis (Bailey et al., 2002; Fernandez-Hidalgo et al., 2006; Guedon et al., 
2002; Shanks et al., 2006; Sherertz et al., 2006).  Not surprisingly, rifampicin was 
found an effective agent as catheter lock when its concentration reached a certain 
high level.  This bactericidal antimicrobial agent was reported effective in 
eradication of biofilms, being superior to most of the other agents (Sherertz et al., 
2006).  However, the high potency of rifampicin in biofilm-killing is compromised 
by the ease of inducing resistance in bacterial populations (Dunne et al., 1993).  
Among the five conventional antimicrobials tested, ciprofloxacin seemed to be the 
most effective one in sterilizing CoNS biofilms; at concentrations of 64-128 µg/mL, 
this antimicrobial agent could completely kill the biofilm-embedded cells.  The 
findings in this study were consistent with a recent study by Lee et al. (2006), in 
which ciprofloxacin and rifampicin were found to achieve a complete eradication of 
staphylococcal biofilms after a short-term treatment, however, vancomycin and 
gentamicin were of much lower effectiveness, even at very high concentrations (Lee 
et al., 2006).  Although there were differences in the detailed MBEC values 
between the present study and the study by Lee et al. (2006), the differences might 
be explained by the different solvents used for testing media and/or by different 
biofilm models.  Sterile saline was used in the present study to mimic the clinical 
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situation, while TSB, a rich medium for bacterial growth, was used in the study by 
Lee et al.  Moreover, in contrast to 24 h biofilm growth in the present study, 
five-day incubation for biofilm formation was used by Lee et al. (2006), which was 
expected to lead to a more mature and resistant biofilm structure. 
 
Combinations of conventional antimicrobials at therapeutic concentrations were not 
effective in complete killing of CoNS embedded in biofilms.  Combinations at the 
pharmacological concentrations were able to eradicate the biofilm cells, but this 
effect could be explained by the sole effect of rifampicin at a high concentration.  
Although vancomycin combined with rifampicin were suggested in the treatment 
against S. epidermidis biofilms (Curtin et al., 2003; Monzon et al., 2002; Polonio et 
al., 2001), this antimicrobial combination was ineffective at a therapeutic 
concentration in the present study.  
 
Beside the low effectiveness of conventional antimicrobial agents, the risk of 
resistance development, high cost of antimicrobial usage, fear of accidental infusion 
of highly concentrated solutions into blood circulation during the lock procedure 
and their related toxicity, cannot be ignored. 
 
Using ethanol as an alternative to conventional antimicrobial agents for catheter 
locks has been suggested to be superior to the use of single antimicrobials and 
antimicrobial combinations, but, no detailed data was presented in their studies 
(Sherertz et al., 2006).   
 
Exposure to 40% ethanol for 1 h, was sufficient to eradicate the biofilm cells and 
could be chosen as an optimum concentration in catheter related sepsis treatment.  
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However, the in vitro observation described in this chapter would need to be 
followed up with clinical studies.  The rationale of concentration choice suggested 
by this study was based on the following aspects: 1) 100% of ethanol might cause 
catheter occlusion (Laird et al., 2005), 95% ethanol was reported to lead to a 
degradation of the catheter biomaterial, and even 75% ethanol has been reported to 
be related to a series of patient side effects (Opilla et al., 2007); a concentration of 
lower than 60% was considered as a suitable concentration as no side-effects have 
been reported; 2) conversely, too low a concentration of ethanol also caries the risk 
of ineffectiveness in biofilm killing, if the exposure is not long enough, and on the 
basis of previous in vitro, animal, and clinical studies, it was suggested that the 
ethanol lock, at a concentration of at least 40%, with a dwell time of 4 h ensures its 
effectiveness (Poole et al., 2004; Shah et al., 2002; Sissons et al., 1996); 3) the 
compatibility of ethanol at certain concentrations with anticoagulant agents should 
also be taken into account.  The ideal catheter lock solution was suggested to 
contain both antimicrobial agents and anticoagulant agents (Allon, 2003), targeting 
two complications associated with catheter application: bacteraemia and thrombosis.  
Twenty-five to sixty percent ethanol have been found to be well compatible with 
heparin and EDTA (Ackoundou-N'guessan et al., 2006; Raad et al., 2007).  With 
regards to exposure time, different dwell time has been examined by researchers 
and 24 h was preferable to clinicians.  However, such a long term may not be 
possible for patients requiring additional therapies.  In addition, long term 
exposure may be accompanied by potential risks, such as spill-out of the ethanol 
into the blood circulation, its associated toxicity and the potential of resistance 
development (Ackoundou-N'guessan, Heng et al. 2006). 
 
The superiority of ethanol over conventional antimicrobials can be explained by its 
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hydrophilic nature and small size which enable it to obtain access to deep biofilm 
cells, since the biofilm matrix is highly hydrated.  This is in contrast to other 
antimicrobial agents that may have restricted diffusion gradients through the 
biofilms matrix.  Although it has been suggested that 1-2 mm thick biofilms might 
have a diffusion delay for ethanol to pass through the dense biofilm structure, no 
solid evidence has been presented (Sissons et al., 1996).  In addition, since ethanol 
has extremely high bactericidal activity against planktonic cells, it could also be 
effective in killing the “less active” cells in biofilms, i.e. the cells presenting 
biofilm-specific genes or the more tolerant “persister” cells. 
 
Interestingly, there were no significant differences found in the present study in the 
MBECs of single antimicrobial agents for strains with different biofilm-forming 
abilities.  The concentrations of these agents required to eradicate the adherent 
cells of the biofilm-negative S. hominis SP2 were the same as those required for S. 
epidermidis RP62a biofilms; though the latter formed much thicker biofilms than 
the former.  Although classified as a biofilm-negative strain, SP2 does form an 
adherent monolayer on various biomaterials (Christensen et al., 1985).  It is 
therefore likely that the biofilm-mode of growth, rather than the ability to form 
biofilm, leads to its resistance to antimicrobial agents.  This finding, together with 
that from Chapters 3, supports the conclusion of Chapter 5, which is that highly 
densely adherent growth mode, rather EPS build-up ability, contributes to the 
antimicrobial resistance of biofilms.  Similar results were also found in a recent 
study, in which a biofilm-negative mutant strain, M187sn3, had at least the same or 
an even higher resistance level to most antimicrobial locks as its biofilm-positive 
ancestor (Edmiston et al., 2006).  
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Currently there is no universally accepted in vitro model of catheter-related biofilm 
infection.  The model of biofilm formation and antimicrobial treatment used in this 
study was intended to replicate the clinical situation as closely as possible.  
Biofilm development and treatment were carried out under static condition and 
antimicrobial agents were prepared in 0.9% saline.  However, the biofilm model 
does differ from clinical biofilms.  Polystyrene was used as the biofilm platform, 
whereas catheters are mostly manufactured from polyurethane and Teflon.  In 
addition, biofilms were prepared with inocula of 107 CFU/mL, in contrast to the 
clinical situation, where catheters are generally seeded with bacteria at densities of 
50-600 CFU/mL (Shah et al., 2002).  Polystyrene was chosen because it is 
commonly available in microbiology laboratories and has been widely used for 
biofilm studies.  The initial inoculum of 107 CFU/mL  was used in this study as 
this density has been accepted as a standard inoculum for in vitro biofilm formation 
(Deighton et al., 2001).
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Chapter 7: Final discussion 
 
This study was initially designed in relation to two clinical problems encountered at 
the RCH, Melbourne, which are: i) CoNS biofilms have been frequently found on 
the implanted CVCs in sick newborns; ii) despite the application of first line 
antimicrobial agents, failure of treatment of neonatal sepsis was frequently reported.  
The study was composed of three portions; examining antimicrobial resistance of 
biofilms formed by clinical CoNS strains, investigating mechanisms leading to 
biofilm resistance, and determining the most effective method to eradicate CoNS 
biofilms.  
 
Antimicrobial agents commonly used to treat CoNS sepsis in neonates (gentamicin, 
penicillin G, oxacillin, vancomycin) as well as two agents that are active against 
resistant staphylococci (ciprofloxacin, rifampicin) were assessed.  This study 
revealed that clinical CoNS isolates are resistant to half of these test agents (i.e. 
penicillin G, gentamicin, and oxacillin).   More significantly, high resistance to 
antimicrobial agents developed when CoNS experienced different biofilm forming 
stages, from planktonic cells at log phase/adherent monolayer to mature 
biofilms/planktonic cells at stationary phase.  This study showed that enhanced 
resistance of biofilm-grown bacteria is likely to contribute to treatment failure.  
Enhancement of CoNS biofilms by oxacillin at clinically achievable concentrations 
could also contribute to treatment failure. 
 
Regarding the mechanisms of biofilm resistance to multiple antimicrobial agents, 
more tolerant-but-killable cells were isolated from biofilms than log planktonic 
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culture containing equivalent cell numbers.  Tolerant cells responded more slowly 
to antimicrobials, but could be eventually eradicated if exposed to a sufficiently 
high level of agent for a long enough time.   Persister cells were also isolated from 
biofilm cell population, but not from planktonic populations, when stringent 
conditions were used (Chapter 5).  Persister cells differed from tolerant cells as 
they were invulnerable to antimicrobial agents.  Both tolerant-but-killable cells 
and persister cells apparently play an important role in biofilm resistance.  
 
Findings from Chapter 3 suggested that both “biofilm-negative” and 
“biofilm-positive” CoNS strains demonstrated similar responses to antimicrobial 
agents when their growth modes changed.  This suggests that the densely adherent 
growth mode might be a determinant in biofilm resistance.  To examine this 
hypothesis, the biofilm MICs, biofilm MBCs obtained by viable counting or broth 
recovery, and MBECs were compared for multilayer biofilms formed by 
“biofilm-positive” S. epidermidis strains and monolayer biofilms formed by their 
“biofilm-negative” mutants/variants.  Monolayer and multilayer biofilms generally 
presented similar susceptibilities to multiple antimicrobial agents.  Both 
monolayer and multilayer biofilms had very high bacterial densities of ~ 1011-12 
CFU/mL, supporting the hypothesis that the adherent growth mode, rather than the 
ability to build up a typical multilayer biofilm structure, contributes to the high 
resistance of biofilms to antimicrobial agents.   
 
The last section of this study was to find an effective solution to the treatment of 
biofilm associated infections.  Ethanol was found to be superior as a catheter lock 
solution to conventional antimicrobial agents.  A time-kill study with ethanol 
revealed that exposure to 40% ethanol for 1 h would be sufficient to eradicate 
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biofilm-grown CoNS.  This in vitro study provided solid evidence to support the 
rationale of using ethanol, instead of conventional antimicrobial agents as catheter 
lock solutions against CoNS biofilms. 
 
One possible limitation of the experimental design in this study is the selection of 
antimicrobial agents.  Most of the CoNS isolates examined in this study were 
classified as resistant to three of the antimicrobial choices, using conventional 
methodology.  As expected most CoNS were even more resistant against these 
antimicrobials under biofilm conditions of growth.  Although these agents would 
not be used clinically to treat resistant CoNS infections, the aim of this study was to 
determine whether enhanced resistance of biofilm-grown bacteria contributes to 
treatment failure.  In addition, the selected agents for this study are the first-line 
antimicrobials used in RCH NICU.  It would be very interesting to examine some 
CoNS-susceptible agents such as linezolid, fusidic acid, daptomycin, fosfomycin or 
tigecyclin for their ability to kill CoNS in different growth modes using the 
methodology developed in this study. 
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Appendix A 
 
List of chemicals, reagents, growth media, commercial kits, consumables,  
and equipments 
 
Chemicals Manufacturers 
Acetone Merck Pty. Ltd., Kilsyth, Australia 
Ammonium oxalate Molekula Pty. Ltd., Gillingham, UK 
Ciprofloxacin Sigma-Aldrich, Castle Hill, Australia 
Crystal violet powder Sigma, St. Louis, USA 
Ethanol (ethyl alcohol; AnalaR) Merck Pty. Ltd., Kilsyth, Australia 
Gentamicin sulfate Sigma-Aldrich, Castle Hill, Australia 
Glucose BDH chemicals Ltd., Poole, UK 
Glycerol AMRESCO Inc., Solon, USA 
Oxacillin sodium salt: monohydrate Sigma-Aldrich, Castle Hill, Australia 
Penicillin G CSL Biotherapies, Parkville, Australia 
Phosphate buffered saline tablet OXOID Ltd., Hampshire, UK 
Rifampicin Sigma-Aldrich, Castle Hill, Australia 
Sodium chloride Merck Pty. Ltd, Kilsyth, Australia 
Sodium hydroxide pellets BDH chemicals Ltd., Poole, UK 
Vancomycin HCL Sigma-Aldrich, Castle Hill, Australia 
Hydrochloric acid 32% Merck Pty. Ltd., Kilsyth, Australia 
 
Reagent/Growth media Manufacturers 
Muller-Hinton broth OXOID Ltd., Hampshire, UK 
Nutrient agar OXOID Ltd., Hampshire, UK 
Tryptone soya broth OXOID Ltd., Hampshire, UK 
 
Commercial Kits Manufacturers 
Live/Dead BacLight bacterial viability kit Molecular Probes Inc., Eugene, OR 
Alexa Fluor 555 conjugated wheat germ  
agglutinin 
 
Molecular Probes Inc., Eugene, OR 
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Equipments and Consumables Manufacturers 
  
Amberlite XAD 16 Sigma-Aldrich, Castle Hill, Australia 
AND weighing balance Bradford, MA, USA. 
Beckman coulter allegra 21R refrigerated centrifuge Beckman Coulter Pty. Ltd, Gladesville, 
Australia 
Biological safety cabinet class II Gelman Sciences Australia 
Branson 450 Sonifier Branson Ultrasonics Co, Danbury, USA 
Centrifuge Sigma Laboratory 3K15 Sigma Chemical Co., St Louis, USA. 
Cotton-tipped swab Medical Wire & Equipment Co. Ltd,  
Corsham, England 
Dynatech spectrophotometer MR7000 Dynatech Laboratories, Chantilly, USA. 
ELISA plate reader, Wallac VICTOR 3 PerkinElmer, Waltham, USA 
Eppendorf tubes (1.5 M) Sarstedt, Postfach, Germany 
Filter, 0.2 µm syringe filter “Acrodisc” Gelman Science, Ann Arbor, MI, USA 
Filter, 0.45 µm syringe filter “Acrodisc” Gelman Science, Ann Arbor, MI, USA 
Filter, 1.2 µm syringe filter “Acrodisc” Pall Corporation, New York, USA 
Finnpipette single channel digital pipettes  Thermo Electron Co., Vantaa, Finland 
Finnpipettes multichannel digital pipette (50-300 µL)Thermo Electron Co., Vantaa, Finland 
Finntip (5 mL) Thermo Electron Co., Vantaa, Finland 
Magnetron sputter coater Dynavac, SC100M, Australia 
Mettler AE 200 balance Toledo, Ohio, USA 
Microcentrifuge (5415C) Eppendorf, Hamburg, Germany 
Microplates, 96-well, tissue culture treated Iwaki, Tokyo, Japan 
Microscope slide Sail Brand, Shanghai, China 
Nikon Diaphot inverted fluorescence microscope Nikon, Tokyo, Japan 
Nikon Eclipse Ti inverted microscope equipped with 
Nikon A1R Fast Laser Scanning Confocal system 
 
Nikon Instrument Inc. Melville, USA 
Olympus 1x51phase-contrast microscope   Olympus Optical Co., Melville, USA 
Parafilm® American National Can, Chicago, USA. 
Petri dishes (90 mm) Techno-Plas, Dandenong South, Australia 
Pipette tips (universal) Greiner Bio-one, Monroe, USA 
pH reader, HANNA instruments, Woonsocket, USA 
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PP-test tubes, 50 mL, sterile Cellstar® Greiner Bio-one, Monroe, USA 
Scanning electron microscope (XL30, Philips) Industrial Equipment and Control Pty, Ltd, 
Australia 
Smoothflow fume cupboard E&I levis Plastics Pty, Ltd, Australia 
Terumo® Syringe 5cc/mL and 10 cc/mL Terumo Co., Binan, Philippines 
Titreteck microplate shaker Flow laboratories Ltd, Germany 
Vortex-2 Genie Scientific Industries Inc., Bohemia, USA 
Zeiss LSM 510 meta with Zeiss Axioplan upright  
microscopes 
Leica Microsystems, Richmond Hill, ON, 
Canada 
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Appendix B 
 
General solutions and growth media 
 
Antimicrobial stock solutions 
Antimicrobial stock solutions were prepared by dissolving antimicrobial powders 
into neutral distilled water (for penicillin, oxacillin, gentamicin, and vancomycin), 
acidic distilled water (PH 2-3 for ciprofloxacin) and acetone (for rifampicin).  
After the antimicrobial powders were completely dissolved, solutions were filtered 
with 0.2 µm syringe filters.  The sterile antimicrobial solutions were then aliquoted 
into 1.5 mL Eppendorf tubes and then stored at -20°C for long term use.   
 
Muller-Hinton Broth  
Twenty-one grams of MHB powder was added into 1 litre of distilled water, 
properly mixed with a magnetic stirrer, and then transferred into 100 mL glass 
bottles.  The medium was then autoclaved at 121°C for 15 min and stored in a 4°C 
refrigerator until use.  
 
Nutrient Agar Plates 
Twenty-eight grams of NA powder was added to 1 L of distilled water, properly 
mixed with a magnetic stirrer, and autoclaved for 15 min at 121°C.  The media 
was then poured into 90 mm Petri dishes and allowed to set in the fume hood.  The 
NA plates were stored in a 4°C refrigerator until use. 
 
Phosphate Buffered Saline  
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One tablet was dissolved in 100 mL distilled water.  The solution was then 
adjusted to PH 7.3 and autoclaved at 121°C for 10 min. 
 
Tryptone Soya Broth  
Fifteen grams of TSB powder was added into 500 mL distilled water, properly 
mixed with a magnetic stirrer, and then transferred into 100 mL glass bottles.  The 
media was then autoclaved for 15 min at 121°C and stored in a 4°C refrigerator 
until used.  
 
4% Sodium Chloride TSB 
Fifteen grams of TSB powder and 20 g of sodium chloride were added into 500 mL 
distilled water, properly mixed with a magnetic stirrer, and then transferred into 100 
mL glass bottles.  The media was then autoclaved for 15 min at 121°C and stored 
in a 4°C refrigerator until use. 
 
Hucker Crystal Violet 
Eight grams of crystal violet powder were added into 80 mL of absolute alcohol, 
and 3.2 g of ammonium oxalate was dissolved into 320 mL of distilled water.  
These two solutions were then properly mixed, filtered with a 0.45 µm syringe filter 
and stored at room temperature until use. 
 
